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of urinary steroids in cases of congenital adrenal 
hyperplasia. While principally to assist in their 
management, the investigation was extended to urinary 
aldosterone and 17-oxosteroid studies. In the children 
of small stature, the metabolism of hydrocortisone has 
been assessed by the estimation of the urinary metabolites 
of this compound. I'rom the findings, hepatic reductase 
activity and 11-oxidation of hydro cortisone have been 
deduced. In Chapter 4 there is a critical analysis of 
the value of urinary aldosterone estimation in infancy 
and /
and childhood.
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Birmingham) did the assays of growth hormone.
Technical assistance for parts of this work was given by 
Mr. Thomas Moodie and Mr. Harry Boyle. The clinical 
photographs were reproduced by Mr. Joseph Devlin. 
Acknowledgments /
Acknowledgments for technical contributions from others 
are made in the text.
The line drawings and graphs may lack an artist's 
touch, but to make this work a more personal achievement, 
they are my own doing.
Parts of this thesis have been published under the 
following titles.
'Pour clinical variants of congenital adrenal 
hyperplasia'. Archives of Disease in Childhood 196^^ 39*66
Aldosterone and 17-hydroxycorticosteroid excretion 
following Ramstedt's operation.
Archives of Disease in Childhood, 1965» 40, 261.
Finally I wish to express sincere thanks to 
Professor J.H. Hutchison for his constant encouragement 
during these research activities and for his stimulus 
in the writing of this work.
Part of this research has been supported by the 
Rankin Fund of the University of Glasgow.
NOMENCLATURE
After .the announcement of the total synthesis of 
cortisone by Sarett (1946) the number of published 
papers on all aspects of steroids, new synthetic 
pathways, optical rotations, clinical uses, steroid 
analogues, etc., increased rapidly.
It became necessary, not only for convenience but 
for mutual understanding, that a standard steroid 
nomenclature should be accepted* This was achieved at 
a conference held at the Giba Foundation, London, in 
1950, and was approved by the international Union of 
Pure and Applied Chemistry (1951)#
Since this work is an application of steroid 
chemical analyses to essentially clinical problems, I 
shall use trivial names wherever possible for ease of 
writing and reading. I prefer the terms corticotrophin 
instead of adrenocorticotrophin and 17-oxosteroid instead 
of 17-ketosteroid. The tetrahydro- prefixing a compound
indicates reduction of the double bond in ring A and 
this is characteristic of the urinary metabolites of 
adrenocorticosteroids.
The following trivial names are used;- 
Trivial /
Trivial Name 
Adrenosterone 
Etiocholanolone 
Aldosterone
Androstanedione 
Androstenedione 
C orticosterone
Cortisone
11-Dehydrocorticosterone
Dehydroepiandrosterone 
Desoxycorticosterone 
Hydrocortisone
18-Hydroxycorticosterone
17a-Hydroxy-ll"deoxycorti-
costerone
18-Eydroxy-ll-deoxycorti"- 
c osterone
17a-Hydroxyprogesterone 
21“Hydroxypregnenolone 
Pregnanetriol /
Systematic Name 
Andro8t-4-ene-3:11:17-trione. 
3cL-Hydroxy-5p-androstane-17-one. 
llp: 21-Diiiydroxy-3: 20-dioxopregne 
4—en—18—al#
5a-Androstane-3:17-dione. 
Androst-4-ene-3:17-dione. 
llp:21-Dihydroxypregn-4-ene 
3:20-dione.
17a:21-Dihydroxypregn-4“ene 
3:11:20-trione•
21-Hydroxypregn-4-ene-3:11:20-
trione .
3p-Hydroxyandrost“5-en-17-one. 
21-Hydroxypregn-4-ene-3:20-dione 
11(3:17a: 21-Trihydroxypregn-4-ene- 
3:20-dione.
llp: 18:21-Trihydroxypregn-4-ene- 
3:20:dione.
17a;21-Dyhydroxypregn-4-ene- 
3:20:dione.
18:21-Dihydroxypregn-4-ene-3:20- 
dione •
17a-Hydroxypregn-4-ene-3:20-dion 
3p:21-Dihydroxypregn-5-ene-20-on
Pregnanetriol 
Pregnenetriol 
Progesterone 
Testosterone 
Tetrahydrocorticosterone
Tetrahydrocortisone
Tetrahydrocortisol
Allo-Tetrahydrocortisol
Betamethasone
Dexamethasone
Fludrocortisone
Triamcinolone
5p-Pregnane-3Cl: 17a: 20a-triol.
3P: 17a:20-Trihydroxypregn-5-ene 
Pregn-4-ene-3:20-dione. 
17P“Hydroxyandrost“4“en™3-one. 
3a:llp:21-Trihydroxy-5P“Pregnan- 
20-one.
3a:17a:21-Trihydroxy-5P-pregnan 
11:20-dione.
3a:lip ; 17a:21-Tetrahydroxy-5p- 
pregnan-20-one.
3a:lip : 17a:21-Tetrahydroxy-5a- 
pregnan-20-one.
9a-Fluoro-16p-methyl-lip: 17a:21 
trihydroxy-pregna-1:4-diene- 
3:20-dione.
9a-Fluoro-16a-methyl-llp; 17 a:21 
trihydroxy-pregna-1:4-diene- 
3:20-dione.
9a-Fluoro-llp: 17a:21-Trihydroxy 
pregn-4-ene-3:20-dione. 
9a-Fluoro-llp:16a:17a:20-tetra- 
hydroxypregna-1:4-diene-3:20- 
dione .
Prednisolone /
Prednisolone lip : 17a:21-Trihydroxypregna-
1:4-diene-3:20-dione.
Prednisone 17a:21-Dihydroxypregna-1:4-diene
3:11:20-trione.
INTRODUCTION
A review of the literature relating to 
adrenocortical 
physiology and pathology.
Leonard Williams, in his Foreword to Biedl’s hook 
'The Internal Secre bory Organs' (1012) says that 'the subject 
of the internal secretions is one which is destined to 
occupy the attention both of the physiologist and clinician 
for a long time to come. The study of the internal 
secretions has already illuminated myxoedema, acromegaly, 
Addison's disease and some others, and the promise which 
it holds is as enticing and fascinating as its pursuit is 
baffling. ' Leonard Llewelyn Bulkeley Williams, M.I)., Glasg., 
clinician, linguist and authur, died on August 20, 1939 at 
the age of 77 and he might have been gratified by the truth 
of his prophecy were he, in the even of his life familiar 
with the effort of Levy-Simpson (1930 and 1938) who by 
then was treating cases of Addison's disease with 
adrenocortical extract and synthetic desoxycorticosterone 
acetate.
The first accounts however of experiments on animal
(rabbits, dogs and cats) survival after extirpation of the
adrenal capsules were published in 1856 by Brown-Seguard.
He concluded, 'Des experiences extrêmement nombreuses que
j'ai faites depuis plus de huit mois concernant ces organes,
m'ont conduit a cette conclusion que la fonction des capsules
surrénales est non-seulement essentielle a la vie, mais
l'une des plus importantes de l'économie'. Harley (I856, 
1857 and 1858) refuted Brown-Sequard's conclusion by 
showing /
showing that his rats lived for weeks or months after 
extirpation of the suprarenals without showing pathological 
signs of suppressed suprarenal function.
This controversy continued over the next twenty years 
or so and was to some extent perpetuated by the work of 
Nothnagel (1Ô79)* He attempted to produce in animals, 
suprarenal lesions which would result in the clinical 
complex of Addison's disease as seen in man. His failure 
to effect total extirpation of suprarenal tissue obscured 
the true importance of the glands.
Stilling (1890) working on rabbits showed tha.t after 
extirpation of one suprarenal, the remaining one underwent 
compensatory hypertrophy and that after bilateral extirpation, 
remnant suprarenal tissue, impossible to remove, by 
hypertrophy became as la.rge as a normal suprarenal. Also 
in 2 out of 40 rabbits he found accessory suprarenale which 
underwent hypertrophy after extirpation of the normal glands. 
The hypertrophied tissue had a histological structure resembli 
cortical substance and was void of medullary elements. He 
was also first to describe cellular masses in the ganglia 
of the abdominal sympathetic and in the intercarotid ganglion 
with a structure similar to the suprarenal medulla. Basing 
his argument on these two findings he explained the failure 
to produce Addison's disease in animals. Nothnagel (1879) 
had not appreciated this possibility.
Abelous and Langlois (I89I) removed one suprarenal 
from /
3 -
from frogs and found that this did not result in death 
while destruction of both invariably did so. Their 
experiments with partial adrenal destruction indicated 
that at least one quarter of each gland was required to 
maintain life in the frogs. These findings were confirmed 
by similar experiments on guinea pigs and rabbits. Later 
in 1897 Langlois published his findings in dogs and showed 
that total extirpation resulted in death within 40 to 
52 hours.
Hultgren and Andersson (I898) considered the problem 
of how much suprarenal tissue was required to maintain life.
In cats, extirpation of one suprarenal with partial 
destruction of the other resulted only in transient emaciation 
but removal of both suprarenale was followed by death within 
68 hours, Strehl and Weiss (1901) working with nine species 
involving 114 animals came to the conclusion that all animals 
die after removal of both suprarenals.
By the turn of the century the evidence from the early 
experiments led to the following conclusions.
1. Signs of suprarenal suppression do not follow the 
removal of one suprarenal. The remaining organ invariably 
undergoes hyperplasia and this hyperplasia is shared by 
any accessory suprarenal cortical tissue which may be present. 
2. Death follows extirpation of both suprarenals within 
a very short time - a few hours to a few days and is not 
due to the operation or subsequent infection but to 
suppression /
suppression of suprarenal function. 3* When the suprarenals 
are removed separately, the interval between each operation 
being days or weeks, life is prolonged beyond the expectancy 
of that when both glands are removed at once. This is due 
to compensatory hypertrophy in the interval of the remaining 
gland and any accessory suprarenal tissue present. The 
final attempt by the accessory tissue alone to maintain 
life is necessarily insufficient. 4. If survival follows
extirpation of both suprarenals, then it is due to the 
presence of accessory suprarenal tissue. 5. Partial 
removal of both suprarenals may be borne without sequelae 
but this depends on the amount of tissue left.
It is clear from the literature that during the first 
decade of the twentieth century many workers were engaged 
in repeating the early animal experiments, the results of 
which had excited so great an interest. The volume of 
published work on suprarenal physiology increased rapidly 
from 1914 to 1939.
To Elliot (1914) must be attributed the first detailed 
description of the nature of death following excision of the 
adrenal glands. (From this time onwards the word 'adrenal* 
replaced suprarenal). His work was on cats and after 
excision of the glands all the cats lost weight but only 
partly due to loss of appetite. There was no relish in 
eating. The approach of death was heralded by 
characteristic /
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characteristic weakness, the animals being bothered by the 
difficulty of standing'. Soon they lay down, chest and 
belly on the ground and shortly fell on to their sides, 
limbs, legs and tail fully extended - an attitude of sheer 
weakness. Emotionally there was no annoyance, the eyeballs 
lost their tension mid became soft, the blood pressure fell 
as did also the rectal temperature to 85^1 before death ensued. 
Alarm would rouse them to co-ordinated and fairly strong 
muscular movements indicating that there was no paralysis 
of the skeletal muscles or their nerves.
The way in vhLch Elliot conducted his experiments led 
him to conclude that life depended either on a continual 
slow excretion from the adrenal medullary cells or on some 
activity of the cortical tissues. He favoured the second 
possibly because he observed that accessory glands which 
hypertrophied after removal of the adrenals were composed 
almost entirely of cortical cells.
The next advance in the understanding of adrenal
physiology came from the work of Rogoff and Stewart, In
a series of papers (1926a,b; 1927a,b; 1928a,b,c,d) on
well-planned experiments, they confirmed that removal of
both adrenals from dogs resulted in death and went on to
show that death could be delayed by the intravenous
administration of Ringer's solution. Af b e r total
adrenalectomy the blood urea and serum calcium rose and the 
specific gravity of the blood increased. Heat and pregnancy 
in /
—  6
in operated bitches tended to prolong life. But their 
main contribution was their proof that a substance could be 
extracted from the adrenal cortex of dogs and sheep which 
prolonged life in dogs after total adrenalectomy. It is 
not to be thought however that Rogoff and Stewart scored 
firsts but rather that they put to scientific testing much 
of the earlier statements and theories. After all, Marshall 
and Davis (1916) had shown a rise in blood urea in cats 
following complete removal of the adrenals and Vulpain and 
Gloez (1857) had been interested in extracts from the adrenal 
glands from which they isolated among other things taurocholic 
acid. So early in 'steroid' chemistry this finding in 
adrenal extracts of a lipophilic hydrocarbon foreshadowed 
a greater truth.
Hartman and Hartman (1928) with various colleagues were 
undoubtedly the first to publish in detail a method for 
extraction of the active substance from the adrenal cortex. 
They used beef adrenals which had been chilled immediately 
after removal. From their preparation they first removed 
epinephrine and then by salting out with sodium chloride 
they obtained a substance which when injected prolonged the 
life of adrenalectomised cats. They proposed th^ Tt this 
substance be named Oortin. The adrenals thereby attained 
endocrine status.
Heretofore in the adrenal field the facts had been 
established /
-  7 "
established by physiologists hut from the partnership of 
Swingle and Pfiffner, (1930, 1934) an amalgam of physiologist 
and biochemist came the next advance. They succeeded in 
preparing an aqueous extract from beef adrenals which had 
physiological activity when administered suhcutaneously 
to cats. Their cats lived in excellent health for more 
than 80 days. Further, their experiments indicated that 
the hormone was not stored in the body but metabolised and 
excreted. During the next two years Pfiffner in conjunction 
with Wintersteiner (Pfiffner and Wintersteiner 1935, 
Wintersteiner and Pfiffner 1935, 1936) showed that the 
active fraction in alcohol absorbed ultra-violet light 
maximally at 236 mp. indicating that the substance possessed 
in its molecule an pup-unsaturated ketone. The active fractio 
they found, could be rendered inactive by treatment with 
benzoyl chloride in pyridine indicating further the 
presence of acylable hydroxyl groupings. Elementary 
analysis and molecular weight determination spoke to a 
composition 0^ or Gg]^  0^. They also extracted
several inactive compounds A, B, G, D, E, F, G.
In the Mayo Clinic, starting about 1930, Mason, Myers 
and Kendall (1936a and b) succeeded in 1933 in extracting 
from adrenals a crystalline organic substance to which they 
assigned the letter E. This compound had a molecular formal
^21 ^30 ^5 and absorbed ultra-violet light maximally at
237 mp. speaking to an -unsaturated carbonyl group.
Using /
—  8 * *
Using Ingle's test (1936) they found Compound E to he 
physiologically active though not as active as Cortin. 
Compound E could he oxidised with chromic acid yielding 
a ketone C^g 0^ which had one sixth to one quarter the
activity of androsterone in stimulating coinh-growth in the 
capon. This finding linked Cortin with the sterol ring 
system. Also Compound E could he oxidised with periodic 
acid to yield an acid CgQ 0^ and formaldehyde.
Clutterhuck and Reuter the year before had shown that these 
products could only come from the group:-
h
R - 0 » G - OH 
M i
H H
They were therefore ahle to suggest a provisional formula 
for Compound E.
CH^OH
I
C - 0
O H
(1,1)
By the end of 1936 they had designated compounds A, B,
C, D and E. Only Compound E had shown physiological 
activity.
Most spectaculr, however, in results as well as in 
scientific content was the work of Reichstein on gland 
extracts provided hy Organon (Holland). luhlishing solely 
(Reichstein /
9 -
(Reichstein 1936a, b, o, d, e,; 1937 a, b, c, d, and 1938) 
and with Steiger (Steiger and Reichstein 1937 a,b,c) he gav 
proof of having isolated compounds vi^ hich he designated A to 
G, and came close to elucidating some of their molecular 
structures* The physiological activity of these compounds 
was assayed at the Organon Laboratory, by the muscle work 
test devised by Everse and de Eremery (1932). Also from 
the gland extracts Reichstein isolated 'androsterone' 
an androgen active in stimulating comb-growth in the capon.
Of all the compounds which had been crystallised by the 
various groups from the amorphous fraction of the adrenocor 
extracts only 6 had physiological activity. There were 
corticosterone, (1,2) 11-dehydrooortoosterone, (1,3) 
desoxycorticosterone (1,4) and the three corresponding 
17-hydroxy derivatives of these (1,5; 1,6; 1,7). Their 
molecular structures were assigned thus:-
HO
0
CH_OE
I
0-0
(1,3) 0 (lg4)
GHgOE
"0
0
HO ,DH
OIUOH
I
0=0
(1,6)
OH^OH
0^0
—  10 —
However, after extraction of these compounds, by 
crystallisation from the lipid soluble fraction there could 
be prepared from a second water soluble extract a principle 
which had a relatively low physiological activity as measured 
by the work test but which also had a high physiological 
activity measured by the growth-survival test. The 
significance of this finding was not to be understood until 
later when it was appreciated that different adrenal compounds 
exerted cifferent physiological activity depending' on their 
molecular structure.
Cartland and huizenga with their colleagues, (1936, and 
1945), working at the Upjohn Laboratories, Kalamazoo, set 
out to prepare commercially and in bulk adrenocortical 
extracts for clinical use. They observed that hog adrenal 
extracts yielded much more active substance in the work test 
than did beef adrenals. Indeed 1,000 lbs. beef adrenals 
yielded '75-100 mg. of 17-hydroxycorticosterone (1,5) while 
1,000 lbs. hog adrenals yielded 600 mg. in pure form. They 
attributed this increase to 11-hydroxylated compounds.
Tests of physiological activity.
The early workers in the field were sa.tisfied that an
adrenocortical extract had activity if when administered
by injection to their totally adrenalectomised animals they
remained alive. A more j reclse index of extract potency
was obviously required and Lfiffner, Sv;ingle and Vars (1934), 
defined /
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defined the dog unit. This was the daily per kilogram dose 
of adrenocortical hormone necessary to maintain normal 
physiological conditions in the test dogs for a period of 
7-10 days, i.e. maintenance of body weight and normal 
blood urea. Grollmaiand Prior (1933) used a rat test, the 
rat unit being the minimum daily dose of cortical hormone 
which would protect for at least 20 days, 50 per cent of a 
group of adrenalectomised animals at 28 days of age, the 
extract being given subcutaneously twice daily. Cartland 
and Kuizenga (1936) modified the rat unit to the minimum 
daily dose of hormone which administered by single 
subcutaneous injection daily for 20 days to 4 week old male 
rats weighing 50-60 g. is sufficient to protect at least 
80 per cent for a 20 day period and to allow a weight gain 
of 20 grams for the 20 days. A comparison of the dog unit 
and Oartland's rat unit indicated that the rat unit was 
22 times as large as the dog unit and on a per kilogram basis 
the growing rats required 300 times as much as the adult 
dogs.
Later Kuizenga, Pelson and Gartland (1940) compared by 
their rat method the effectiveness of oral and parenteral 
corticosterone (1,2), 11-dehydrocorticosterone (1,3) and 
desoxycorticosterone (1,4). The former two substances were
isolated from the least water-soluble fraction of the gland 
extract, in pure form and identified by their melting points 
and specific rotations. Synthetic desoxycorticosterone 
acetate /
—  12 —
acetate was used. They were therefore able to administer 
weighed amounts of these hormones. Corticosterone and 
ll-dehydrocorticosterone were as effective orally as 
parenterally while desoxycorticosterone was 35 times more 
potent parenterally then when orally administered.
It was Steiger end iieichstein (1937) who first 
prepared chemically, from inactive stigraasterol, 21-oxy- 
progesterone, now known as desoxycorticosterone (1,4) and 
showed that this new substance had high cortical hormone 
activity.
Ingle devised a rat work test. In conjunction with 
Heron and Hales (1934) he M  found that in contrast to the 
progressively increasing fatigue of skeletal muscles to 
repeated contractions which occurred in most animals, the 
rat gastrocnemius could maintain contractions at 3 per 
second against 100 g. weight for up to 17 days. They were 
unable to produce complete gastrocnemius fatigue by 
electrical stimulation in norraal animals. After total 
adrenalectomy (Hales, Haslerud and Ingle, 1935) the capacity 
for work was reduced to a maximum of 36 hours but fatigue 
could be reversed or prevented by the administration of 
adrenocortical extracts (supplied by Hartman and colleagues). 
The capacity for work increased in proportion to the 
amount of hormone administered until an optimal dosage was 
reached (Ingle, 1936). Rats adrenalectomised and 
nephrectomised survived for 4 - 1 0  hours but when given 
cortin /
- 13 “
cortin they survived on average 33*7 hours (Ingle and 
Kendall 1936). By using such animals in the work test 
these authors found that they could determine the 
presence or absence of activity in extracts within 12 hours. 
This had obvious practical advantages.
Ingle's greater contribution to the understanding of 
steroid action was also based on his rat work test.
In 1940 (Ingle, 1940a) he found that the property for 
maintaining work capacity was possessed by corticosterone 
(1,2), 11-dehydrocorticosterone (1,3), 17-hydroxycorticosterone 
(1,9), 17-hydroxy-ll-dehydrocorticosterone (1,6) and by 
desoxycorticosterone (1,4) but while the former 4 were 
effective when given suhcutaneously at the 0.125 mg. per 
dose level the latter showed activity only when 2 mg. were 
used. Reduction of the ethylenic bond in 17-hydroxy-11- 
dehydrocorticosterone (1,6) rendered it inactive (l,g).
GHmOH CH^OH
I 2 I 2
CO  C'O
m
(1,8)0 (1.6) OH"
Desoxycorticosterone however had been recognised as 
extremely active in maintaining life and this at first sight 
seemed opposed to Ingle's observation. In subsequent work 
Ingle (1940b) was able to show that while desoxycorticosterone 
was /
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was the most active known compound for life maintaining 
it had very little activity in maintaining work capacity.
On the other hand, 17-hydroxy-ll-dehydrocorticosterone 
(1,6) had little or no life-inaintaining effects hut was 
extremely active in the work performance test. This ability 
to maintain work was a ca^pacit/ of the 0-11 oxygenated 
cortical steroids.
The next link in the chain was supplied hy Ingle and 
Leukens (1941) who showed that the work performance of 
adrenalectomised rats was improved by the intravenous 
administration of glucose in any concentration thus 
suggesting a link between the 0-11 oxygenated cortical 
steroids and carbohydrate metabolism.
Almost synchronously Orattan and Jensen (1940) showed
that corticosterone and 17-hydroxycorticosterone increased
the deposition of liver glycogen and had a pronounced
anti-insulin effect. hesoxycorticosterone even at 4 times
the dosage level failed to show a similar response. Thus
the adrenocortical hormones which had increased work
capacity (Ingle 1940) were those which increased deposition
of liver glycogen. The 0-11 oxygenated steroids had
therefore a significant effect on carbohydrate metabolism.
Their final conclusions were that the functions of the adrena.'
cortex might be twofold, namely, to regulate carbohydrate
metabolism and to maintain electrolyte balance and that 
these /
15
these functions were by different cortical principles*
These ideas had had earlier ventilation. Hartman 
and his colleagues (1939) had sepa.rated adrenal extracts 
into two fractions, one with little or no sodium retaining 
effect and one causing sodium retention. üortin alone, 
they found, maintained the animal in good general condition 
although the plasma sodium concentration fell* The 
addition of their 'sodium factor' promptly raised plasma 
sodium to normal levels. They found too that 
desoxycortioosterone had a sodium retaining action and that 
the potency of their 'sodium factor' was approximately equal 
to the potency of desoxycorticosterone (Hartman and 
Spoor, 1940).
In 1855 Thomas Addison described cases of the lethal 
condition which since then has been known as Addison's 
disease. The suprarenal gland was from the first 
incriminated and empirically more than rationally sufferers 
vfere given orally, subcutaneous and rectally, large doses of 
epinephrin, the first humoral substance extracted from the 
adrenal. Dr. A.I. Muirhead (1921), himself a. sufferer from 
Addison's disease describes his treatment with a preparation 
of dried whole suprarenal gland orally and compares the 
effects with oral, subcutaneous and rectal adrenaline.
It was not until 1932 that Loeb (1932) showed the 
biochemical disturbances in Addison's disease. In the 
serum /
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serum of 3 patients there was a decrease in total base 
entirely at the expense of sodium. The serum potassium 
was either high normal or definitely increased, the blood 
urea was raised and the chlorides were reduced. In 
conjunction with Atchley, Benedict and Leland (1933)
Loeb further demonstrated that in 3 adrenaleeternised dogs 
the loss of sodium from the body was an important factor 
in producing the clinical features of adrenal insufficiency 
and that the loss was entirely through urinary excretion.
A significant finding also was the fact that both the 
total amount of sodium and the concentration of sodium 
increased in the urine despite an increase in urine volume.
He postulated from this work that one function of the 
adrenal cortex was to control the concentration of sodium 
in the blood and tissue fluids.
Harrop, Soffer, Ellsworth and Treschar (1933) confirmed 
that finding by showing in adrenalectomised dogs that 
haemoconeentrâtion was due to loss of sodium and chloride 
plus their component of body water and that this loss was 
via the kidney. Administration of cortical extract 
reversed the changes observed and they concluded that 
the cortical hormone regulated sodium and chloride metabolism 
and consequently the balance and distribution of water.
Their evidence pointed to the kidney as the site of the
regulatory action of the cortical hormone. 
The /
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The most natural clinical development from this 
newly established biochemical similarity between the case 
of Addison's disease and the bilaterally adrenalectomised 
animal was the attempted treatment of Addison's disea.se 
with adrenocortical extracts. Rogoff and Stewart (1929) 
treated 7 cases, 4 males and 3 females with their own 
preparation which they had named *interrenalin* and they 
reported improvement. Rowntree, Green, Swingle and 
Pfiffner (1931) treated 5 cases with Swingle and Pfiffner's 
preparation given intramuscularly and intravenously and 
reported good success. In this country Levy-Simpson (1930) 
was the first to use cortical extract - given him by Swingle 
and Pfiffner, to treat Addison's disease.
In 2 papers, Thorn, Garbutt, Hitchcock and Hartmann 
(1937a,b) demonstrated the effect of subcutaneously administers 
cortical extract on the electrolyte balance in Addison's 
disease. Not only was the negative sodium and chloride 
balance corrected to a positive one, but a potassium 
diuresis accompanied this. There was also a rise in the 
blood pressure and gain in weight. These features 
persisted during the period of cortin administration.
It will be remembered that about this time Reichstein 
and Steiger (1937) had synthesized chemically desoxycorti- 
costerone. Levy-Simpson (1938) was again the first to use 
this substance as the acetate in the treatment of Addison's 
disease. He successfully treated 2 patients. In a 
fuller /
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fuller report Thorn, Howard and Emerson (1939) confirmed 
Levy-Simpson's experience with desoxycortioosterone 
acetate, showing that its effects simulated those of cortin, 
Using 2 - 30 mg. in oil per day given intramuscularly in 
8 patients they showed even when oral salt was withheld, 
that there was an increase in body weight, a rise in blood 
pressure, an increase in plasma volume, a restoration of 
serum electrolytes to normal, a positive sodium balance, 
a potassium diuresis and improved muscular strength. All 
of these features were reversed on withdrawal of 
desoxycortioosterone acetate. Other users of 
desoxycortioosterone acetate (Kuhlman, Ragan, Eerrebee, 
Atchley and Loeb, 1939) found that some of their patients 
developed cardiac insufficiency and muscular weakness even 
although their blood pressure remained normal. Two of 
them died suddenly at home. They then investigated the 
effects of desoxycortioosterone acetate in dogs and found 
that it did lower the serum potassium and produced periodic 
muscle weakness. There was increased water intake and 
excretion with raising of the blood pressure and on 
E.C.G, examination typical T-wave changes of hypokalaemia 
developed.
Desoxycortioosterone acetate then was not without its 
dangers, none-the-less it claimed a definite place in the
treatment of Addison's disease. The following year 
Moehlig (1940) reported the implantation of desoxycorti­
oosterone acetate /
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acetate pellets. 4 pellets each 150 mg. replaced treatment 
with adrenal extract plus salt and the general improvement, 
gain in weight, maintenance of blood pressure which followed 
all remained for 5 months. ho change in the typical 
Addisonian, pigmentation however was noted.
During the few years which followed, various investigators 
added to the total knowledge of the various actions of the 
adrenal extract. Conn and Silverman (1939) showed that 
cortical extracts were effective in Addison's disease when 
administered orally and that only half as much was required 
orally as parenterally to maintain sodium and chloride 
balance. Again, if salt were adoed to the diet - 7 g. 
sodium chloride daily - the oral dose could further be 
halved. Perla and colleagues (1930) found thrit rats and mice 
resisted surgical and histamine shock better after receiving 
cortical extract (Cortin) or desoxycortioosterone acetate 
and the effects were more pronounced if parenteral saline 
was combined. Of interest from the paediatric point of 
view was Wells and Kendall's (1940) findings that both 
corticosterone (1,2) and 17-hydroxy-ll-dehydrocortioosterone 
(1,6; cortisone) retarded somatic growth when administered 
10 rat 8.
It was not until 1946 that cortisone was synthesised 
chemica]ly. Starting with desoxycholic acid Sarett (1946)
prepared cortisone monoacetate and found it identical to 
biologically /
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biologically obtained cortisone acetate supplied by 
Kendall. By 1949 sufficient cortisone acetate Had been 
made by Merck and Co. Inc. to allow Bench to report on 
its beneficial effects on 16 cases of rheumatoid arthritis. 
This preliminary report (Bench, Kendall, Slocumb and Policy, 
1949) also indicated that 100 mg. of cortisone acetate was 
only equivalent in efficiency to 89 mg. cortisone alcohol 
and that multiple small doses intramuscularly were better 
than a single la,rger dose. An important observation 
ma,de by these workers, one to be used the following year 
by Wilkins in the treatment of congenital adrenal 
hyperplasia, was that the urinary excretion of 
17-ketosteroids fell during treatment with cortisone acetate.
Pharmaceutical firms w^ ere not slow to appreciate the 
commercial potential in the bulk synthesis of steroid 
hormones. The search was on for analogues with equal or 
even greater pharmacological potency.
Meanwhile, Grundy, Simpson and Tait (1952) announced 
the isolation from beef adrenals of a substance with profound 
effects on mineral metabolism which was not any of the known 
biologically active cortical hormones. Later the same year 
Simpson and Tait (1952) demonstrated that a substance secreted 
in significant amounts was present in venous blood of the 
monkey and the dog which had marked effects on the urinary 
sodium/potassium ratio of adrenalectomised rats. It 
was 25 times as potent as an equivalent weight of cortisone 
in /
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in retaining sodium* This substance was characterised 
as l8-oxycorticosterone or corticosterone-18-aldehyde and 
named aldosterone (Simpson, Tait, Wettstein, Neher, von Euw, 
Schindler and Reichstein, 1954)*
Glucocorticoid, mineralocorticoid - androgen.
The reader will recall the earlier mention of 
Reichstein's (1936) finding 'adrenosterone' in adrenocortical 
extracts* This observation not only linked adrenocortical 
hormones with the sterol m u d  eus but indicated that the 
adrenal cortex also secreted hormones having biological 
androgenicity. Kendall, Mason and Myers (1938) oxidised 
their Compound E with chromic acid and the resulting 
diketone had one sixth to one quarter the activity of 
androsterone in stimulating capon comb-growth. Hodler (1936) 
extracted from the alkaline fraction of beef adrenals a 
masculinising hormone and from the benzene discard of the 
Swingle and Pfiffner extraction, Pottenger and Simonsen (1938) 
purified a white amorphous powder which when given to female 
rats induced functional atrophy of the uteri and uterine horns 
and in male rats increased testicular weight and spermatogenesi! 
Broster and Vines (1937) extracted from the urine of 
virilised women, a biochemical compound which they claimed 
was specific to virilism of adrenal origin. This compound 
was active in the capon comb-growth test. After unilateral 
adrenalectomy quantities of the compound in the urine 
diminished /
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diminished and it was not found at all in the urine of 
normal women. That the adrenals synthesise at least 
2 androgens has been shown by Short (I960) who demonstrated 
androstenedione and 11-hydroxyandrostenedione in adrenal 
venous blood.
These 3 groups of steroid hormones have recently 
(Symington, 1962) been shown to originate from 2 
histological zones of the adrenal cortex. Mineralocorticoids 
are synthesised in the zona glomerulosa while glucocorticoids 
and androgens are produced in the zona reticularis.
In Symington's view zona fasciculata acts as a storage zone 
for steroid precursors so that in conditions of stress there 
is available material for immediate steroid synthesis.
1953 saw the first of the synthetic steroid analogues.
Fried oud Sabo (1953) working in the Squibb Institute
prepared ITa-hydroxy-corticosterone and its 9ci-fluoro-
derivative starting with ll-epi-17—hydroxycorticosterone.
This 9ci"-fluoro-derivative possessed strong salt retaining
activity. Herzog and colleagues (1955) reported the
beneficial effects of two new anti-arthritic steroids.
They were prednisone and prednisolone and these were 3
to 4 times as active as cortisone or hydrocortisone. From
Merck and Co. Inc., 9ci“fluoro-prednisolone acetate emerged
(Hirchmann, Miller, Wood and Jones, 1956) while 16a-hydroxy-
lation of this compound was achieved by Bernstein and
co-workers (1956). This was an important achievement for 
in /
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in tests this new compound, triamcinolone and its diacetate 
were found to be 30-36 times more active than 
hydrocortisone in the rat liver glycogen test but they 
were without salt retaining properties. They concluded 
that 16a-hydroxylation abolishes the sodium retaining 
property of 9 cu-f lu or inat e d steroids. This paved the way 
for dexamethasone (Arth and colleagues, 1958) a,nd 
betamethasone (Traub, Hoffsommer, Slates and Wendler, 1958) 
the former with a I6a-methyl group and the latter having a 
16(3-methyl group. Both were claimed to exhibit an 
unusually high anti-inflammatory activity without having 
salt retaining properties. Chart I shows the molecular 
structures of these compounds and their accepted 
glucocorticoid and mineralocorticoid activity compared to 
hydrocortisone,
At this point I will not review the literature on the 
biosynthetic pathways assigned to aldosterone, hydrocortisone 
or the androgens for I am aware that the capacity of the 
average human being for sustained attention is greatly 
exaggerated and in every sphere there is need to practise 
the art of leaving off. For that matter everything is 
too long - lectures, speeches, sermons, books (Sir Robert 
Hutchison 1939).
None-the-less, the relevance of the foregoing to 
paediatric problems may be briefly cited. Gannata (1922) 
described a case of Addison's disease in an infant. In the 
literature /
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literature he found only 2 other cases. Phillips 
(1887) reported 4 cases of spurious hermaphroditism 
in one family; this condition is now known as congenital 
adrenal hyperplasia. The medical treatment of this 
disease advanced markedly when Wilkins, Lewis,Klein and 
Rosemherg (1950) showed that cortisone suppressed the 
associated high adrenal androgen secretion. Hubble (1965) 
has recently claimed that dexamethasone while retarding 
linear growth in congenital adrenal hyperplasia, holds 
back skeletal maturation to a greater degree. In the 
text I shall present the results of treating congenital 
adrenal hyperplasia with prednisolone. Sikl (1948) 
described a case of congenital adrenal hypoplasia in an infant 
who died at 33 days. In I960 Boyd and Macdonald described 
the condition in a family, the male members only being 
affected. Histologically the adrenal tissue had a 
characteristic morphology.
The scope then of this thesis will be as extensive as 
the field surveyed in the hope that having adequately 
reviewed the literature, I shall not only have repeated the 
work of others - necessarily because the diagnosis, treatment 
and management of patients was essential - but also that 
some paediatric adrenal problems if not solved will have 
been at least investigated.
CONGENITAL ADRENAL HYPERPLASIA
Some clinical 
and
biochemical considerations.
25-
It is ai-propriate to open this Chapter with some 
emhryological, anatomical and physiological considerations.
The adrenal glands in man are formed from two separate 
primo rid a,, an ectodermal portion which becomes the medulla 
and a mesodermal portion which becomes the cortex of the 
adult gland. Columnar mésothélial cells on the rnsterior 
abdominal v/all, between the mesentery and the developing 
gonad, proliferate at about the 8 mm. stage to form a mass 
of cells which separate from the coelomic epithelium to 
become differentiated into large acidophilic cells.
About the 12 mm, stage a further mésothélial proliferation 
of smaller cells spreads over the surface of the original 
condensation. These smaller cells become the definitive 
cortex while the initial proliferation becomes the so-called 
foetal cortex or X-%one,
Sympathetic cells appear on the raedio-dorsal aspect 
of the cortex about the 11 mm, stage and invo.de it at 
the 14 mi7i. stage. By the 26 mm. stage they form a cell 
mass on the medial aspect of the more extensive cortex and 
are completely encapsulated later by it.
Early atterp/ts to demonstrate steroidogenesis in 
foetal glands failed to reveal activity (Gersh and Grollman, 
1939)» but more convincing evidence that the foetal gland 
is capable of steroid biosynthesis qualitatively similar 
to /
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to the adult is provided by the work of hanman and 
Silverman (1957) and Solomon, Lanman, Lind and Liebermann 
(1958), the latter showing that the X-zone itself is 
active. Only the foetal glomerular zone is thought to 
be inactive. Koss (1962) using electron microscopy 
showed a lack of structural elements in foetal glemerulosa 
cells and this seems consistent with non-function. Some, 
however, believe that the foetal glomerular zone is 
capable of steroidogenesis (Symington, 1967). It may 
be that with an adequate foeto-placentad. exchazige of sodium 
and water, there is no need for a foetal production of 
mineralocorticoid. One further interesting finding from 
in vitro studies with foetal zone tissue by Soloman and 
colleagues (1961) was the production of 16p-hydroxyprogesterone 
in high yield and it is of interest that the synthetic 
analogues of hydrocortisone with no salt retaining properties 
each have a 0-16 substitution (Chart 1). Also, the 
foetal adrenal cortex has been shown to have at a very 
early stage of pregnancy almost the complete enzyme- 
histochemical characteristics of the adult tissue (Oavellero, 
Magrini, Dellepiane and Oizelj, 1965). The foetal adrenal 
gland then is capable of synthesising the 
cyclophentenophenanthrene nucleus, of converting the 
A5-3P-hydroxy configuration to the A4-3”-ketone, of 
hydroxylation in the 17-» 21-, and 11-positions and of 
replacing the 0-20; 021 sidechain with a 17 ketone,
spite /
Despite this, Gathro, Birchall, Mitchell and Forsyth 
(1965), have isolated 3(3, 21-dihydroxypregn-5“ene-20 - one 
from one day old infants' urine, a substance not prominent 
in adult urine and Villee and Boring (1965) on incubating 
slices of adrenal cortex from a newborn hydrocephalic 
child, with progesterone-4-G^^ and pregnenolone-7 
obtained hydrocortisone, androstenedione, corticosterone, 
progesterone, dehydroepimidrosterone, 17o.-hydroxypregnenolone 
and l6a-hydroxypregnenolone. Very little androstenedione 
was obtained from progesterone. They conclude that 
progesterone is not necessary in the newborn for the 
production of hydrocortisone. This differs from the 
adult. Thus although the foetal adrenal cortex has 
normally active enzyme systems the activity of these 
differs from the normal adult pattern and seems to utilise 
biosynthetic pathways not yet completely understood.
The human foetal adrenal gland is proportionately 
10 to 20 times larger than that of the adult, in the main 
due to hypertrophy of the central reticular zone known 
as the foetal zone. Shortly after birth this zone 
involutes by haemorrhage and necrosis and the gland 
remains proportionately small, gaining its birth weight 
again some time after puberty.
The stimulus which causes foetal adrenal hypertrophy 
has long been a point of controversy but since the 
foetal adrenal cortex is capable at least qualitatively, 
of /
of producing the same hormones as the adult gland there 
seems no reason to think that a trophic hormone other 
then, corticotrophin should effect this highly specialised 
biosynthesis.
The condition which we now know as congenital adrenal 
hyperplasia has been recognised for more than a century, 
de Crechio (l865) described a patient with hypospadias, 
lack of external gonads, with internal genitalia of a 
female and with enlarged adrenal glands. Fibiger (1905) 
described three female pseudohermaphrodites with hyperplastic 
adrenals and observed that 3 siblings (2 female and 1 male) 
of one of his patients who died s,t 6^ weeks from dehydration, 
vomiting and diarrhoea, had similar symptoms before their 
deaths. Deprë^ and Semelaigne (1925) describing a male 
infant, recognised the association of dehydration, vomiting 
and diarrhoea leading to death with congenital adrenal 
hyperplasia. During the late 1930's several workers 
(Wertheman, 1935) to mention but one, reported increased 
excretion of urina,ry 17”Oxosteroids in patients with 
congenital adrenal hyperplasia and in 1946 Blackman 
published his observations from autopsy material showing 
that in congenital adrenal hyperplasia the reticular zone 
of the cortex was hyperplastic.
It will be recalled from the introductory chapter
that /
that Hench and colleagues (1949) observed the fall in 
urinary 17-oxosteroids in arthritic patients treated with 
cortisone acetate. The following year, Wilkins, Lewis, 
Klein and Rosenberg (1950) demonstrated that cortisone 
given to a female pseudohermaphrodite suppressed the 
secretion of adrenal hormones responsible for the high 
urinary excretion of 17-oxosteroids and 11-oxysteroids.
An important step in the understanding of this 
condition came from the work of Bartter, Albright, Forbes, 
Leaf, Dempsey and Carroll (1951). They administered to 
3 patients with the disease both corticotrophin and 
cortisone. Corticotrophin caused a rise in urinary 
17-0X0Steroids and other reducing corticosteroids while 
cortisone resulted in a fall in urinary 17-oxosteroids. 
When administered together there was a rise in urinary 
17-0X0steroids resembling the effects of administered 
corticotrophin alone. Their conclusions were that the 
high urinary excretion of 17-oxosteroids seen in the 
untreated case was due to excess adrenal stimulation 
with corticotrophin and since cortisone suppressed 
17-oxosteroid secretion its action was likely to be 
mediated through suppression of corticotrophin. It 
was probably, they thought, that the adrenal glands 
were unable to produce cortisone sufficient to suppress 
corticotrophin production. How nea.r the truth they were, 
Jailer, Louchart and Cahill (1952) took the argument
a /
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Ohart 2. The "biosynthetic pathways for corticosterone
and hydrocortisone*
-a further step forward hy showing that administration 
of corticotrophin to 7 patients did not result in an 
increased adrenal production of hydrocortisone as indicated 
by an increase in urinary formaldehydogenic corticosteroids.
It was not until 1954 that Hechter and Pincus (1954) 
brought together the various fragments of information, 
derived by several workers from adrenal gland perfusion 
experiments, and showed a reaction sequence for 
corticosteroid biosynthesis. Briefly it is as 
follows. Within the cortex of the adrenal, under the 
influence of corticotrophin, cholesterol is converted to 
pregnenolone (by sidechain scission from to a G^^ steroid) 
by the formation of an a,p-unsaturated ketone in King A, 
pregnenolone is converted to progesterone ; G-21
hydroxylation of progesterone follows with or without 
G-17 hydroxylation to form either desoxycortioosterone 
or 17a-de8oxycorticosterone (11-deoxycortisol); llp- 
hydroxylation in Ring G of both these latter, forms 
corticosterone and 17u-hydroxycorticosterone (hydrocortisone) 
respectively. This is illustrated in Ghart 2.
From this, the basic defect in congenital adrenal 
hyperplasia became more clearly understood. Butler and 
Marrian (1937) had isolated pregnanetriol from the urine 
of two women with the disease and apart from the 
recognition of this substance as a new triol, its 
significance remained obscured. When Jailor (1951) 
administered /
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administered 1 /'a-hydroxyprogesterone to affected patients 
he found an increase in urinary 17-oxosteroids and 
pregnanetriol. He suggested that these patients were 
unable to convert 17a-hydroxyprogesterone to hydrocortisone 
Later Girard, Gold, vande Wiele and Liebermann (1955) 
administered to patients both 17o.-hydroxyprogesterone 
and 17n-hydroxydesoxycorticosterone (11-deoxycortisol) 
and from the urinary findings postulated that they had 
a defect in 0-21 - hydroxylation. The following year 
Hberlein and Bongiovanni (1956) demonstrated that 
in cases of congenital adrenal hyperplasia with 
hypertension there wa.s a defect in G-11 - hydroxylation 
and from Bongiovanni (1961) came the finding that in 
some male cases with cryptorchidism and hypospadias, 
there is a. defect in 3P"hydroxysteroid, dehydrogenation, 
Ghart 3 illustrates the sites where blocks in the 
biosynthesis of hydrocortisone have been detected and as 
a result of these, the metabolites which anight be found 
increased in the urine.
Congenital adrenal hyperplasia is therefore a true 
inborn error of metabolism - the error being a, defect 
in the biosynthesis of hydrocortisone. Genetic studies 
of families with the condition suggest a recessive 
autosomal mode of inheritance with the clinical expression 
in the homozyous state. Neither the incidence of the 
gene nor of the disease itself is kno'Vi with accuracy, 
both /
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Ohart 3* Urinary metabolites of hydrocortisone and its 
precursors in relation to the enzyme sequence
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both probably varying considerably in different 
populations.
Being an inborn error of metabolism, the condition 
is present from the beginning of steroidogenesis in the 
foetal cortex. As mentioned this is at a very early 
stage of pregnancy and the failure of hydrocortisone 
synthesis by a negative feedback to the foetal pituitary 
increases the output of corticotrophin which stimulates 
the adrenal cortex. Cortical hyperplasia results 
giving rise to an increased secretion of foetal androgens 
and it is to these that the abnormal genital development, 
particularly in the female foetus, is attributed.
Developmentally, it is about the 10 mm. stage (Table 1)
when the paramesonephric ducts on each side appear as
invaginations of the coelomic epithelium and as solid
buds, they burrow caudally. Until about the 2? mm. stage
the ducts in both male and female are identical. Prom
then on in the female as they increase in length a lumen
appears in the upper part and becomes continuous with the
ostium of the invagination — thus the uterine tubes are
formed. Caudally the paramesonephric ducts fuse and at
the 56 mm. stage a single cavity forms within to become
the utero-vagina.l canal opening into the urogenital sinus.
At the 63 mm. stage, on each side of the sinus the sinu-
vaginal bulbs form and that part of the urogenital sinus 
immediately /
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Table 1. Developmental processes in relation to 
size of foetus and gestational period.
Developmental Process
Approx. 
Size of 
Embryo.
Approx. Time 
Period of 
Gestation.
Genetic and chromosal inheritance. Zygote. Fertilization,
Primordia of gonads. 4-5 mm. 30-32 days.
Paramesonephric ducts develop. 10 mm. 37 days.
Primordia of adrenal cortex. 12 mm. 39 days.
Differentiation in genital duct 
system of male and female i.e. 
meso- and paramesonephric duct 
systems. 35-40 mm. 9-10 weeks
Sinu-vaginal bulbs in female for 
part of vagina and in male for 
prostate• 55 mm. 3 months.
Divergence of differentiation of 
external genitalia. 50 mm. 2^-3 months 1
Definitive forms of external 
genitalia in both sexes.
100-125 mm. 4-5 months.
jb -
immédiately cranial to the hulhs narrows and elongates 
to form the female urethra. Meanwhile the sinu-vaginal 
hulhs develop and fuse, later to become canalised completely 
so that by the 162 mm, stage the vagina is formed. By 
growth and elongation of the anterior vaginal wall, the 
vagina is carried downwards towards the perineum thus 
separating the urethra and vaginal orifices. In the male, 
after the 27 mm. stage, the paramesonephric ducts 
degenerate and persist only as remnants.
The external genitalia of the foetus 'in the neuter 
phase' appear as a central genital tubercle, flanked on 
either side by the genital swellings. The portion 
between these swellings is the shallow ectodermal 
closure which later is separated into a posterior portion 
destined to become the anus and an a.nterior portion which 
becomes the urogenital sulcus. Further sex differentiation 
depends on the grow^th of the genital tubercle. In the male 
it becomes the definitive phallus and from the anterior 
part of the urogenital sinus the urethral groove develops 
to extend along the ventral surface of the genital 
tubercle as the urethral folds and becomes the urethra.
In the female, at the 25 stage, the urethral
tubercle is bent caudally and is not encroached upon by the 
urethral groove. Therefore there is no penile urethra.
The genital swellings enlarge to become the labia majora, 
the /
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the labia minora being the unfnsed urethral folds.
This foetal sexual differentiation is controlled by 
foetal endocrine secretions and lost (1961) has shown 
that foetal androgens exert a stimulating influence on 
mesonephric duct derivatives, a mosculinising effect on the 
urogenital sinus and external genitalia, and a suppressing 
effect on the paramesonephric dérivâtes.
Thus in congenital adrenal hyperplasia, where the foetal 
androgens from the adrenal cortex are increased in both 
sexes, the male child exhibits macrogenitosomia praecox 
and in the female, olitoral enlargement and fusion of the 
labia majora posteriorly leaving anteriorly a single 
perineal opening into a urogenital sinus. Frequently 
the urethra in the female fails to descend so that it 
communicates with the urogenital sinus through the anterior 
vaginal wall. Fortunately there is no suppression of the 
paramesonephric dérivâtes and the female case has a vagina, 
uterus and tubes.
Clinically, affected neonates may be detected by the 
somatic abnormali ties men cioned but it is vitally more 
important to recognise the possible biochemical upset 
resulting from complete failure of hydrocortisone 
biosynthesis. The features are those of adrenal 
insufficiency.
Before this information was available Butler, Boss 
and Talbot (1939) described a male infant, aged 20 months 
with /
with macrogenitosomia praecox who'showed also low serum 
sodium and high serum potassium levels and who had 
collapsed frequently from the age of 2 weeks if fluid 
and salt were restricted. By giving relatively large 
quantities of sodium chloride and a potent adrenocortical 
extract the child gained weight and remained in 
reasonable health. The following year Wilkins, 
lleischmami and Howard (1940) described a boy aged 3 years 
7 months 'Adth macrogenitosomia from birth; pub arche at the 
age of 15 months and testicular enlargement from the 
age of 18 months. From the age of 1 year he had shown 
a marked craving for salt and highly salted food. He 
died suddenly and at the time of death the serum sodium 
was lllmEq./litre. At autopsy the adrenals were 
enlarged with marked hyperplasia of the androgenic foetal 
cortex. There were also aberrant adrenal cells in the 
testes.
Although the powerful mineralocorticoid, aldosterone
had been isolated from beef adrenals in 1952 (Grundy,
Simpson and Tait, 1952) it was not until 1959 that
Blizzard, Biddle, migeon and Wilkins (1959) were able
to show that in cases of congenital adrenal hyperplasia
with salt-loss there was no increase in urinary aldosterone
if oral salt was withheld. Bryan, Kliman and Bartter (1962)
demonstrated impaired production of aldosterone in salt- 
losing /
39
losing cases and showed that salt restriction increases 
aldosterone secretion minimally.
It is clear from Chart 4 that failure of aldosterone 
production in the context of congenital adrenal hyperplasia 
could be due either to a block in C-21-hydroxylation or to 
a failure of 3p-hydroxystei"oid dehydrogenation. If 
G-21-hydroxylation is completely absent then in addition to 
the somatic abnormalities the patient has salt-loss.
If the defect is only partial, then by hypertrophy the 
gland compensates and produces adequate amounts of 
glucocorticoids and mineralocorticoids. Such a patient 
has no salt-loss. In both instances because of the 
hyperplasia there in increased production of adrenal 
androgens resulting in early and rapid increase in stature 
and muscular development, advanced ossification with early 
epiphyseal closure, early pubarche often during the first 
year of life associated with macrogenitosomia praecox 
in the male and masculisation in the female. If 3(3- 
hydroxysteroid dehydrogenation is defective there is 
impaired formation of the A4-3-oxo configuration in Ring A 
of the steroid nucleus. This is an important conversion 
for it is this configuration which gives to glucocorticoids, 
mineralocorticoids and androgens physiological activity. 
Thus in congenital adrenal hyperplasia due to this enzyme 
deficiency neither hydrocortisone, aldosterone nor 
testosterone /
—  4^
HO
A-5-pr e ga eno 1 on e
( 3(3-01)
(21-OH)
progesterone
0
desoxycorticosterone
(11-OH)
HO
0
corticosterone0-0
HO
(18-OH)
aldosterone
Chart 4. The biosynthetic pathway for aldosterone.
4J. -
testosterone can by synthesised. The patients have 
salt-loss, showing early signs of adrenal insufficienoy 
and in addition the male case is incompletely masculinized 
( cryptorchidism, bifid scrotum, hypospadias) for lack of 
potent foetal androgen. That foetal testes are 
capable of synthesising testosterone, albeit in small 
amounts, has been shown by lice, Johanson and Sternberg 
(1966).
A discussion on the management of congenital adrenal 
hyperplasia will be more appropriate after the presentation 
of the clinical and scientific data concerning the 
11 cases to be presented in this chapter.
CASE RE1QRT6.
This series of 11 cases is comprised of 8 females 
and 3 males (Table 2). Two males and 2 females have 
salt-loss, and 7 have no salt-loss. One male (Case 4) 
has deficiency of the enzyme 3P-hydroxysteroid (3P-ol) 
dehydrogenase and the other 3 with salt-loss have 
21-hydroxylase deficiency. The 7 without salt-loss 
(6 females and 1 male) have partial 21-hydroxylase 
deficiency. Two cases (Cases 4 and 10) are the second 
affected children in their families. The sibling of 
Case 4, an alleged male, died aged 1 month in I960 as a 
result /
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result of diarrhoea, vomiting and dehydration. He is
said to have had a normal penis, scrotum and testes.
At autopsy the adrenals were hyperplastic and the
diagnosis was made post-mortem. The sibling of Case
10, a registered male, died aged 1 month in 1952 from
diarrhoea, vomiting and dehydration. He is said to have
had a penis with hypospadias and a scrotum containing
two testes. At autopsy uhe adrenals were hyperplastic
weighing 16 g. and 17 g. There is no comment regarding
internal genitalia found at autopsy. Since Case 4
has 3p-hydroxysteroid dehydrogenase deficiency, his
dea.d sibling could not have been completely masculinized,
since deficiency of this enzyme results in incomplete
masculinization. It is unlikely that 2 gene mutations
would occur in 1 family. For a similar reason, the dead
sibling of Case 10 (21-hydroxylase deficiency) could not
have been a male with hypospadias since macrogenitosomia
is characteristic of the affected male with this enzyme
deficiency. Dr. M, a , Ferguson-Smith was invited to
determine the sexes of these two children from H and E
stained sections from specimens taken at autopsy. His
comments are ithat both are chromatin negative. If one 
does not doubt the pathologist's findings referable to
the gonads and adrenals then there is a possibility that
other clinical types of congenital adrenal hyperplasia
exists.
Table 3 /
Table 3 » Chronological data and development in 
relation to treatment.
Case 1. F 2. F 3. M 4. M 5. M
Date of 
birth 27.1.54 16.5.55 8.7.58 10.10.62 13.1.62
Ages at 
diagnosis 5 weeks 2 weeks 15 mos. 2 days 2 weeks
Salt-losing ho Yes jMo Yes ÎI0
Age at 
beginning 
of treat­
ment .
6 years 
10 moa. 3 weeks 15 mos. 2 days 16 weeks
Bone age at 
beginning of 
treatment
N 0 rmal H ormal 4 yeers U orma.l 0 0 rmal
Treatment P 1 I.7.Saline 
1 0, DOGA
DX.P.
C.
Clr.DX.P C. PTA.
Onset of 
puberty
L.enses
9.75 yr.
Menses 
H i  yr.
Pubarche 
3 yr.
Not yet Not yet
Age at 
opiphyseal 
closure or 
present 
bone age
11 years 13.6 years 11.6 year s 8.7
years
7.8
years
Actualj 
age 5 
Actual) 
height;
J 8,n. 
1967
13 years
143 cm.
H i  years 
1.37 cm.
8i years 
121 cm.
4 years 
3 mo s. 
93 cms.
5 years 
105 cms.
Pother
height
s 152 cm. 160 cm. 156 cm. 158.75cm. 161.5cm.
Father
height
8 159 cm. 17 2 cm. 16 2 cm. |176.5 cm. 182.8cm.
P. Prednisolone
Gc Cortisone
DX. dexaiaethasone
DUO A , desoxycorticosterone o.cetate
1 , i'AA, prednisolone trimethylacetate
F. Female
j - ale
Table 4
—  L\.l\.
Uome data of cases 6 - 11.
Case 6.Female 7 .Female 8 .Female 9 .Female 10.Female 11.Male
Date
of
Birth
7.8.56 23.4.65 28.9.63 24.2.63 11.7.66 18.12.66
Age
at
diag­
nosis
8 yrs. 
2 mos. 8 weeks 3 years 3i years 4 weeks 17 days
B one 
age ai 
diag­
nosis
11 yrs. N ormal 7 years 6.2 yrs. N 0 rmal N ormal
Treat-!
ment
± . Bone DX DX C;9 flF. C;D0CA:9flF,
±’o j^jrednisolone
DX. dexaanethesone 
C. cortisone
9a-flF 9oL-f luorohydrocortisone
Table 5» Biochemical findings in salt-losing ca.ses of 
congenital adrenal hyperplasia.
Case Sex Clinical 
Tins et
8 e rum 
mFq
electrolytes
./litre Birth
height
Kg.
Admission 
V*/eight 
Kg.
Enzyme 
Def ect
k '*’ Na'*" Urea
2 F 2 weeks 13.8 131 67.5 3.2 2.9 21-CH
4 M 2 days b.5 140 93.3 3.2 3.2 3 ■"Ol
10 F 30 days 9.5 130 200 3.5 3.2 21-OK
11 M 12 days 5.0
.
118 40 2.63 2.1 21-OH
Table 3 gives data of Cases 1 - 5  who have been 
under observation for more than 4 years. In Table 4 are 
the corresponding data for Cases 6 - 1 1  and although these 
patients have been under treat'rent for a short time only 
they are included because urine obtained before treatment 
was started in each case has provided material for 
research. Also some clinical aspects of their 
manageixent are of importance.
Incidence.
Four of the 11 cases are indigenous to Glasgow, 
the others coming from neighbouring shires - Lanarkshire 3, 
Ayrshire 2, Stirlingshire 1, and .Renfrewshire 1.
It would be inadvisable on these few cases to calculate 
the incidence of heterozygotes in the general population. 
Further, it is a cause for concern that 2 neonates have 
died from the salt-losing variety of the disease, the 
diagnosis having been made at autopsy. The true incidence 
of the disease might therefore be higher than is known 
since diarrhoea and vomiting in an infant is all too 
frequently assumed to have an infective basis. It is 
probable that in some compensated cases, adrenal 
insufficiency is precipitated by an infection and the 
true diagnosis missed. Wilkins (1962) has put the 
incidence in the general population of the heterozygote 
between 1 in 50 to 1 in 100, while childs, Grumbach and Van 
Wyk (1956) estimate it at 1 per 128. On either score, 
if /
12 days 5 years
Case 4. 3e-hydroxysteroid dehydrogenase deficiency.
46
if these figures are applicable to the population 
in this area, more cases of the homozygotes might be 
expected and at least 2 are on record from postmortem 
diagnoses.
Salt-losing cases.
The salt-losing cases present in the early days 
or weeks of life with variable vomiting and diarrhoea 
but consistently with dehydration - (see photograph 
Case 4) which reflects in their admission weights being 
under their birth weight (Table 5). Fantus' test on 
the urine will indicate at this stage that excess 
sodium chloride, the chief inorganic constituent of 
normal urine, is being excreted. This information 
is of great value for in diarrhoea and vomiting due to 
infection, or with vomiting due to congenital pyloric 
stenosis, the urinary sodium chloride excretion is 
diminished. Further, infants with adrenal 
insufficiency will excrete large nuantities of urine and 
the test can readily be performed.
Biochemically the serum electrolytes and blood urea
are characteristic of adrenal insufficiency, The serum
potassium and blood urea are raised and serum sodium low
normal or low. Of these, the serum potassium shows the
earliest change and is raised before the serum sodium
falls. This is seen in Case 4 (Table 6), in whom at 
age 2 days the serum potassium was 6.5 mFq./litre.
In /
"f-u
In association with genital abnormalities and a positive 
Fantus' Test, an early rise in serum potassium is 
significant. An E.C.G. at this stage may not show 
evidence of potassium intoxication although very shortly 
thereafter the typical tall, broad T-wave becomes 
evident.
Fantus' Test. 1 drop of 20/ potassium chromâte solution 
is added to 10 drops of urine. 2.9/ silver nitrate 
solution is added drop-wise, the tube being shaken after 
each addition until a yellow to brown end point is 
reached. The number of drops of silver nitrate used 
gives the concentration of chloride in the urine expressed 
as sodium chloride per litre of urine. Values in 
excess of 3 g./litre, before salt is added to the 
treatment are excessive.
At this stage the true sex of the child is less 
important than the correction of the biochemical 
abnormality. All 4 cases with salt-loss (Gases 4,
10 and 11, I have attended personally), received added 
salt immediately on diagnosis, in Gases 2, 10 and 11 as 
intravenous half-strength physiological saline (200 ml./kg. 
body weight per day), and in Case 4 orally. During the 
first 24-hour period corticosteroids were withheld and 
this permitted a collection of urine unadulterated by 
exogenous steroids. These specimens were reserved for 
steroid analysis.
Experience from Gases 2, 10 and 11 and from 2 other 
patients who died as a result of congenital adrenal 
hypoplasia, indicates that the sudden onset of adrenal 
insufficiency /
4y
insufficiency occurs from the tenth to the fourteenth 
day of life. Case 10 had had symptoms from the 
second week of life hut had been receiving from then 
onwards added salt in the feeds, prescribed by the 
medical attendant for the wrong reason. Case 4 was 
diagnosed at age 2 days and the excessive urinary loss 
of sodium chloride, often as high as 10 g./litre, was 
matched with oral replacement. Intravenous fluid 
therapy therefore was not required.
Notwithstanding adequate salt replacement, 
intravenously or orally, those with salt-loss have required 
remarkably high daily steroid replacements, both 
glucocorticoids and mineralocorticoids, to maintain 
them in good clinical condition, more than is required to 
suppress the abnormally high urinary excretion of 
17-0X0steroids. This is shown in Table 6.
Table /
■J\J
Table 6. Daily requirements of salt and exogenous
steroids to maintain good clinical response, 
in 4 cases of congenital adrenal hyperplasa 
with salt-loss.
Case. 1 7 -o s  before
treatment 
mg./day.
1 Daily requirements to 
maintain good clinical 
response.
17-08  after 
treatment 
mg./day.
.......  _
Salt DOGA 
gm. mg.
9a,-fl.
F.mg.
Cortisone
mg.
2 F. 3.08 3 3 — 50 0 .7
4 M. 4 .8 3 3 100 1 .9
10 F. 1 .8 1 0 .1 5 50 0 .8
11 M.
................
1 .5  3 0 .3 100 1 .8
DOGA desoxycorticosterone acetate.
9a-fl.F 9Gi,-f luorohydrocortisone.
The daily hydrocortisone secretion rate for adults 
is 5.0 - 27.9 mgm. (Cope and Black, 1958) and for 
children aged 2 months to 16 years (Loras and colleagues, 
1965) 9-9 mgm. (mean value). Yet Cases 2 and 10 
required 50 g. hydrocortisone daily and Oases 4 and 11, 
100 mg. daily. This is in keeping with the early 
experimental findings (Cartland and Kuizenga, 1936) 
that adrenalectomised growing rats required 300 times 
as much cortical hormone on a per kilogram basis to 
maintain life, as did the adult adrenalectomised dog.
The values for the urinary 17-oxosteroids after treq^ment 
are /
are slighly higher than the accepted normal for this 
age grnup (0.5 mg. f 0.2) hut these values are augmented 
by a contribution from the administered cortisone,
1 - 2  per cent of which is excreted as a 17-oxosteroid.
Case 2 is now 12 years. Until 6 years she was maintained 
on DOCA subcutaneous implants (200 mg.) every 4 to 6 weeks, 
prednisolone 7.5 mg. daily and added salt to satisfy a 
craving which had slowly developed. She was, in fact, 
eating 25 - 30 g. salt daily which created intense thirst 
with consequent polydipsia and polyuria of 3 litres per 
day. During her early years she had frequent adrenal 
crises associated with the zymotic illnesses. Under my 
personal supervision she was given 9a-fluorohydrocortisone 
0.1 mg. daily, increasing by 0.1 mg. daily at weekly 
intervals. When the dosage reached 0.3 mg. daily she 
apruptly stopped eating salt and the polydipsia and 
polyuria ceased. Until the present she has remained 
normotensive, and has been free from adrenal crises.
She menstruated for the first time on 1.1.1967.
Case 4 is now 4 years 3 months. During the first 
nine months of life he was maintained on cortisone 37.5 
mg. daily, DOCA intramuscularly 1 mg. daily and 6 - 8 g. 
salt daily. He had one adrenal crisis during this 
period. At age 9 months DOCA was replaced by 
9a-fluorohydrocortisone 0.1 mg. b.d. and on the second 
day of administration he refused the customary salted 
food /
food and has since then required no extra salt. He has 
remained normotensive requiring now 9o,-fluorohydrocortisone 
0.1 mg. da.ily. There have been no further adrenal crises.
Cases 10 and 11 have both received 9a-fluorohydro­
cortisone orally (0.15 mg. daily) when they were able to 
retain milk feeds. This has simplified their management 
in the acute phase of treatment after diagnosis, and 
although both require extra salt (up to 2 g. daily) this 
was a temporary requirement. These patients are at 
present 6 months and 1 month respectively and are making 
progress although Case 11 has required, before progress 
was evident, DOCA 3 mg. daily, 9n-fluorohydrocortisone 
0.3 mg. daily and cortisone 100 mg. daily.
From this experience, I make the claim that 9n- 
fluorohydrocortisone with its powerful mineralocorticoid 
effect, is a drug eminently suitable for correcting the 
salt-losing state in neonates and can be given with 
safety one the infant retains oral feeds. With carefully 
graduated dosage, there is no need for long-continued 
extra dietary salt, neither is there great risk of hyper­
tension or oedema. DOCA has an undoubted place in the 
treatment of adrenal crises or when vomiting is troublesome, 
but from this limited experience of 4 cases I have found 
that crises are fewer when daily 9n-fluorohydrocortisone 
is the mineralocorticoid used.
H on- /
Case 3. Macrogenitosomia praecox aged 4 years with
sister (Case 7) aged 3 months
Non-salt-losing cases.
The 7 cases in this group, with the exception of 
Case 7> presented with genital abnormalities* Gases 
1 and 5 were investigated within the first few weeks of 
life, while Gases 3, 6, 8 and 9 did not come under 
observation until aged 15 months, 8 years, 3 years and 
34- years respectively, this delay being due largely to 
parental desire to conceal the abnormalities of the 
genitalia. Cases 1, 5, 7 and 8 had an enlarged clitoris 
with a single perineal opening into a urogenital sinus, 
Cases 6 and 9 had an enlarged clitoris but with a normal 
vaginal opening and Case 3 had macrogenitosomia praecox. 
Case 7, a registered male, but a genetic female, was the 
sister of Case 3 (see photograph) and had a massive 
encephalocele. In this group it is important to 
establish the genetic sex. Case 8 had been admitted to 
a surgical ward to have the 'hypospadias urethral opening' 
brought to the tip of the 'penis by plastic surgery 
but when her true sex was determined she was submitted 
to further endocrine studies and the true diagnosis made. 
Of the 7 without salt-loss, 6 are genetic females and one 
a male.
Vaginograms and cystograms were performed on all the
female eases, salt-loser and non-salt-losers. Only Case
6 has a normally sited vagina and urethra, Gases 1, 2,
5, 7 and 8 having a urogenital sinus leading into a 
vagina /
At birth
Case 1. VIrillsm:no salt-loss
Vaginoplasty with 
amputation of 
clito ris .
14 vears
V  V  —
vagina, and Gases 9 and 10 have a vaginal orifice through 
which the bladder can be entered by a catheter from a point 
0.5 cm. along the anterior vaginal wall.
Surgical treatment of the perineum.
Because of the gross cerebral abnormality in Case 
7, all treatment was withheld, the parents took the infant 
home and she has since died in Ireland.
Although Case 1, (see photograph) was diagnosed early 
in 1954, suppressive treatment was not then started. There 
were long lapses between follow-up attendances. In I960 
when aged 6 years she attended a surgical clinic and was 
admitted for investigations. These included laparotomy 
to determine the nature of the internal genitalia, and 
when uterus, tubes and ovaries were seen amputation of the 
clitoris was performed. In 1962 when aged 8 years, the 
urogenital sinus was explored through a midline incision.
A small normally sited vaginal opening was found with a 
urethral opening on its anterior wall immediately within 
it. Mucosa was sutured to skin and the wound allowed to 
heal. The good results are seen in the photograph.
From 1962 she has been on suppressive trea,tment which will 
shortly be discussed.
Cases 2, 5 and 8 had similar anatomical abnormalities.
Cases 2 and 5 were diagnosed at birth and have since then
been receiving steroid therapy. Ca.se 2 has salt-loss 
and /
12 years
Case 2. Virilism with salt-loss. Vaginoplasty only
5 years
Case 5. Virilism:no salt-loss. Vaginoplasty only.
3.5 years
Case 8. Viril ism:no salt-loss. Vaginoplasty only.
-  0 (
and is well controlled with Su-fluorohydrocortisone and 
prednisolone. When aged 9 years vaginoplasty was 
performed, (Mr. Wallace M. Dennison) hut the clitoris 
(2.5 cm.) was not amputated on the reasoning that with 
adequate suppressive treatment there should he no further 
clitoral growth and by subsequent adnexal development it 
would become normally concealed. Vaginoplasty (W.M.D.) 
was performed on Case 5 when aged 4 years and again the 
clitoris 1.5 cm. was not amputated. Both cases 2 and 
5 required supportive therapy during the operation, Case 
5 collapsing twice during the period of anaesthesia.
In 1950 when Case 8 (no salt-loss) came under observation 
it was decided to perform the vaginoplasty immediately 
and to commence suppressive treatment concurrently. The 
clitoris was not amputated. The clinical photographs 
show the post-operative results (q.v.).
Few papers comment on the surgical treatment of 
congenital adrenal hyperplasia. In the past the surgeon 
was invited to implant DOCA pellets subcutaneously and 
correction of the external genitalia was postponed 
until puberty or later by which time in the absence of 
steroid replacement therapy menses did not occur. Haiti 
and Newnes (1964) recommend subtotal clitoroidectomy and 
vaginoplasty at the age of 18 months to 2 years.
Under adequate suppressive therapy a large clitoris 
diminishes /
o.
diminishes in size and only when treatment has been 
commenced late need amputation be considered.
Lattimer (i960) has given details of a procedure which 
aims at reduction in clitoral size but with preservation 
of the glans. This may be important for later marital 
relationships. Subtotal amputation of the clitoris is 
therefore inadvised since some reduction in size can be 
expected during treatment. If at puberty the clitoral 
size is still unacceptable, the Lattimer operation 
(1961) would seem to be preferable to amputation.
Growth.
only Gases 1 to 5 will be discussed, these having 
been under observation and treatment for more than 4 
years. Increased statural growth in congenital adrenal 
hyperplasia is caused by the excessive secretion of 
adrenal androgens. These also cause early epiphyseal 
fusion, growth ceasing early and the patients becoming 
small adults. It is the rule in the untreated case for 
ossification to proceed much more rapidly than height is 
gained so that although patients are taller than average 
until epiphyseal fusion the maximum height achieved falls 
short of norraa.l adult standards.
The aim of suppressive treatment with reference to
growth is to .supp>ress adrenal androgen production sufficiently
to delay epiphyseal fusion but at a dosage level which 
will /
will allow normal linear growth. However, the 
ultimate h^right atte.ined will in part he determined hy 
genetic factors governing family height so that each 
patient has to he seen against his own genetic background. 
Wilkins and his colleagues (1950) supjiressed the androgen 
secretion with cortisone and reviewed the effects after 
4 years (Wilkins and Cara, 1954) . The same group (G-rern, 
Cleveland, Wilkins, 1961) reported that triamcinolone 
suppressed androgen production, osseous development and 
growth, the latter two equally, Side-effects such as 
fever delirium and blurring of the optic discs, were too 
frequently encountered to justify its continued use.
The use of the long-acting steroid preparations, 
prednisolone trimethylacetate and methylprednisolone 
acetate given intramuscularly at intervals up to 28 days 
is reported (Dingman, Maran an and Staub, 1962) to give 
uniformly smooth a,drenal suppression although in one 
of their children growth was slowed but osseous 
development continued. In anotner child, both ossification 
and growth were slowed and in the other four patients 
they only claim that excessive retardation of growth 
was not apparent.
The ideal drug would suppress adrenal androgen
secretion, retard the skeletal maturation and allow
somatic growth to proceed normally. lînfortunately, 
the /
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the synthetic glucocorticoid substances used in suppressive 
doses all retard somatic growth hut Hubble (1965) has 
given evidence that dexamethasonej at least in the simple 
virilising form of congenital adrenal hyperplasia 
retards bone matura..tiun more than it does linear growth.
The growth charts for the five cases are shown in 
Charts 5, 6, 7, 9 and. 10.
The overadl evidence from this group is that when 
the dosage of suppressive steroids is so graduated to allov/ 
linear growth, bone maturation advances more rapidly 
creating an increasing gap between height age and bone 
age, If steroid dosage is increased to delay bone 
matunation, the trend in the growth curve flattens more 
than does the curve for ossification. This is seen in 
Cases 1, 2, 3 and 4. Only in Case 5 are both parameters 
increasing in parallel, bone .maturation being in advance.
Case 1 (female simple virilism: Chart 5) was not
treated until aged 8 years 10 months v/hen prednisolone 
10 mg, daily was given. Linear growth till then had 
proceeded along the 50th percentile and from Ô years to 
9 years there was a 14 cm. gain in height which might 
ha.ve represented the prepubertal growth spurt for 
menstruation occurred within a fu-^ -ther year. At the onset 
of menstruation, one year after treatment, the bone age 
was 14 years. Epiphyseal fusion followed rapidly 
despite /
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Ohart 60 Oase 2 - female with salt-^ loss® Linear growth and
bone maturation in relation to suppressive treatment
despite an increase in prednisolone to 12,5 mg. daily 
and presumably both factors contributed to the 
final short stature of 140 cm.
Case 2 (female with salt-loss: Chart 6) required
high steroid dosage during the first 4i years of life 
as shown. Both linear growth and bone maturation 
were retarded almost equally. Between 4 years 9 months 
and 7 years 9 months the daily glucocorticoid was 
reduced to 7.5 mg. prednisolone or the equivalent of 
dexamethasone allowing a. more rapid increase in bone 
age than height age although the height did approach the 
50th percentile. During one year, 7 year 9 months to 
8 years 7 months when all glucocorticoid drugs were 
withdrawn there was no gross widening of the gap 
and the actual height came near to the 50th percentile. 
However, it was clear that 9ci-fluorohydrocortisone, 
the only drug used during that period did not prevent 
further adrenal hyperplasia and prednisolone was 
restarted at 5 - 10 mg. daily. With this, growth has 
almost ceased while the bone age has continued to advance 
When the bone age reached 13*5 years the girl menstruated 
Epiphyseal fusion has not yet taken place, her height 
being 137 cm.
It is interesting that Cases 1 and 2 menstruated at
an age more in relation to their bone age than to their 
chronological /
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Chart 7* Case 3 ” male with macrogenitosomia praeoox. Linear
growth and bone maturation in relation to suppressive 
treatment.
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chronological age although to start menstruation at 
11*1 years is probably not abnormal. Visser (1966) 
has also noted the correlation of the onset of 
puberty with bone age.
Case 3 (male with macrogenitosomia praecox; Chart 7) 
showed a remarkably rapid bone maturation during the first 
years despite high cortisone dosage and his height then 
was above the 97th percentile. Since he appeared to 
require about 150 mg. cortisone daily, medication was 
changed to dexamethasone 3 mg. daily with a reduction 
after 3 months to 2 mg. daily. The curve of the bone 
age flattened and his growth curve less so. He is now 
on the 50th percentile for height with a bone age of
10.5 years. This one case in the series supports 
Professor D. Hubble's view (1965) that dexamethasone 
retards bone maturation more than linear growth. One 
point of clinical interest in Case 3 is that the testes are 
normally large and it is generally recognised that in 
congenital adrenal hyperplasia the testes remain infantile 
in size. The possibility of his being a case of true 
sexual precocity was considered but a positive dexamethasone 
suppression test, (Chart 8) the high urinary pregnanetriol 
values (Table 2) and later an affected female sibling all 
supported the diagnosis of congenital adrenal hyperplasia. 
There is a possibility that the enlarged testes contain 
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adrenal rest tissue. His plasma corticotrophin level 
was elevated (5 milli-units/100 ml.) and Hamwi, G-winup,
Mostow and Besch (1963) Have shown that prolonged excessive 
corticotrophin production does activate testicular rest 
tissue.
Case 4 (male with salt-loss: 3P“0l deficiency) is
of considerable clinical and biochemical interest. He i s 
a genetic male with cryptorchidism, hypospadias, bifid 
scrotum and has salt-loss typical of the syndrome 
(Bongiovanni, 1961). It is generally accepted that 
testosterone is the most potent androgen and in congenital 
adrenal hyperplasia its production rate is increased 
(Visser, 1966). In the absence of 3P'“hydroxysteroid 
dehydrogenase, the A4“3“Oxo configuration in Ring A 
cannot be achieved and this configuration is necessary 
for biologically active testosterone. Case 4 cannot 
synthesize testosterone or androstenedione an adrenal 
G19"precursor of testosterone of lesser biological activity. 
The adrenal 019~precursor, dehydroepiandrosterone is 
therefore his most potent androgen. Dehydroepiandrosterone 
has a potency of l/13th to l/14th (Pieser & Fieser, 1959) 
that of testosterone.
It might have been expected that bone maturation in this 
case would have been retarded or at le fist readily controlled.
With this reasoning and in the hope that increased 
adrenal production of dehydroepiandrosterone might 
stimulate /
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stimulate testicular descent, glucocorticoid was 
withdrawn from age 1 year to 2 years 3 months and he was 
controlled on 9a-fluorohydrocortisone alone, (Chart 9)* 
During this period the bone age increased rapidly to 5*7 
years while his height only approached the 50th percentile. 
Since then prednisolone has been introduced and although 
he received up to 20 mg, daily there has been no marked 
arrest in the onward progress of bone maturation. This 
raises the possibility that the adrenal gland may secrete 
an androgen at least as potent as testosterone in these 
cases of congenital adrenal hyperplasia. One further 
point is of interest. During the period when 
glucocorticoids were withdravm, what was the nature of the 
endogenous adrena.l androgens secreted? An attempt 
will be made to answei’ this from urinriry studies to be 
reported presently.
Case 5 (female, simjle virilism: Chart 10). Until
aged 2| years she has been very responsive to cortisone 
50 mg. daily, or prednisolone trimethylacetate 25 to
37.5 mgo at 4 weekly intervals, both bone age and height 
being under the 50th percentile. At age 1 year 9 months 
cortisone was reduced bo 25 mg. daily which allowed an 
escape of bone maturation with a much slower increase in 
height. From age 4 years cortisone 50 mg. daily allO'^  ed 
linear growth to continue at the same time restricting 
ossification perhaps more so.
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From this series of 5 cases, it would a.ppea^ r that each 
patient presents a different growth response to treatment* 
While the aim is to achieve maximum height by delaying 
fusion of epiphysis, the fact that steroids themselves 
inhibit linear growth, almost dooms the exercise to 
failure except in the mildest cases. Genetic factors 
may play a part in the ultimate height attained and in 
this series all the parents might be regarded as the smaller 
members of the community. (Tallest in the series 182.8 cm.)
Clearly the present synthetic steroid analogues 
ha.ve been of undoubted value, particularly in the 
virilized female, to allow normal sexual development. 
Successful pregn0,ncies in cases of congenital adrenal 
hyperplasia have been reported. (baron 1959; Mason 1961; 
Swyer and Bonham, 1961). The powerful salt-retaining 
substance ga™fluorohydrocortisone is of proven value in 
the salt-losing case particularly for maintenance and I 
believe that this drug can be increased to 0.3 to 0.4 mg. 
daily without producing unwanted side-effacts. This, 
of course is only so if no extra salt other than that 
added while cooking is allowed. Indeed 3 older children 
with salt-loss in this series voluntarily refused extra 
salt when the dosage of 9a-fluorohydrocortisone reached 
optimum levels.
We still await the introduction of a drug which will 
specifically /
specifically control bone maturation thus necessitating 
glucocorticoid for replacement only rather than for 
complete adrenal suppression. Such a drug may have 
been discovered by Sobering A.G. Berlin, Cyproterone
(1, 2-methylen'-6--chlor“A4, 6™pregnadien-17“0l“3 > 20-dione)
a powerful antiandrogenic drug has been shown capable of 
inhibiting normal masculine development in rat foetuses 
so that when the drug is fed to pregnant rats, the whole 
litter consists of somatic femeles even though some are 
genetic males (Newmann and Elgar, 1966). Cyproterone 
is very much at the experimental stage but it holds out 
possibilities as valuable as the present animal 
experiments are fascinating.
Deaths.
In the series of 11 cases, one, case 9 died. This 
child, a female, camie under observation when 3 years 
5 months. A vaginal opening was present through which 
a catheter could be passed into the bladder from a meatus 
^ inch inside the anterior vaginal wall. The clitoris 
was 1 cm. long. She was adpuately controlled on 
dexamethasone 0.75 mg. daily and 2 g. extra salt daily. 
After 4 months she developed a viral bronchitis during 
which the family practitioner discontinued steroid 
treatment. She collapsed and died suddenly on the
2nd day of the illness.
The /
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Adrenal glands from Case 9. Postmortem specimens.
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The adrenal glands are shown hut because of autolysis 
the histological appearance of the tissue is unrepresentative 
and is not shown.
Steroid analyses in diagnosis, management
and research.
The simplest and most rapidly performed quantitative 
estimation of urinary steroids is that of 17-oxosteroids.
As a diagnostic procedure, the test is extremely valuable 
since in congenital adrenal hyperplasia the daily excretion 
of 17-0X 0steroids is invariably increased. On the result 
of this test, I have made the diagnosis in the case of 
this series (Table 2) although clearly the clinical and 
biochemical features were supportive. The estimation of 
pregnanetriol is more time-consuming and although it was 
performed (Tahle 2) the higher results obtained served 
generally to confirm the diagnosis. It will be remembered 
however that in congenital adrenal hyperplasia due to a 
deficiency of 3{3“hydroxysteriod dehydrogenase, urinary 
pregnenetriol (2,1) and not pregnanetriol (2,2) would 
be excreted in increased amounts.
C H
H - O - O H
(2,1)H O
i“3
H - C - ’ O H
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Also with such a defect, the adrenal androgen 
would also have the A.5-configurâtion in Ring B but 
would nonetheless react positively with the Ziiïmiermann 
reagent - assuming that the androgen under these 
circumstances retains a 17-ketone. The urinary 
17-0X0steroids in Oase 4 (30-hydroxysteroid dehydrogenase 
deficiency) were found to be increased (4.7 mg.) before 
treatment commenced.
Once treatment is started, part of the administered 
steroid will be excreted in the urine as a 17-oxosteroid 
and for this reason, the estimation of urinary 
pregnanetriol might afford a truer index of adrenal 
suppression. G-allagher (1954) found that about 2 per 
cent of hydrocortisone (800 mg.) administered to a subject 
could be recovered from the urine as 17-oxosteroids.
If this finding is applicable to infancy and childhood, 
the contribution bo the urinary 17-oxosteroids by orally 
administered steroids, cortisone, prednisolone or 
prednisone, will be micrograms only and this will not 
significantly increase the daily 17-oxosteroid excretion. 
The metabolites of the C-16 substituted (Chart 1) 
synthetic analogues (dexamethasone, betamethasone and 
triameinolone) retain this configuration and therefore 
do not yield Zimmermann chromogens. Such drugs do not
contribute to the total urinary 17-oxosteroids estimated 
by this reaction.
It /
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It will be seen from the composite charts (Charts 
5“10) that the level of urinary 17-oxosteroids reflects 
the progress in bone maturation more than it does 
that of the linear growth. In the 5 cases presented 
the excretion of 17-oxosteroids was rapidly suppressed 
but the difficulty in maintaining continuous even 
suppression is clear in retrospect.
Despite ostensibly good control achieved in Gase 1 
there was escape after puberty from age 10 to 11 years, 
when bone maturation progressed to epiphyseal fusion 
while the height remained static. She is now biochemically 
controlled, with a daily urine.ry 17-oxosteroid level 
just under 2 mg./day. ohe reports, however, that 
when the daily dosage of prednisolone is 10 - 12.5 mg. 
the menstrual flow lasts 4-5 days with an average loss 
but lasts only 1 day end is scant when prednisolone is 
reduced to 5 mg. daily. It may be that after puberty 
v/hen epiphyseal fusion is complete the correct dosage 
schedule should be geared to achieving a normal menstrual 
cycle and flow rather than to a biochemical test. Three 
women who each had a successful pregnancy baron, 1959;
Mason, 1961 and Swyer and Bonhajn, 1961) v/ere receiving 
hydrocortisone 100 mg. intramiusoularly every third day, 
cortisone 25 mg. thrice daily and prednisolone 5 mg. 
thrice daily respectively.
Gases 2 and 4 (salt-losers) and Case 5 (non-salt- 
losing) /
- (
losing) required high dosage of cortisone during their 
early life to maintain clinical progress and although 
the levels of urinary 17-oxosteroids were about 2 mg./day 
the retardation of growth was greater than might have 
been expected with urinary 17-oxosteroid levels of this 
order. i resumably the high doses of glucocorticoids 
inhibited protein anabolism and retarded growth - well 
recognised effects of steroid administrâtion.
Gase 3 is of considerable interest. From age
1 year 3 months when he first presented, until age 3 years
1 month, serial X-rays at short intervals showed an
unrestrained advance in bone age from 2.8 years to 8
years despite large daily doses of cortisone. During
this period biochemical control was assessed by the
Fraction Il/lII index (Hill, I960). This index is the
ratio of the ll-deoxy-17-oxosteroids to the ll-oxy-17-
oxosteroids derived from the 17-ketogenic steroids.
Being a ratio, complete 24-hour collections of urine are
not necessary. While of some value the test falls on
two scores, firstly that absolute values are not obtained
and secondly Gox (1962) has pointed out that
pregnanetriolone is slower to be removed under treatment
than is pregnanetriol, both being present in the urine
of the compensated and salt-losing patient with
21-hydroxylase deficiency. The nett result would be a 
more /
-more rapid fall in the ll-deoxy-l?-oxosteroids than, in 
the ll-oxy-17-oxosteroids.
Despite these considerations the Factor II/III ratio in 
Gase 3 remained high at 1-2.5 (normal 0.5) while on 
cortisone. The correctness of the diagnosis was 
questioned. Cortisone was abruptly stopped without 
any apparent untoward effects. After a suitable period 
of treatment, plasma corticotrophin was estimated and 
reported by Dr. Beryl Connor as 5 milli-units/100 ml.
Adrenal suppression tests were performed using 
dexamethasone and when adequate suppression (Chart 8) 
was observed, treatment with dexamethason was commenced. 
Later the adrenal glands were shown to be unresponsive 
to corticotrophin stimulation during dexamethasone treatment 
About this time the patient removed to Irela.nd and is now 
in the care of Professor I.J. Carre.
Aldosterone excretion in congenital 
adrenal hyperplasia.
It might be expected that aldosterone production 
in the salt-losing syndrome and in the compensated case 
would differ. If 21-hydroxylation.is completely absent 
it would be reasonable to expect a complete failure
in aldosterone production v/hile if the defect is partial,
near normal production might be expected.
At present there is no agreement on the level of
aldosterone production particularly in the salt-losing 
case. /
/ V
case. Fradar, Spaiir and. Leher (1955) have reported high 
urinary aldosterone values while Blizzard, Liddle, Tigeon 
and Wilkins (1959) found that urinary aldosterone, 
hy a bio-assay technique was abnormally low. decently 
two groups have demonstrated depressed aldosterone 
production and excretion in the salt-losing form (Bryan,
Kliman and Bartter, 1965; hew, Miller and Peterson, 1966) 
while the latter group has shown tha.t in compensated, cases 
the urinary excretion of aldosterone is normal.
To explain why some cases with a 21-hydroxylase 
defect synthesize neither hydrocortisone nor aldosterone 
while others syntheseize aldosterone but not 
hydrocortisone, at least in adequate amounts, one might 
postulate that in all cases there is a defect in 
21-hydroxylation of 17a-hydroxyprogesterone - therefore 
impaired hydrocortisone production without salt loss - 
and in addition in the salt-losing form there is a 
defect in the 21-hydroxylation of progesterone. This 
postulate will be proven when it is shown from incubation 
studies that adrenal tissue from the salt-losing case 
can 21-hydroxylate progesterone while that from the 
salt-losing case cannot.
Secretion rates and incubation studies are outside the 
scope of this work, but I have estimated the urinary 
excretion of aldosterone (free and 3-oxo-conjugated) and 
tetrahydroaldosterone in the 11 cases of this series. 
Brooks' /
Brooks’ (I960) method was employed for the free 
aldosterone and that of lasqualini, hegrand and Jayle 
(1963) for tetrahydroaldosterone•
Of the total aldosterone secreted, 5 - 15^ appears 
as the 3~oxO“Conjugate in the urine and a further 
10% as tetrahydroaldosterone conjugated with glucuronic 
acid (loss, 1959)• Table 7 shows the daily excretion 
of aldosterone and tetrahydroaldosterone in the 
present series. tree aldosterone was not detected in 
the urine of the salt-losing cases. To observe the 
ability to increase aldosterone production in response to 
salt deprivation, salt was withheld from Gase 4, but she 
developed hypotension and lethargy within six hours and 
the test was abandoned. Balt restriction therefore was 
not attempted in the other 3 salt-losing cases.
In the same group tetrahydroaldosterone was detected in 
Gase 4 only (8 mg. per day). This was an unexpected 
finding since Case 4 has a defect in 3P“hydroxysteroid 
dehydrogenase. If satisfactory hydroxylation were 
achieved at positions G-l8 and G-21, Gase 4 might produce 
the hypothetical compound (2,3) not dissimilar structurally 
to aldosterone (2,4).
GH OH
0=0 I ^
HO'
(2,3)
HO
(2,4)
I
HO-
(2,5)
( { -
Table 7 • The daily urinary excretion of free aldosterone 
and tetrahydroaldosterone in salt-losing and 
non salt-losing congenital adrena,! hyperplasia.
Case
Sex
Enzyme
Block
Clinical
Type
Age _____ Hg- Pe: r day
Aldosterone TetraHÿâro-
aldosterone
1 F 21-üH No salt-loss 8yr.lOmo. 3.5 39.0
2 F 21-OH Salt-loss 7yr.2mo. 0 2.2
3 M 21-OH No salt-loss 3yr.2mo. 2.5 26.0
4 M 3 -ol Salt-loss 4 - 7dys. 0 0
3.5 yr. 0 1.0
5 F 21-OH No salt-loss 2yr.3mo. 1.2 1.0
6 F 21-OH No salt-loss 8yr • 6.35 45.2
7 1’ 21-OH No salt-loss 9 wks. 0 4.6
8 F 21-OH No salt-loss 2yr.lOmo. 3.75 15.8
9 F 21-OH No salt-loss 3yr.5mo. 2.0 12.5
10 F 21-OH Salt-loss 6 wks. 0 0
11 M 21-OH Salt-loss 3 wks. 0
°
While unlikely to he physiologically active as a 
mineralocorticoid, this compound (2,3) would he 
excreted as a disulphate, having a 21-dihydroxy
structure (Pasqualini and Jayle, 1962). The compound 
(2,5) has in fact heen isolated hy these authors from 
human urine, and Gathro, Birchall, Mitchell and 
Forsyth (1965) have identified this same compound in the 
urine of Gase 4 in excess amounts. It would not, 
however, he hydrolysed hy p-glucuronidase although the 
British Limpet preparation of p-glucuronidase powder 
may also contain steroid sulphatases. These sulphateses 
are only active for the 3P~sulphates of 5o. and A-5"-compounds 
and are not active for 21-sulphates (Hoy, 1956).
According to the modern genetic concept of 1 gene 1 enzyme, 
it is probable that the conversion of a A-5“3P-“Ol compound 
to a A4*"3"Oxo compound is a 2-step reaction involving a 
3(3-hydroxydehydrogenase and an i some rase. This 
reaction is indicated thus:-
3^ -ol Isomerase
’OO . - . . .
(2,7) ° (2,8) (a,9)
While A.5“30“GH compounds (2,6) have been detected in 
the urine of healthy infants and children with 3p- 
hydroxysteroid dehydrogenase deficiency (Bongiovanni 1962; 
Reynolds 1965), so far compounds having A5P-3-0X0 (2,7) 
and /
HO
yy
and &4-3p-ol (2,9) configurations in Rings A and B have 
not Been isolated from the urine of these cases. Ewalt, 
Werbin and Chaikoff (1964) and Kruskemper, Forchielli 
and Ringold (1964) have presented evidence for 2 adrenal 
isomerases specific for G-19 and G-21 A6-3-oxosteroids 
and these could be separated from the 3p-hydroxjsteroid 
dehydrogenase•
The substance which I have estimated in Case 4 as 
tetrahydroaldosterone gives a blue tétrazolium reduction 
in the loci of tetrahydroaldosterone in the 3 chromatograms 
used in the method. The possibility that
0
HO
CHgOH
C OHO-'-
(2^ 10)
this compound has other than a 3u,ol,5P configuration 
(2,10) exists and the further possibility that it is a 
metabolite of a A-5 -3-0X0 compound having the 
conf iguration A-5 -3“U -ol (2,11) is being investigated. 
The difficulty of obtaining standard steroids with 
this configuration is at the moment an impediment.
Free aldosterone was detected in the urine of all 
the non salt-losing cases. These figures are within the 
normal range for age (Miniok and Conn, 1964) and are in 
agreement with those found by others in the simple
virilising form (hew, Miller and leterson, 1966).
The same authors (New, Miller and Peterson, 1966)
" ' ■ ng /
using different chromatographic solvent systems report 
urinary tetrahydroaldosterone for simple viriUsing 
cases aged 7 months to 10 years as 10-57 pg. /day.
These agree with the present findings and indicate in 
conjugation with the normal excretion of free aldosterone 
that there is no disturbance in the production of 
aldosterone in the non salt-losing form of congenital 
adrenal hyperplasia. This investigation of aldosterone 
excretion in the present series was not designed to answer 
the basic problem of the preferences of 21-hydroxylase 
in both forms of the disease but further work on the 
urinary steroid metabolites in Case 4 (3P~hydroxysteroid 
dehydrogenase deficiency) might uncover pathways of 
steroid metabolism still obscure.
The nature of the urinary 17-oxosteroid 
in congenital adrenad. hyperplasia.
At birth the infant with congenital adrenal hyperplasia 
does not show advanced ossification yet abundant evidence 
was quoted in the introduction to this chapter indicating 
that foetal androgens in excess amounts are being produced 
from an early stage of pregnancy. The increased urinary 
17”Oxosteroids have been shown to be due to 
dehydroepiandrosterone and androstenedione (Pulcushima, 
Bradlow, Heilman, Zumoff and Gallagher, 1961) and 
begenhart, Visser, Wilmink and Frankena, 1965., 
report /
report high excretion f.md secretion rates of 
testosterone in congenital adrenal hyperplasia.
Testosterone is the most potent endogenous androgen so 
far known and it is held responsible for the virilism, 
macrogenitosomia praecox, rapid growth and accelerated 
bone maturation characteristic of the syndrome. In 
the comb-growth test, dehydroepiandrosterone and 
androstenedione have only one-sixth and one-eighth the 
androgenic activity of testosterone. Recently 
Reynolds (1965) has isolated from the urine of 
cases with 3-(3-hydroxysteroid dehydrogenase deficiency,
16-oxo-androstenediol (2,12) and 16a-hydroxydehydroepiandros-
0
OHterone (2,13)•
HO HO
(2,13)(2,12)
Both compounds, however, have been found in the urine of 
normal infants (Reynolds, 1964; Bongiovanni, 1962) and 
would therefore seem unlikely to be more potent androgens 
than testosterone. It is equally unlikely that they 
have any function after birth since they are reduced in 
quantity with age and were found in only one of Reynolds 
(1965) cases after the a.ge of 5 months.
Case 4 of this series, with 3P-hydroxysteroid dehydrogenase 
deficiency showed, during the period of glucocorticoid 
withdrawal /
—  UcL
withdrawal, a rapid advance in bone maturation. In 
theory he cannot synthesize testosterone so that an 
androgen or androgens as potent as testosterone would 
seem to be available. If such a compound exists, is it 
peculiar to all forms of congenital adrenal hyperplasia 
or only to the 3p-hydroxysteroid dehydrogenase deficiency 
type?
To examine this question it was decided to carry out 
a qualitative and where possible a quantitative analysis 
of the urinary ll-deoxy-17-oxosteroids and 17-hydroxy-C-19- 
compounds, excreted by the 11 cases of the series. 
Pre-treatment urine was used where possible but in two 
instances urine obtained while the glucocorticoids were 
withdrawn formed the basis of the analysis.
The total conjugates of the G-19 compounds were 
extracted by the method of DePaoli, Nishizawa and Eik-Nes 
(1963) and the glucuronides and sulphates hydrolysed 
as indicated by these authors. The combined steroids 
were purified on silica gel and the aliquots 
chromatographed on the Bush 3 system, before and after 
oxidation.
In Table 8 is shown the age of each patient at the
time of the analysis, the total 17-oxosteroids in the
sample of urine assayed, and a breakdown of the
17-oxosteroids into the various fractions as indicated. 
Dehydroepiandrosterone /
Dehydroepiandrosterone formed about 10^ (mean 
9,4 for 10 cases) of the total 17-oxosteroids with the 
mean androsterone/etiocholanolone ratio greater than 
unity. Case 4 had the greatest output of dehydro- 
epiandosterone (18.96% of the daily total).
Androsterone and etiocholanolone were also detected in 
this case and the immediate precursor of these must 
have had the &4-3-oxo-configuration. These findings
might suggest that here less dehydroepiandrosterone 
is converted to androstenedione than in the others of 
the series and this would be in keeping with a block in 
3(3-hydroxysteroid dehydrogenase activity. It is generally 
accepted that only the A4“3“Oxo compounds are metabolised 
to form the 3oL-ol metabolites such as are androsterone 
(2,14) and etiocholanolone (2,15). Cathro and colleagues 
(1965) have demonstrated excess amounts of 3P”hydroxy- 
compounds in third day urine from this case
(21-hydroxypregnenolone, 132 pg./day and dehydroepiandros­
terone, 30.3 pg./day) but have also shown that in the 
newborn during the early days of life 3P-hydroxysteroid 
dehydrogenase is temporarily inefficient. On theoretical 
grounds, Case 4 may have in part recovered some of this 
enzyme activity and at present the deficiency is less than 
at birth. This is suggested also on clinical grounds
for he now requires only 0.1 mg. 9a-fInorohydrocortisone 
as mineralocorticoid substitution. It will be remembered 
Iso /
also that traces of tetrahydroaldosterone were 
detected.
Few reports of this type of analysis are available 
for comparison. Masuda (1957) has studied the 
pattern of urinary 17-oxo-steroids in 5 untreated 
cases of congenital adrenal hyperplasia. Only 2 were 
in the paediatric age group - boys with macrogenitosomia 
praecox, aged and 7& years. He found that 
dehydroepiandrosterone, androsterone and etiocholanolone 
were all increased and the ratio androsterone/etiocholanolone 
was greater than unity. Rubin, Dorfman and Pincus (1954) 
and Jailer, Gold, vande Wiele and Lieberman (1955) had 
earlier drawn attention to the high ratio of 
androsterone/etiocholanolone in congenital adrenal 
hyperplasia. The real significance of these findings 
is that they reflect increased /
HO HO HOH
(2,17)
0
0
(2,18)
HO
(2,19) (2,20)
oo -
increased secretion by tne hyperplastic adrenal cortex. 
Dehydroepiandrosterone (2,16) is secreted by the adrenal 
as the sulphate (Baulieu, 1962) and is a precursor of 
testosterone (2,l8) via androstenedione (2,17)
(Mahesh & Dreenblatt, 1962). However, Klempien, Voigt 
and Tanun (1961) have given evidence that the major 
pathway from dehydroepiandrosterone to testosterone is 
via A-5~androstene“-3P> 17pdiol (2,19) and not A4” 
androstenedione (2,17). If this is so, it is an important 
step, for in congenital adrenal hyperplasia the high 
levels of circulating dehydroepiandrosterone might push 
the reaction in favour of testosterone (2,l8) production.
An earlier quoted, increased secretion and excretion of 
testosterone in congenital adrenal hyperplasia has been 
reported by Visser (1966).
From Klempien*s finding, Ah-androstene-lp,17Pdiol 
might reasonably be expecced to undergo dehydrogenation 
at 03 with isomérisation of the Ah-structure to a A-4, 
to form testosterone. However, dehydrogenation followed 
by reduction of ring J3 to the 5a compound would result 
in androstane-176”Ol”3“One (2,20). This compound hes 
been prepared in vitro by Butenandt, Tschering and Hanish 
(1935), and it is almost as active as testosterone in the 
0omb-growth test. Its synthesis in congenital hyperplasia 
has not heretofore been reported but I am of the 
opinion /
opinion that I have detected a, substance in Cases 4 
-and 11 which behaves ch roinat ogra .hically before and after 
oxi da t i on 'wl th chr omi c acid si mi le r o androstrne-17 f - 
ol-3-one. In ext o,cts p reviously oxidised with chromic 
acid, a Zizimiermann positive spot was present in tbr Bush C 
system at ( ppc ) 3 • 2. This spot was not found in
unoxidised extracts. It seemed possible that this 
unkno^vn 17-ketone might have derived f: o^m a compound 
h--ving a 17-hydroxyl group. To test this hypothesis 
chr0''iri togr'j_hic strips of the unoxidised extracts we-e 
oxidised with copj.er acetate in methanol according to 
o eher (1964) and the re after a faint Z immp rmanri 
;'’ea,ction wa.s observed at (D C) ^ • 28 where none 
had occun-ed before. The chromatic behaviour of several 
likely isomers wa.s studied and and r o s t an e -1'7 b - o 1- 3 - on e 
compared most nearly to the unknown. Comj>lete 
inentifica.tion of this compound awaits further analysis 
by gas/liquid chromatographic techniques. If, however, 
the unknown substance is androstane™-17P”Ol-3"-one, the 
continuing bone ma/turation observed in Case 4 when 
glucocorticoid sUjgjressive drugs were withdravm, is 
more readily understandable, unless he also wa.s 
synthesising testosterone, which is theoretically 
unlikely, by the pathway suggested, by Klempien, Voigt 
an d T a.mm (1961) .
The increased excretion of androsterone and etiocholanolone 
(Table 8) /
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(Table 3) observed in the series reflects increased 
adrenal production of their precursors. Androsterone 
(3a,5u) derives from dehydroepiandrosterone, Al­
and rostenedi one and testosterone. Etiocholanolone 
(3a,56) is preferentially formed from pregnanetriol, 
17a-*hydroxypregnanolone and 17a-hydroxyprogesterone.
Thus both G-19 and 0-21 steroids are being produced 
in excess amounts. In both Masuda's (1957) and 
Birke and colleagues' (1953) reports, 116-hydroxylated- 
56-17-0X0steroid8 were not found and it has been 
suggested that this finding might indicate different 
metabolic pathways for 17-oxosteroids and corticosteroid.s 
in congenital adrena.l hyperplasia (Bergstrand, Birke and 
Plantic, 1959)*
My finding of an increased excretion of both androsterone 
and etiocholanolone, with the ratio androsterone/ 
-etiocholanolone greater than 1, is in keeping with these 
authors' findings. Only in Case 4 was this not so 
although the differences were minimal (androsterone 
454 pg./d., etiocholanolone 463 pg,/d.). It would be 
unwise to claim tha/t this isolated finding is significant 
but further investigation along the lines suggested by 
Bergstrand, Birke and Plantin (1959) might elucidate 
its meaning.
A-A-androstenedione was detected in the urine of 
C 8- s e s /
Gases 1, 2, 3 and 6 but in each the amount was less than 
5 (Jig./day (visual comparison with 5 (Ag. standards on 
sidelanes of chromatogram). Testosterone, 
estimated as A^-androstenedione after oxida.tion with 
chromic acid was detected only in trace amount in 
Oases 1 - 9  (excepting Case 4). There is very little 
published data on testosterone excretion rates for 
normal children but excretion is thought to be less than 
5 pg./day.
In 11 cases of congenital adrenal hyperplasia,
Degenhart, Visser, Wilmink and Frankena (1965) found 
excretion rates ranging from 11 - 261 pg./day. The 
values found in this study are much lower and are 
related to differences in the techniques used.
It is clear from this work, and the literature that 
the study of urinary steroid patterns in congenital adrenal 
hyperplasia is not exhausted and cases with 36”hydroxysteroid 
dehydrogenase deficiency hold a source of material 
yet to be investigated.
For instance, little is known of the steroidogenic 
capacity of the testes in these patients. Should their 
testes be placed in the scrotum at an early age? Has 
testicular descent failed due to the adrenal or a 
coneocomitant testicular biosynthetic defect? Is there 
in fact a clinical syndrome associated with a 36" 
hydroxysteroid dehydrogenase deficiency without an 
associated /
associated A-5-isomerase deficiency or does a deficiency 
of A 5-isomerase alone present as a clinical entity?
This chapter, far from answering any specific 
question has, as far as the author is concerned, 
opened the door to a field of research based on methods 
outside the scope of this present work.
S T U D I E S  O F  C O R T I S O L
Metabolism
in
children of short stature.
yu
Frequently children of short stature are brought to 
the paediatrician in the hope that the particular cause 
of the retardation will be discovered and removed, to allow 
normal growth to proceed. Vhen organic disease such as 
coeliac disease or hypothyroidism is found dietary measures 
or substitutionary treatment result in resumption of 
normal growth. Gross and irremediable congenital 
abnormalities in the cardiovascular and renal systems 
frequently result in stunting of growth and the true facts 
must ti^ en be given to the parents. When these and other 
organic conditions known to result in dwarfism have been 
excluded there remains a group of children whose small 
stature is less easily explained. In some, hereditary 
factors may play a part and it is often helpful to know 
the family growth pattern. Parents and siblings may 
however be normally tall and this serves rather to 
emphasise the smallness of the patient.
In assessing the small child it is clinically 
convenient to correlate height and weight with age so that 
the terms height age and weight age when applied to a 
particular patient may give the impression of a. small, 
fat child or a tall thin one, and while this is of 
immediate value it does not serve as a good standard by 
which to compare children of different chronologica.l ages.
Growth /
-  yj.
Growth charts prepared by Tanner and Whitehouse 
in part fill this gap. On these charts heights and 
weights for age are plotted in relation to average limits 
of normality between the 3rd and 97th percentile so that 
trends in the development (height or weight) of a child 
may be followed over several years, particularly if 
therapeutic measures are instituted, A good example 
is seen in the case of a child with coeliac disease who 
at the time of diagnosis may be below the 3rd percentile 
for both height and weight and when treatment with 
gluten-free diet is instituted the growth curves move 
towards the 50th percentile.
The subjects of Che present investigation are a 
group of small children who have been placed in 3 
categories according to clinical considerations.
1. M aInutrition.
While inadequate growth due to inadequate calorie 
intake is rare in the general child population of the 
United ningdom environmental factors such os neglect and 
poverty sometimes militante against adequate nutrition. 
Children from such environments, accustomed to little 
food, readily develop small appetites, the anorexia 
resulting only in less food being macte available to the 
children. Group 1 consists of 16 children (Table Ij 
who were inmates of an orphanage (Quarrier’s Homes, 
Bridge /
Bridge of Weir). All had been subjected to varying degrees 
of malnutrition and this with other social factors had 
resulted in their admission to the orphanage. All had 
retarded bone age and all were below the 3rd percentile for 
height. Only 2 were above the 50th percentile for weight,
5 were on the 10th percentile, 4 were on the 3rd and 5 were 
beneath the 3rd percentile. There wa.s no evidence of organic
or endocrine disease in any of this group. There was no 
available data, on the family growth pattern although Gases 
1 - 4  v/ere siblings as were also Gases 5 and 6.
Table 1. Data concerning the Group I children of
small stature.
Case Sex Age Bone Age Percentile
Years Years Height Weight
1 L.I. F 4.5 4 ”3 -3
2 E.I. F 6.5 6 -3 -3
3 G.I. M 10 8 "3 "3
4 M.I, F 11.5 9.5 “3 3
5 A.M. F 6.5 5.5 ”3 3
6 J.M. M 13.3 7 -3 10
7 M.McL. F 7.25 4.5 -3 10
8 T.G. M 7.5 6.5 “3 10
9 G.E. M 8 4 -3 ”3
10 W.M. M 8.75 6.5 -3 -3
11 G.8. M 10 8 -3 95
12 S.D, F 10 9 -3 10
13 G.T. F 2.5 1.5 -3 75
14 G.T. M 5.25 3.5 "3 "3
15 G.B. M 6 3 “3 10
16 J.M. F 6.5 6 "3 3
V  o
2, Congenital growth retardation.
Primordial dwarfism has been applied to this group 
in whom smallness has been apparent since birth. Warkany, 
Monroe and Sutherland (1961) used the term 'intra-uterine 
growth retardation' to indicate that in these children 
growth inhibiting factors seem to be operative from a 
very early stage. They are usually small at birth 
although born at term and their growth proceeds slowly. 
Ussification at different centres may vary but there 
is usually no gross specific retardation. Their mental 
age is normal and sexual maturation is not delayed. When 
epiphyseal fusion takes place they are small, normally 
proportioned adults. Group 2 of this series consists 
of 4 children classified as primordial dwarfs, (Table 2.). 
Bone age was minimally retarded in all 4 and all were 
below the 3rd percentile for height. Organic disease was 
excluded.
Table 2. Data concerning the primordial and hypopituitary
dwarfs in the series.
Case Sex Age Bone Age Percentile Diagnosis
J.G. M
Years
3
Years
2.3
Height
-3 Primordial
R.H. M 3 0.6 "3 Primordial
J • A • M 3.8 0.75 -3 Primordial
D.P. M 4.5 1.5 “3 Primordial
B.C. F 13 6.0 -3 Hypopituikai^
W.McI. M 13 5.6 “3 Hypopituitai;
— yn —
Fig. 1. W.Mcl. Male case of hypopituitary dwarfism. 
Gynaecomastia due to treatment with ethyl 
estrenol.
- 95 -
*
Fig. 2. E.O. Female case of hypopituitary dwarfism. 
Breast enlargement due to treatment with 
ethylestrenol.
3. Congenital hypopituitary dwarfism.
This condition is generally regarded as the gradual
onset of growth retardation in the 2nd or 3rd year of
life associated with bji immature facies, a height-age
more retarded than skeleteal age, with a height well
below the 3rd percentile after the age of 4 years.
These patients usually show increased insulin
sensitivity and some degree of impaired sexual
development. Evidence of subthyroidism and hypofunction
of the adrenal cortex are usually considered to be present
although in variable degrees. Group 3 of this series
consists of a boy and a girl, both aged 13 years whose
parents gave a history of the onset of growth retardation
during the second year of life. Both showed immature
facies (see photographs), and their height and bone
ages were grossly retarded (Table 2). At present
neither are showing evidence of sexual development
although both have developed breasts when treated with
ethyl estrenol. In a group of 20 children being
treated with this anabolic steroid, they are the only
2 who have shov\n breast enlargement. Since the
treatment of small stature is outside the scope of
this investigation the above findings must remain
sub judice. The boy showed increased insulin
sensitivity and no increase in growth hormone secretion 
during /
J I
during hypoglycaemia (Table 3)• These two children are 
classified as examples of congenital hypopituitary 
dwarfism.
Table 3« Growth hormone and blood sugar levels after
intravenous insulin (o.l unit/Kg. body weight) 
in 2 cases of hypopituitary dwarfism.
Plasma HGH 
mpg./ml.
Blood Sugar 
mg./lOO ml.
Minut e s Male
W.McM.
Female
E.O. W.McM. E.O.
0 3 0 102 79
10 3 14 51 29
20 4 25 16
30 3 27 67 42
40 3 16 42
50 2 — 42
60 — 20 51 53
70 —
80 — — 43
100 1 7 51 74
Urinary steroid metabolites 
The object of the investigation was to study the 
adrenal function in these 3 groups of children by an 
analysis of the urinary steroid metabolites. It might 
have been expected that in the primordial and 
hypopituitary /
hypopituitary group, adrenal function would he impaired 
and that resting values might afford little information, 
especially if the analyses were to include estimation of 
the free unmetaholised corticosteroids, hydrocortisone 
and cortisone. Gope and hurlock (1954) have pointed out 
that under basal conditions urinary hydrocortisone levels 
are unsuitable for detecting adrenal hypofunction.
Thus it was decided that each patient would receive a standard 
adrenal stimulation with corticotrophin and the adrenal 
response to this as reflected in the urinary steroid 
metabolites would form the basis of the comparison.
A group of 14 other children, whose ages ranged from 
3 months to 10 years, who were recovering from 
non-endocrine disease, were included in the study as 
normals.
Each child received corticotrophin (Acthar gel-H.P. 
Armour) 20 mg. at 12-hourly intervals for 2 days and on 
the second day, a 24-hour collection of urine was made 
using a small amount of chloroform as the preservative.
This urine was analysed for hydrocortisone, cortisone and 
their tetrahydrometabolites by the methods set out in 
Chapter 5. The results obtained from this investigation 
are shown in Table 4 (normal children), Table 5 
(malnutrition group) and Table 6 (primordial and 
hypopituitary groups).
The body handling of corticosteroid is contained in 
the /
y y
the processes, secretion, plasma binding, degradation 
and excretion. Under normal basal conditions only that 
fraction of circulating corticosteroid which is not 
plasma bound, is available for excretion in the free 
state or for degradation. Thus binding inhibits both 
degradation and excretion of the free unmetabolised 
substance. To estimate one fraction of a corticosteroid 
gives little information regarding the processes between 
secretion and excretion. Further in certain diseases the 
total process of steroid metabolism is altered. Thus 
Doe, Zimmermann, Flink and Ulstrom (I960) found that in 
Cushing's Syndrome, the elevated levels of total plasma 
17-hydroxycorticosteroids were due to an increase in the 
non-protein-bound fraction and Cope and Black (1959) 
showed that the rise in urinary hydrocortisone was twice 
as great as the increase in 17-oxogenic steroids, this 
being due to a greater proportion of free cortisol.
Degradation of corticosteroids is effected mainly in 
the liver by reductases and it would appear that these 
have marked specificity. A A4-steroid reductase 56 is 
specific for reducing the double bond of cortisone and 
hydrocortisone while a A4-steroid reductase 5a produces 
the 5a-metabolites. Both these reductase systems are 
irreversible and cannot re-introduce a double bond into 
the ring A saturated steroid. 56“^e^.uctase has been 
f ound /
J L V U
found in the soluble fraction of mammalian liver while 
the 9^-reductase is a microsomal enzyme.
To estimate total urinary 17-hydroxycortisteroids 
only would therefore give no information regarding these 
processes and if a greater understanding of adrenal 
function in these forms of dwarfism selected for the 
study is to be obtained an analysis of the several 
urinary metabolites of hydrocortisone might prove of 
value. Thus hydrocortisone, cortisone, tetrahydrocortisol 
(3a, 56) allo-tetrahydrocortisol (3u, 5a) and 
tetrahydrocortisone were estimated and compared with 
the values found in the normal children.
hormals.
From Table 4 (normal group) it will be seen that 
free hydrocortisone appears in the urine at levels ranging 
from 125 to 482pg.per day with a mean for the group of 
335pg*per day. Free cortisone is also present 
(l8-120pg. per day) with a mean of 54pg. per day.
The hydrocortisone/cortisone ratio was 4 to 9*1 (mean 6.4). 
Hydrocortisone is the principal adrenocortical 
glue00orticosteroid. Cortisone is not itself secreted 
by the adrenal cortex but it is formed peripherally by 
the 11-dehydrogenation of hydrocortisone. Little is 
known /
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known of the extent of cortisone formation except that 
a substantial fraction of the urinary metabolites of 
hydrocortisone is tetrahydrocortisone (3a, 56, ll-oxo).
Thus before reduction is complete 11-dehydrogenation of 
hydrocortisone would appear to play an important part.
An examination of the values obtained for the 3 metabolites, 
tetrahydrocortisol (THF), allo-tetrahydrocortisol 
(allo-THF) and tetrahydrocortisone (THE) immediately 
reveals that there is a wide range for each child in the 
group. What does however emerge is the relative 
constancy of the proportion of allo-tetrahydrocortisol 
in the total metabolites of the individual case. This 
finding probably indicates a functional constancy of 
reductase 5a whose function might also be hormone 
controlled. For instance Guignard - De Maeyer, Grigler 
and Gold (1963) noted that in 12 cases of Cushing's 
syndrome there were relatively small amounts of the 5a 
reduced metabolite of hydrocortisone while in congenital 
adrenal hyperplasia (2 cases) the percentage of 
allo-tetrahydrocortisol was minimally above normal.
The ratio allo-tetrahydrocortisol (3a, 5a) to 
tetrahydrocortisol (3a, 56) gives an estimate of hydro­
cortisone metabolism with reference to hepatic 5a- and 
56"]^Gducta8e8. Again in the normal group this ratio
is remarkably constant. The above-mentioned authors 
have /
-LUJJ -
have observed a fall in the ratio allo-tetrahydrocortisol/ 
tetrahydrooortisol (5ci/5P) in children given corticotrophin 
and they suggest that the fall might indicate a limitation 
of 5a"reductase capacity or perhaps an increase in 
53-*reductase. They found the 5a/53 ratio in 4 instances 
to range from 0.12 to 0*30 with a mean of 0.17. In the 
present series of 14 normal children the range was from 
0.14 to 0.49 with a mean of 0.21. Visser and Cost
(1964) when reporting on a family with a defect in the 
biosynthesis of aldosterone give some data on hydrocortisone 
metabolism in 3 normal infants aged 3? 5 and 8 months.
In the resting state they found the 5u/5P ratio to be 
8.2 and 5*3 while after corticotrophin stimulation (6.6,
5, 3» 4, 6 and 3.4) no gross change was observed.
The ratio allo-tetrahydrocortisol plus tetrahydro- 
cortisol/tetrahydrocortisone (allo-THF^-THF/THE) gives 
an indication of 11™oxidation of hydrocortisone.
In terms of actual quantities of tetrahydrocortisone (THE) 
the normal infants and children in this series excreted 
more of this metabolite than the combined 5a and 5(3 
metabolites of hydrocortisone. Further there tends to 
be a slight increase with age and although this does not 
corroborate Visser and Cost's (1964) figures it agrees wmth 
those found by Gupta (1966). The 11-oxidation index found
in this group ranged from 0.3 - 0.91 with a mean of 0.52.
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Because of the very few studies of this kind 
reported in paediatric literature further comraent on the 
significance of these findings must be withheld meantime.
Malnut rition.
In Table 5 are the results of a similar analysis 
of the same urinary steroids found in the 16 children 
whose small stature is attributed to deficient calorie 
intake. once again it will be seen that there is a 
very wide scatter of the various metabolites for each 
individual although there seems to be a pattern emerging 
not dissimilar to that found in the normal group.
Observe that the mean daily excretion of free hydro™ 
cortisone is 322 pg. per day compared with 335pg. per day 
in the normal group. This difference is not significant. 
Cortisone is excreted in somewhat less amiounts the meaJi 
being 44pg. per day with the range of 1? - 75 pg. per day 
(normals, mean 54pg. per day; range 18 - 120pg. per day). 
The range of the ratio of hydrocortisone to cortisone 
was nob dissimilar in both groups although the mean 
was slightly higher in the children of sma.ll stature.
This suggests that although they did not excrete as much 
free hydrocortisone as the normals there was a reduction 
in the conversion of hydrocortisone to cortisone.
Because of the over-all differences in the total quantity 
of urinary steroids estimated in each case a correlation 
of /
of values found for the 3 metabolites would serve little 
purpose. Table 5 however does show that of the total 
metabolites estimated allo-tetrahydrocortisol still forms 
a proportion (7 per cent) similar to that of the normal 
group (6.6 per cent). Also the activity of hepatic 
reductase 5^ is simila.r to that of the normal group (0.2 
and 0.21). The 11-oxidation index however shows a slight 
rise from the normal mean of 0.52 to 0.95 which bears out 
bhe finding of a higher hydrocortisone/cortisone ratio 
in the group. If an interpretation is pexmissible at 
this stage, it might be that these children of small 
stature retain more hydrocortisone in their circulating 
hormone pool, perhaps primarily for its more active 
glucocorticoid effects as well as for its anti-stress 
activity. This statement assumes that the nutritional 
deprivation may result in a, lowering of the blood sugar 
level which is restored to normal by increased circulation 
of active glucocorticoid.
Irimordial Dwarfs.
In Table 6 are the corresponding values found in the 
4 cases of primordial dwa,rfism. Immediately it is clear
that these children excrete less of each fraction than 
do those of the first two groups the mean ratio 
of hydrocortisone/cortisone remains similar to the normal 
group although the total quantities of both hydrocortisone 
and cortisone are markedly reduced (mean 139pgn/day).
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Allo-tetraiiydrocortisol holds a normal percentage of the 
total metabolites although there might be a slight 
restriction or limitation of 5a-reductase as seen in a 
somewhat lower ratio of allo-tetrahydrocortisol/tetra- 
hydrocortisol (0.147). It might, however, be argued that 
5P-reductase is increased but information on minor alterations 
in this ratio is scant. The mean 11-oxidation index 
in the group is 0.795 which is higher than that of the 
normal group. The range however of the individual values 
is well within the normal range, and the higher meon value 
is probably not significant especially since the 
hydrocortisone/cortisone ralio is judged normal.
Pituitary Dwarfs.
In Table 6 is also shown the comparable figures for 
the 2 cases of hypopituitary dwarfism. It is regrettable 
that only 2 cases had been sufficiently thoroughly 
investigated to justify inclusion for it is in these 
2 children that the most striking changes are observed. 
Although the total urinary metabolites remain low, more 
comparable to the values found in the primordial dwarfs 
the daily excretion of free hydrocortisone is remarkably 
high (800 and 870pg. per day). While the excretion 
of cortisone is also high (56 and 75pg. per day) the 
very high ratio hydrocortisone/cortisone (12.1 and 13) 
indicates a body handling of hydrocortisone in favour of 
maintaining /
maintaining increased circulation of free glucocorticoid.
The percentage of a.llo-tetrahydrocortisol has increased 
to 12.1 and 13 per cent of the total metabolites while the 
5a/5P ratio remains reasonably normal at 0.22 and 0.23 
(normal group mean 0.21). The significance of this 
high percentage of allo-tetrahydrocortisol is not clear 
but Bush and Willoughby (1957) have reported high values 
in hirsute women.
The other striking feature of these 2 cases is the 
high 11™oxidation index (2 and 2.06) which has been 
obtained by a shift of metabolism in favour of higher 
values for tetrahydrooortisol than tetrahydrocortisone.
In the other children studied of all groups, more 
tetrahydrocortisone than tetrahydrooortisol was invariably 
isolated.
Results interpreted.
The results obtained in this analysis have been 
reviewed. Are they of significance in relation to the 
conditions in which they have been found?
As stated earlier hydrocortisone secreted by the 
adrenal cortex circulates in part unbound to protein.
Only this fraction is free for glomerular filtration and 
can be detected in the urine. Resting vs.lues of urinary 
hydrocortisone are of no value in detecting hypiofunction 
of the adrenal cortex but Ross (I960) has stressed its value 
in the diagnosis of Cushing's syndrome when it is increased.
The /
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The fraction of protein-hound hydrocortisone is hound 
to a globulin named 'transcortin* and binding tends to 
inhibit both excretion and metabolism. It is assumed 
that the free steroid is released from the binding 
protein according to body requirements so that there is 
an available circulating pool of active material.
The main site of metabolic degradation is in the 
liver by the system of and 5p-reductases and after 
reduction the tetrahydrometabolites, conjugated mainly 
with glucuronic acid, are excreted in the urine.
There are few abnormal protein-binding conditions 
and the alterations observed in the metabolism of 
hydrocortisone in the primordial and hypopituitary 
dwarfs are unlikely to be due to alterations in transcortin 
levels or activity.
Apart from the slight increase in the 11-oxidation
index found in the group of small children in whom
malnutrition might have been a causal factor no substantial
difference was noted between their hydrocortisone metabolism
and that of the normal group. The influence of calorie
intake on human growth is well recognised. Small appetites
may result in less food being made available which in
turn predisposes to anorexia. Such a circumstance may
well reduce the available carbohydrate required to maintain
adequate blood sugar levels and as a compensatory mechanism, 
endogenous glucocorticoids assume a greater role in 
maint aining /
H i .  -
maintaining adequate blood sugar levels. Hence less 
hydrocortisone is converted peripherally to cortisone, 
hydrocortisone being the more active glueocorticosteroid. 
The net result might therefore be a diminution of 
tetrahydrocortisone (THE) which might account for the 
slightly raised 11-oxidation index.
In primordial dwarfism little is known of the 
pi tui t ary/ad renal function. One case described by 
Hubble (bl966) had a fasting growth hormone level of 12 
mpg./ml. They do not respond to treatment with growth 
hormone (Shepherd, Waxma.n, Bernstein and Perrier, I960) 
and the results of this present investigation indicates 
that they secrete smaller quantities of free hydrocortisone 
than do normal children when subjected to a standard 
corticotrophin stress. Otherwise their metabolism of 
hydrocortisone does not differ from the normal pattern.
According to modern concept, growth proceeds by cell 
multiplication and by increase in cell size. In the 
young embryo multiplication is more important while in 
postnatal life increase in cell size is the determining 
factor for growth. Gheek and Cooke (1964) have suggested 
that in primordial dwarfism there is a decreased m m b e r  
of cells of normal size so the demand for growth hormone 
is less. If this hypothesis is applicable to the
cellular content of the adrenal cortex then it is 
reasonable that in response to a standard stimulus the 
secretion /
secretion of hydrocortisone should he less than in the 
average normal subject.
In hypopituitarism, with growth hormone failure, 
hypoglycaemic unresponsiveness is characteristic often 
in association with evidence of thyroid and adrenocortical 
insufficiency. It is seldom that the complete picture 
is seen and it is an impression that some cases are 
deficient in growth hormone alone. The 2 cases 
investigated here, had lowered growth hormone levels 
(Table 3) and one (W.McI.) exhibited hypoglycaemic symptoms 
during an insulin unresponsiveness test. Both showed 
infantilism and the areas of their pituitary fossae were 
30.5 sq.imn. and 42 sq.mm. (both below the 5th percentile 
for age) by the Silverman technique. The protein bound 
iodine level was normal in both. The finding of a high 
daily excretion of free hydrocortisone in both was 
unexpected although in that the total urinary metabolites 
were low clearly indicates that this latter finding did 
not indicate an increased adrenocortical activity, but 
rather an alteration in hydrocortisone metabolism. The 
evidence suggests that in these two children the body 
requirements for free hydrocortisone, probably for its 
glucocorticoid action, has resulted in a reduction in its 
conversion to cortisone as evidenced by the low excretion 
of tetrahydrocortisone and the high 11-oxidation index.
The /
The present understanding of the action of human 
growth hormone could support this hypothesis. Rahen
(1965) asserts that human growth hormone is a single 
substance causing both growth by protein synthesis and 
lipolysis. Levine and Luft (1964) however consider 
that two hormonal fractions compose human growth hormone, 
one promoting protein synthesis and increasing insulin 
secretion and the other having a diabetogenic effect - 
resisting insulin activity - and a lipid mobilising action. 
Randle, Garland, Hales and Newsholme (1963) have suggested 
that free fatty acids released from adipose tissue under 
the influence of growth hormone inhibits carbohydrate 
metabolism in muscle and thereby causes a rise in blood 
sugar. This mechanism for maintaining the blood sugar level 
may break down when growth hormone production is impaired 
and the alternative action of glucocorticosteroids would 
then be of importance. Long, Katzin and Fry (1940) have 
shown that the source of the carbohydrate to maintain 
adequate blood sugar levels by glucocorticoid activity 
is from increased protein catabolism. Corticotrophin 
then, through its action on the adrenal cortex, antagonises 
human growth hormone. If this is the mechanism operating 
in growth hormone deficient children then failure of 
synthesis as well as increased protein catabolism adequately 
explains their growth retardation but it might also account
for the higher level of free urinary cortisol found.
It /
It is possible however that since it is only the 
free protein-unbound hydrocortisone which is filtered by 
the glomerulus that less protein binding takes place in 
growth hormone deficiency. An extensive search of the 
literature has cast no light on this problem although 
Korner (1965) has shown that one action of growth hormone 
is to stimulate RNA synthesis. It is conceivable that 
deficiency of growth hormone might result in reduction of 
the labile pool of proteins and that the specific 
globulin, transcortin, is quantitatively reduced.
Since so little contemporary work on this subject 
is available for comparison the full significance of these 
findings cannot be stated. It is clear that further study 
of the type already completed here in association with 
an evaluation of plasma steroids, free and protein-bound, 
is essential in the hope that it will yield information 
which will help to add a cubit to the height of these 
children of short stature.
STUDIES IN ADDÜSTEWNE EXCRETION.
Urinary aldosterone in cases of congenital 
pyloric stenosis and in nephrosis.
The isolation and characterisation of aldosterone by 
Grundy, Simpson, Tait and colleagues (1952 and 1954) was a 
remarkable achievement and subsequent investigations of 
its actions led to a fuller understanding of renal tubular 
reabsorption of sodium and potassium.
However, the concentration of aldosterone in urine 
is approximately one in 200 million, and in blood one 
in 1,000 million (Ross, 1959) which demands that methods 
for its quantitative estimation must not only be specific 
but accurate and reliable. While the paediatrician is 
familiar with the mineralocorticoid effects of milligram 
quantities of desoxycorticosterone, it is perhaps not 
without some reluctance that tenths of a milligram of 
9a-fluorohydrocortisone, a more powerful salt-retaining 
steroid than desoxycorticosterone, are being introduced 
to the therapeutic armamentarium for the management of the 
salt-losing syndrome in congenital adrenal hyperplasia.
It is against this background that the microgram or 
perhaps nanogram quantities of aldosterone, likely to 
be encountered in paediatric practice are to be seen. Has 
the estimation of urinary aldosterone, often in less than 
microgram amounts, a place in paediatric diagnosis or is 
the estimation of research value only?
Salt-losing states demand iminediate correction by 
measures often including the administration of synthetic 
mineralocorticoid /
mineralocorticoid and such measures may rapidly remove 
the stimulus for aldosterone secretion. To delay treatment 
while a urine collection is made may well prove fatal. 
Conditions exist in which aldosterone excretion is markedly 
diminished, for example the salt-losing form of congenital 
adrenal hyperplasia, while increased excretion has 
been reported in nephrosis (Luetscher and Johnson, 1954). 
Visser and Cost (1954) have described a. family with a 
biosynthetic defect in the production of aldosterone but 
diagnosis of this condition depends on more elaborate 
biochemical procedures than demonstrating an absence of 
aldosterone in the urine. I'hese authors emphasise tho.t 
the finding of aldosterone precursors in the urine is 
essential to the diagnosis and there are few paediatric 
centres where urinary te brahydrodesoxycorticosterone,
101 rahyd r 0 c 0 rt i c 0 s10 ron0 and t e t rahy d ro-18-hyd roxy c o rti- 
costerone could be estimated with precision. Further 
the cases referred to are unique in the literature.
Conn's (1955) syndrome of hyper-aldosteronism is 
ra.re in paediatric practice but exhibits the same clinical 
features of hypokalaemia, alkalosis, muscle weakness with 
attacks of tetany and raised blood pressure typical of the 
adult form of the disease. In Conn's syndrome the 
urinary excretion of aldosterone is increased but without 
demonstrating a raised aldosterone secretion rate no surgeon 
would be prepared to undertake the hazardous task of 
exploring /
exploring the adrenals for an adenoma which might be 
remarkably small. The estimation of aldosterone secretion 
rate requires the administration of tritium-labelled 
aldosterone and at present ethical considerations 
restrict our injecting children with radio-active material. 
Nonetheless, Laragh (1950) has suggested that measurement 
of secretion rate is a more reliable index of increased 
production than the quantity of the acid hydrolysable 
metabolite usually measured.
Conn’s concept of 'primary aldosteronism' does not 
include oedema although it is present in those conditions 
which give rise to secondary aldosteronism such as cardiac 
failure and nephrosis. Fine, Meisalas, Colsky and Cxenhorn, 
(1957) have however described oedema in association with 
adrenal tumour and hyperaldosteronism.
Of the conditions in which secondary hyperaldosterone
is seen, nephrosis is not rare in hospital paediatric
practice in Glasgow. During the years 1963 to 1966,
74 children with nephrosis have been in-patients in
Professor J.H. Hutchison's wards in the Royal Hospital-
for Sick Children, Glasgow. Some of these however are
re-admissions of cases in relapse. In a selected number
(6) of these the urinary excretion of a.ldosterone was
monitored during the oedmatous and diuretic phases.
Congenital pyloric stenosis is also a condition in which 
the /
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the excretion of aldosterone might he increased because 
of the loss of sodium and chloride due to vomiting.
In 15 cases of this condition the daily urinary 
aldosterone was estimated.
These results will be discussed.
Methods of Estima.tion
The early biological assay techniques for 
aldosterone estimation devised by Dorfman, Potts and Feil 
(1947) and used by Luetscher and colleagues ( 1951) v\?ere 
displaced by }i)hysicochemical methods devised by Ayres,
Gorrod, Simps.n and Tait (1957) and Brooks (I96O).
Ayres and co-workers (1957) introduced the principle of 
isotope dilution for the estimation of aldosterone.
This involved the use of G^^'-labelled acetic anhydride 
to form the diacetate of aldosterone and after 
separation of the diacetate by column chromatography, the 
specific activity of the aldosterone diacetate was 
determined. From knowledge of the original radioactivity 
present, quantitation of the separated aldosterone could 
be calculated. With this method, recovery rates of 37 
per cent have been reported.
With the introduction of tritium-labelled 
aldosterone double labelling methods for aldosterone 
estimations were devised by Kliman and Peterson (1958) 
and they claim that with this method 0.01 pg. of aldosterone 
can be detected.
The /
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The principal excretory pro-net of aldosterone is a 
3“0X0“C0njugate, split by hydrolysis at pH 1 to liberate 
free aldosterone (Jones, Lloyd-Jones, Riondal, Tait,
Tait, Bulbrook and Greenwood, 1959). Only about 10 per 
cent of the total aldosterone secreted is excreted in the 
urine in this form (Iviills, 1954; Neher and Wettstein, 
1955). A further 10-15 per cent is excreted as 
tetrahydroaldosterone conjugated with glucuronic acid 
(Ulick, Laragh, Lieberman and Loeb, 1958). By the 
method used in this work only the free and the 3“Oxo- 
conjugate of aldosterone are estimated.
There is no large series of normal values for
urinary aldosterone in infancy and childhood quoted in
the literature. Minick and Conn (1964) give values for
aldosterone excretion in 30 norma.l children ranging from
4 months to 13 years 8 months with recovery rates from
75 - 85 per cent. The range is from 1 pg. at 4 months
to 9 pg. at 13 years 8 months but they a.lso found a daily
excretion of 12 pg. per day in a 22 year old male and
6 pg. in a 54 year old woman. It is clear from these
findings that there is a wide range of normal values from
infancy to adult life and while values greatly in excess
of the accepted normal range would be significant, undue
stress should not be placed on values less than 1 pg.
estimated by the present physico-chemical method. In 
these /
1 2 0
these circumstances secretion rate studies using double 
isotope-labelling techniques are clearly indicated, 
although if a low secretion rate causes clinical symptoms 
the emphasis would naturally be on treatment in the first 
instance.
The investigations to be discussed in this Chapter 
concern the estimation of urinary free aldosterone in 
15 male infants with pyloric stenosis and 6 children with 
nephrosis admitted to the Royal Hospital for Sick Children, 
Glasgow.
Urine was collected from the infants by securing a 
length of (1.27 cm.) wide Raul's tubing over the 
penis with 'Sleek'. The free end was knotted and the 
urine which collected was transferred at intervals to 
suitable containers. 5 consecutive 24-hour urine collections 
were made using chloroform as preservative* The 6 
children with nephrosis were continent of urine and 
co-operated in urine collecting satisfactorily.
Uccasionally, during the diuretic phase nocturnal enuresis 
resulted in incomplete collections and these are 
indicated. 105 urine collections involving 135 
estimations of free urinary aldosterone were undertaken.
The basic method used is that of Brooks (I96O ) as 
amplified in Chapter 5*
Pyloric Stenosis 
The management of infants with pyloric stenosis 
has /
has local variations. In this department a regime 
of simplicity has been adopted in which the patient 
is disturbed as little as possible. The diagnosis 
is made on palpation of a pyloric 'tumour' during a test 
feed, and only rarely is diagnostic assistance sought 
from a barium meal.
A gastric lavage is done not less than four hours 
before operation. lyloromyotomy is performed under 
generalcrlocal anaesthesia according to the surgeon's 
preference and the child returned to the medical ward.
The feeding regime at the time of the investigation 
was to commence 4 hours after operation with 8 ml. half- 
cream National Dried Milk alternating hourly with 
half-strength physiological saline in unrestricted quantities. 
The volume of milk is gradually increased and also the 
interval between feeds until on the third post-operative 
day 45 ml. milk is being given 4 hourly. Water at this 
stage is given instead of saline. On subsequent days 
the volume of each milk feed is increased by 15 ml. until 
an appropriate full feed y^^reached. The child is 
discharged on the 5th post-operative day and returns 
on the 12th day for removal of sutures. Breast-fed 
infants are given expressed breast milk and allowed home 
usually on the 2nd post-operative day to continue breast­
feeding. The sutures are also removed on the 12th post­
operative day.
Biochemical /
Biochemical studies are not done routinely and 
parenteral fluid and electrolyte replacements are undertaken 
only in the infrequent cases in which dehydration is severe.
During the past 4 years 58 cases, on average, have 
been treated annually in this unit with one death (a 
mortality rate of less than 0 .5%).
The present study was designed to determine the 
level of free aldosterone excretion in 15 of these 
infants. It was thought that they might shown an 
increased excretion of aldosterone since they also exhibit 
a marked tendency for renal conservation of sodium 
chloride. In addition bo the loss of chloride in the 
vomit, there is also loss of sodium and potassium and the 
total body electolyte concentration is reduced. This 
further contributes to dehydration. Increased aldosterone 
production might be expected to combat these changes.
Table 1. Urinary excretion of free aldosterone in 
cases of pyloric stenosis treated by 
Ramstedt operation.
Case
No.
Age 
(wk. )
5-day 
Total
Per Day Per Day 
Corrected
1-7 Aldosterone not detected in single 
24-hour collections.
8 11 11.5 2.3 3.0
9 6 3.0 0 .6 1.0
10 5 2.0 0.4 0 .6
11 /
base
No.
Age
(wk.)
5-day
Total.
Per Day Per Day 
Corrected
11 5 2.5 0.5 1.0
12 3 3.0 0.6 0.8
13 10 2.5 0.5 1.1
14 10 Nil —
15 7 7.5 1.5 2.7
Aldosterone
The estimation of aldosterone by the method used 
involves three chromatographic systems. Small losses 
occur inevitably at various stages and it is necessary 
to measure the final percentage recovery. This is done 
by adding 10 muc. (millimicrocurie) 7-H^-aldosterone 
to the urine before extraction and measuring the 
specific activity of an aliquot of the diacetate fraction. 
Another aliquot of this fraction containing approximately 
the same amount of aldosterone as the standards to be 
used, is applied to rhe final chromatogram. Since the 
amount of aldosterone likely to be encountered was 
not known, the optimum aliquot a^.plied to the final 
chromatograph was found by trial and error. In Gases 
1 “ 7 , using 24-hour urine volumes, insignificantly 
different galvanometer readings for blank and fluorescence 
were obtained, even when using three-quarters of the 
aldosterone extract and with satisfactory recovery rates. 
Subsequently, bhe urine from each patient was bulked for 
5 consecutive 24-hour periods and the daily excretion of 
free /
free aldosterone taken as one-fifth of the total.
Thus in only 7 of the 15 cases studied were reliable 
re suit s obt ■ ined ( Table 1 ) . With ra c ove ry rat e s 
ranging from 43 - 75 per cent, the daily urinary excretion 
of free aldosterone ranged from 0.6 to 3 pg.
In Table 2 the calculated excretion of free aldosterone 
for the first 24-hour period in Cases 1 - 7 is shown.
Table 2. Daily excretion of free aldosterone calculated
from recovery rates and fluorimeter sensitivity: 
total single 24-hour urine specimens were extracted
Case
No.
1
2
3
4
5
6 
7
fo recovery
54
46
60
60
56
36
62
Aliquot 
of Extract 
Ai plied
0.25
0.25
0.25
0.5
0.5
0.75
0.75
Calculated
Daily
Aldosterone 
Excreted (pg.)
0.7 
0.8 
0.6 
0.3 
0.3 
0.35 
0.2
The average paper blank reading in each experiment 
was equivalent to 0.3 pg. aldosterone. Under test 
conditions a ratio of 1 - 4 for blank to aldosterone 
diacetate standard readings was consistently achieved 
by a minimum of 0.5 Pg. amounts. While readings could 
be /
be obtained for 0.1 pg. aldosterone diacetate a 'noise to 
signal' ratio of at least 1 to 4 was accepted as a better 
working rule. It will be seen from Tables 1 and 2 that 
the calculated daily excretion of free aldosterone and that 
actually found from bulked 5-day collections of urine are 
in agreement and in each case the daily urinary excretion 
is 3 pg. or less. Since only two fractions are estimated 
by the method used, and together these fractions represent 
5 - 15fo of the total daily secretion of aldosterone by the 
adrenal cortex (Ross, 1959; Jones, Lloyd-Jones, Riondel, 
Tait, Tait, Bulbrook and Greenwood, 1959)> daily secretion 
rates for aldosterone from 5 - 6 0  pg. might be expected in 
infants up to 3 months of age.
Data on the aldosterone secretion rate for infants 
in this age-group are scant, but Degenhart, Visser,
Wilmink and Üroughs (1965), using the double-isotope 
dilution technique of Kliman and leterson (I960), found 
the aldosterone secretion rate to be 60 pg./24 hours and
13.5 pg./24 hours in two infants, aged 2 months and 4 months 
respectively. After 4 to 6 days of salt deprivation the 
secretion rates were 100 pg./24 hours and 225 pg./24 hours 
respectively. In the present series all the urine 
collections for aldosterone estimation were made after the 
operation and during the period when an increased salt 
intake was encouraged. Indeed all cases received during
the 3 days after operation more salt than would have 
been /
been contained in standard milk feeds appropriate 
for the infants' ages. This might have depressed aldosterone 
production. The values found for free urinary aldosterone 
agree with those found by the others whose work has been 
quoted and since only very small amounts of free 
aldosterone appear in the urine of this age group, if 
more critical information is required then other methods 
for aldosterone secretion should probably be undertaken.
Nephrosis.
Massive oedema, hypoproteinaemia, hypercholesterolaemia 
and gross albuminuria were present in each of the six 
cases studied. In early experiments while perfecting 
the method for urinary aldosterone estimation I had been 
unable to isolate and quantitate free aldosterone in cases 
of nephrosis by the method used (Brooks, I960). Furthermore, 
for measuring recovery rates the tritiated aldosterone 
(10 muc.) which had been added to the urine aliquots 
before hydrolysis on counting, indicated ridiculously low 
recovery rates. This early failure was attributed to 
inexperience until in a series of estimations of urinary 
aldosterone (urines from a group of normal children^ 
quite fortuitously a specimen of urine from a case of 
nephrosis was included. Only in this latter specimen 
was the recovery rate unsatisfactorily low and free 
aldosterone was not detected. This finding was 
disquieting /
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disciuieting for it is commonly accepted that nephrosis 
is one of the three main conditions in which there is 
a high aldosterone excretion secondary to non-adrenal 
pathology (Luetscher and Johnson, 1954). The other 
two Conditions are congestive cardiac failure (Stringer and 
Wener, 1953) and hepatic cirrhosis (Chart and Shipley,
1963) .
It was therefore planned that the daily urinary 
excretion of aldosterone would be estimated in selected 
nephrotic patients (6) from the oedematous, oliguric, 
albuminuric phase right through to the diuretic phase 
when albuminuria has cleared*
Re suit s.
The results of this investigation are shown in 
Tables 3 “ 8 - Each patient shows a progressive 
reduction in albuminuria and only in one case (DN) was 
there a continuing mild (1.5 g./litre) albuminuria when 
the experiment was concluded. All showed a reduction 
in weight which corresponded to the urinary diuresis.
It will be further observed that the greatest diuresis 
occurred synchronously with a marked reduction in the 
albuminuria. In columns 4 and 5 of Tables 3 - 8  will 
be found the values for daily aldosterone excretion with 
their corresponding recovery rates. It is pointed out
here that urine:- , samples were processed in batches of 6 
and since it was necessary to use the maximum quantity 
of /
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of the urine extract for the final chromatogram, in the 
hope that there would he adequate quantities of aldosterone 
to give a fluorescent spot, only one test in six was 
submitted for scintillation/counting, to estimate 
recovery. As will be seen, free aldosterone was not 
detected in sjiy of these patients during the period when 
albuminuria was marked and it was only when the albuminuria, 
cleared the measurable quantities of aldosterone were 
isolated. In none however could the values be truly 
considered in excess of normal.
Discussion.
What is the significance of these findings? Can 
they be justified on technical or biochemical considerations?
Some technical problems of the method are worthy of 
note. The hydrolytic process to free the A4-3-oxo- 
conjugate of aldosterone is carried out at pH 1. With 
this degree of acidity the proteins in the urine are 
precipitated to form a thick curd. On even the most 
gentle agitation of the urine with chloroform for 
extraction there is formed a thick, creamy emulsion in 
which is trapped some of the chloroform. The approved 
technique for separation is to drain off the chloroform 
as much as will separate on standing and then to centrifuge 
the emulsion thus releasing the trapped chloroform, which 
is then beneath the emulsion in the test tube. The 
emulsion /
emulsion may be further washed with chloroform and 
re-centrifuged in the hope that all the aldosterone 
likely to be adherent to the protein will be recovered.
Does this process however release the aldosterone or does 
the albumin exercise a particular affinity for aldosterone? 
If this were so a possible explanation of the findings 
would be at hand.
To test this hypothesis human plasma was added to 
500 ml. water to make protein concentrations of 2, 4 and 
6 g. per litre. To a fourth flask no protein was added.
It was assumed that the plasma used contained 5 g. total 
proteins/100 ml. To each flask 10 pg. aldosterone was 
then added and the procedure for hydrolysis extraction, 
separation and quantitation followed. It was felt that 
to add more than normal amounts of aldosterone would 
have been inconsistent with the nature of the experiment 
for if protein binding played a part in the low recoveries 
then greater quantities of aldosterone might have saturated 
the protein to create further unnatural conditions. In 
Table 9.. the results of the experiment are shown.
Table /
Table 9 . Recovery of aldosterone added to water containing 
hninan plasma to give protein concentrations of 
2, 4 and 6 gm./litre.
Water/ml. ProteinO/litre
Added
Aldosterone
Aldosterone 
Recovered pg.
500 2 10 pg. 3.0
500 4 10 pg. 1.5
500 6 10 pg. 2.0
500 0 10 pg. 8.0
These findings supported the hypothesis that it is with 
difficulty that free aldosterone is recovered from 
high-protein containing fluids, A further experiment 
was devised. One specimen of urine containing 4 gm. of 
albumin or more from each of the patients was 
selected and the pH brought to 1 with hydrochloric acid. 
When the precipitated proteins settled they were separated 
and to the remaining aqueous phase chloroform was added 
and hydrolysis allowed to proceed for Id hours. The 
separated proteins were when suspended in water (100 ml.) 
and the pH re-adjusted to 1. The contents of the 
flasks were then boiled for exactly 10 minutes, cooled 
rapidly in ice-water and extracted twice with half 
volumes of chloroform. The extracts from each fraction 
were processed separately eind quantitated. The results 
are shown in Table IH.
Table /
Table 10. Recovery of aldosterone from the protein
precipitate of urine and the aqueous phase
in 6 cases of nephrosis.
Aldosterone pg. per 100 ml. urine
Protein
H/hitre
Protein
precipitate
Aqueous
phase
Total Calculated
daily
excretion ug.
1. 4 2 0.2 2.2 Z.2 X 6.9 = 15.2
2. 6.5 3.5 0.6 4.1 4.1 X 3.2 = 13.12
3. 8.0 1.8 0 1.8 1.8 X 5,4 = 9.72
4. 5.0 4.0 1.0 5.0 5.0 X 4.6 = 23.25
5. 9.0 2.1 0 2.1 2.1 X 4.2 = 9. 87
6. 6.0 3.8 0 3.8 3.8 X 3.0 = 11.4
The findings here indicate that the major portion of the 
aldosterone is in the protein precipitate and that it is 
released by boiling at pH 1.
Since /
Since the daily urine volume of ühese patients duinng the 
oedematous phase seldom is in excess of a few hundred 
millilibres the daily output of aldosterone is still 
vithin the normal range.
E.J. doss published in 1959 his book entitled 
"Aldosterone in Clinical and Experimental Medicine"
(doss, 1959). He quotes 10 papers from 3 groups of 
investigators to support the claim that there is 
increased production of aldosterone in nephrosis.
6 papers from Luetscher and colleagues (1950-1954) 
indicate that the high sodium-retaining activity of 
extracts from urine of patients with nephrosis 
is due to aldosterone.
The methods for extraction are similar to those 
used in this work but their quantitation was by bioassay 
techniques rather than chemical.
In Luetscher and Johnson's (1954) paper 5 children 
with a nephrotic syndrome were studied. Pooled urine 
( 1 - 5  da,ys) for each patient was used, the protein 
content ranging from 1.7 to 7.3 g./24 hours for the 5 cases. 
Using a bioassay technique based on the excretion of sodium 
and potassium by adrenalectomised rats, they estimated the 
urinary sodium-retaining factor as 7.8 to 8.4 pg. DOGA 
equivalents. The equivalent of 1/7 2 of the daily 
urinary output was used per assay. Their only 
comment /
comment regarding the proteinuria is to say that it is 
not an important factor in the sodium-retaining 
activity of the extract.
In another communication, Luetscher and Doming (1950) 
show the effect of cortisone and intravenous plasma on 
the course of nephrosis. On cortisone ad.one 
3 patients, aged 5, 7 end 56" years showed a fall in 
albuminuria but a less impressive fall in the urinary 
sodium-retaining factor (2.0 pg. - 1.9 pg.; 3.1 pg.
to 1.2 pg.; 4.6 pg. - 3.1 pg. DOGA equivalents).
In graphs which they show of 2 patients given 
intravenous albumin (10 - 50 g./day) it appears tha,t 
during the period of administration, although the body 
weight fell in keeping with a diuresis, the albuminuria 
increased to l8 and 34 g. and at this time the urinary 
sodium-reraining factor fell to 1.8 and 2 pg. (DOGA 
equivalent). There was no appreciable change in the 
plo.sma protein level during the administration of 
albumin.
The interpretation of the fall in urinary sodium- 
retaining corticoids in these two patients is summed 
up in the author's words that 'it is of interest the,t 
assays of sodium-ret-lining corticoid showed a 
decrease in normal levels during or after diuresis
induced by albumin'. It is of interest if it is accepted 
that /
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that albuminuria is not an important factor in the 
estimation of the sodium-reta.ining activity of nephrotic 
urine.
In another paper by Luetscher and colleagues, (Axelr;^, 
Cates, Johnson and Luetscher, 1955) the urine extracts 
from 3 nephrotic children (aged 10, 4 and 4 years) are 
compared with a urine extract from 1 normal child. 
Comparable figures are given as 6.3 and 10.8 pg.; 8 pg.,
14.1 and 15*2 pg. (pg. DCA equivalents per 33 minute urine 
volumes). These are compared with the one normal value 
of 0.8 and 1.14 pg. (pg. DCA equivalent per 33 minute 
urine volume).
It must be remembered however that in alkali ion 
tests aldosterone possesses more than 100 times the 
mineralocorticoid activity of desoxycorticosterone while 
in Addison's disease aldosterone is only 20 - 30 tiines 
as potent as desoxycorticosterone.
If then the values in pg. DCA equivalents a,re expressed 
as true pg. aldosterone, there is no gross increase in 
urinary aldosterone output in the patients quoted.
Further aldosterone lacks the property of promoting 
water retention, which is so characteristic of desoxy- 
corticosterone so that increased aldosterone alone cannot 
be the cause of the oedema in nephrosis.
Two further points require consideration. The 
plasma /
plasma binding of hydrocortisone is to the protein 
* transcortin’ and this is an a^^-globulin (Slaunwhyte 
and Sandberg, 1959). In nephrosis plasma a^-globulin 
is reduced in quantity and the deficit is found in the 
urine. These authors have shown that the 'transcortin' 
binding capacity is reduced in nephrosis.
The binding of aldosterone however is less well 
documented although from well planned experiments by 
Daughaday, Holloszy and Mariz (1961) it would appear 
that albumin is the chief medium for transporting 
aldosterone in the circulation. At lower temperatures 
than 37^6 aldosterone is bound pirtly to albumin and 
partly to a^-globulin and these are just the conditions 
prevailing in the nephrotic urine, namely a high albumin 
and a^-globulin content. Aldosterone then is likely 
to be bound to both protein fractions in the urine from 
cases of nephrosis and it would appear that this fact 
has not received much consideration in the estimation 
of urinary aldosterone in nephrosis.
Bartter (1956) while reviewing the role of aldosterone 
in normal homeostasis cites a case of idiopathic 
hypoproteinaemia whose daily urinary a,ldosterone during 
the hypoproteinaemic phase was in excess of 120 pg./day 
(range over 10 days, 60 to 204 pg./day). When 
given albumin intravenously (50 g. daily) over 7 days 
the /
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the urinary excretion of aldosterone fell to 10 - 20 pg./day,
there was a sodium diuresis and the patients's weight
fell from 61 kg. to 57 kg. The author argues that
there was an expansion of the vascular compartment resulting
in a lowering of aldosterone secretion with marked
urinary loss of sodium.
On th^'^ basis that only unbound circulating cortisteroids 
are free both W  exert rheir physiological activity and 
for glomerular filtration, it is clear that with a low 
plasma albumin, which would normally bind aldosterone, 
more free hormone will be circulating to cause sodium 
retention and more will be available for excretion. 
Intravenous albumin restores the level of the binding 
protein, to which circulating aldosterone ha,s an 
affinity and it is thereby inactivated and its 
excretion inhibited. This would seem to be at least 
an alternative explanation of Bartter*s findings.
Of the factors which determine the excretion of
aldosterone, in the light of present knowledge, no
dogma is justifiable for it would seem that here again
it is probably incorrect to assume that a high excretion
rate results from increased secretion or conversely that
a low excretion rate indicates a reduction in the production
of aldosterone. That the exc^-etion of frer aldosterone
in nephrosis is high is quoted freely in the literature 
but /
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but few papers consider the part played in this alleged 
finding of the hypoproteinaemia (hypoalbuminaemia) and 
the massive albuminuria characteristic of the oedematous 
phase of the disease.
It appears from Luetscher's work that extraction with 
chloroform should release Ghe bound aldosterone although 
koss (1967) and (Irant (1967) have been unable to clarify 
this point. In discussion with Klopper (1966) I have 
found that he, too, has considerable difficulty in 
extracting steroidal material from high protein-containing 
biological fluids and has a scepticism which doubts 
reports wherein no special extraction procedures have 
been employed.
'Lliere are few references to investigations aimed at 
the separation of free aldosterone from high protein- 
containing urine, but this work demonstrates that with 
ordinary extraction procedures free aldosterone was 
not obtained from the high protein-containing urine of 
nephrotic patients but when the protein precipitate was 
boiled at pH 1 before extraction, free aldosterone was then 
found. Such strong acid hydrolysis would normally 
degrade most corticosteroids but r.xley, Ingall,
Lorymberski and Woods, (1961) have shown that 
17-deoxycortioosteroid8 do withstand boiling in strong 
acids for at least 10 minutes. They used this 
method /
method of hydrolysis for the block estimation of 
urinary 17“deoxyco.rticosteroids of which aldoste>"one 
is an examj,le.
Nummary
Once again it may be that in this delicate type of 
analysis secretion rate studies based on the isolation of 
aldosterone from pla.sma will give the answer to this and 
other unsolved p-nblems regarding this j powerful, 
raineralocorticosteroid in c;:ses uf nephrosis.
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Determination of 17-oxosteroids 
in urine.
After measuring the daily urine volume, duplicate 
aliquots (10 ml.) are measured into 8 inch B 24 tubes.
The tubes are placed in a boiling water bath and 
concentrated hydrochloric acid (1 ml.) added to each 
tube and the contents mixed. Boiling is continued for 
exactly 10 minutes to effect hydrolysis of conjugated 
17-0X0steroids.
The tubes are then cooled in ice water immediately. 
Chloroform (10 ml.) is added to each tube, which is 
stoppered and inverted sharply twenty times to extract 
the steroids into the organic (chloroform) phase. After 
the layers separate, the upper urine layer is removed by 
suction and the chloroform washed successively, once With
2.5 N - sodium hydroxide (2 ml.) ajid twice with distilled 
water (2 ml.), the aqueous phases being removed by suction 
after each wash.
While effecting complete removal of the aqueous
phases there are small losses of the organic phase but
always 5 ml. chloroform can be obtained from each of the
duplicates. At no time has automatic pipetting been
used. The chloroform (5 ml.) is then placed in B 10
test tubes and evapora.ted under a stream of nitrogen in 
a /
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a water bath at 40^0. The residues are subjected to a 
modified Zimmermann reaction.
Once weekly recovery experiments have been included 
by adding to 2 additional aliquots (10 ml.) of urine,
20 pg. of a typical 17-oxosteroid - (dehydroepiandrosterone 
DHEA). This is a convenient 17-oxosteroid for use 
also as a standard in the Zimmermann reaction.
141
Zimmermann colour reaction.
This reaction is carried out in B 10 test tubes.
The steroid residues from the above extractions are 
dissolved in the Zimmermann reagent (0.25 ml.).
The tubes are stoppered and gently rotated to ensure 
that all the steroid extract is in solution. They 
are then placed in the dark at 20^0 for 1 hour. 
Thpreafter, ethanol (3 ml.) is added to each tube and 
after mixing the optical densities are read at 440, 520 
and 600 mp. on an Unicam S.P.600 spectrophotometer using
a 10 mm. light path. The Allen (1950) correction
formula is applied. 2 standards of DHEA (10 pg.) and 
2 blanks containing only the Zimmermann reagent are 
treated in the same way. After subtracting the
blank readings from both standards and test readings the
microgram equivalents of the test samples are calculated 
and appropriately adjusted for the total daily urine 
volume. The final result is expressed as mg. 17- 
oxosteroids per 24 hours.
From 1963, instead of reading the optical density 
of the Zimmermann chromogens in ethanol they have been 
extracted into ether and the optical density of the ether 
layer measured. This is achieved by adding to each 
tube aqueous ethanol (2 ml. 505^ ) followed,; by diethyl 
ether (3 ml.) Fig. i shows the improved colour 
obtained /
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Fig. 1. Zimmermann chromogens in ethanol (le ft of
pairs) and in diethyl ether(right of pairs).
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obtained by this step.
The Zimmermann reagent is made immediately before 
use by adding 0.5 per cent purified m-dinitrobenzene 
in ethanol (2 ml.) to 25 per cent tetramiethyl ammonium 
hydroxide (B.D.H.; 1 ml.). Both reagents are stored 
at 5^0 and the m-dinitrobenzene is made freshly each 
week. Ethanol is aldehyde-free and the diethyl ether 
is peroxide free.
Girard T Reagent.
This reagent will combine with ketones to form water 
soluble complexes. By partitioning the reaction mixture 
between water and benzene non-steroidal non-ketonic 
material will be extracted into the organic phase 
which may then be discarded. The ketonic-Girard 
complexes in the aqueous phase may then be hydrolysed 
by strong acid at room temperature to release the free 
ketones. These may then be extracted into organic 
phase for quantitation. TheoresBtically, by this 
process, 17-oxosteroids may be extracted from urine 
extracts freed from non-steroidal chromogenic material.
The procedure is carried out as follows.
Urine aliquots (10 ml.) are hydrolysed, extracted and 
blown to dryness as earlier indicated. Ethanol (2 ml.), 
Girard Reagent T (0.2 g.) and glacial acetic acid (0.5 ml.) 
are added to the dried extraxts and refluxed for 20 
minutes. /
— 144 —
minutes. After cooling, 3 N-sodium hydroxide (3 ml.) 
and water (50 ml.) are added and furcher extraction 
with benzene (50 ml.) is carried out. After 
separation the benzene is discarded. Concentrated 
hydrochloric acid (5 ml.) is added to the aqueous phase 
and hydrolysis allowed to proceed at room temperature 
for 1.5 hours. The freed ketones are then extracted 
with benzene (50 ml.), the benzene separated, washed 
and evaporated to dryness in vacuo. The Zimmermann 
reaction is then performed on the residue as before.
The Allen formula (1950).
This correction formula has been applied to all 
spectrophotometric readings and to facilitate 
understanding of the scientific data, shortly to be 
given, I include here a note on its significance.
Allen studied the absorption curves of the colours 
produced by dehydroepiandrosterone (50 pg.), 
pregnanediol (500 pg.) and an urinary extract treated 
separately with ethyl alcohol (90%) and concentrated 
sulphuric acid in the ratio: 1:4 v/v. Both
dehydroepiandrosterone and pregnanediol gave absorption 
maxima the former at 600 mp. and the other at 480 mp., 
while between these wave lengths a urine extract alone 
gave an absorption curve which aq;proached a straight 
line, decreasing from 480 mp. to 600 mp*
By /
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By developing the colour reaction in a mixture 
of dehydroepiandrosterone, pregnanediol and urine 
extract he found that the resulting absorption curve 
contained the elements of the absorption curve of each 
substance. He was therefore able to devise a formula 
which permits the analysis of mixed absorption curves 
provided the absorption curve of the contaminating 
substance closely approaches a straight line. The 
equation is:
G B X ^  = - 0B^4-0I).X X a b
2
where OD is the observed density at wave length x, 
at the absorption maximum; OD^ and OD^ are the 
observed densities at wa.ve lengths a and b ; a and 
b being equidistant from x; CD is the calculated 
density due to substance X having an absorption maximum 
at wave length x.
In Fig.2 I illustrate this correction calculation 
using dehydroepiandrosterone (DHEA) and a urine extract.
It will be seen that the optical density of the Zimmermann 
colour at ^20 mp. for urine plus steroid (237) is 
greater than the optical density at 520 mp. for the 
steroid alone (206). The difference is the contribution 
by the impure substances in the Zimmermann reagent and 
urine extract. By taking optical density readings 
at /
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at 440, 520 and 600 mp. and applying the formula 
the true contribution of dehydroepiandrosterone to the 
curve of the mixture may be calculated.
Discussion on IT-oxosteroid method.
2,000 estimations, each one in duplicate have been 
done in the course of this work. Duplicates differing 
by more than plus or minus 5?° from their mean were 
rejected and the test repeated.
Table 1 shows the typical results of an experiment 
to test the recovery rate of dehydroepiandrosterone 
(DHEA) from adult urine. The steroid was added to 
separate aliquots of urine before and after hydrolysis. 
Table 2 shows the results of a similar experiment using 
'inf ant'urine.
From Tables 1 and 2 it will be noted that the 
recovery rates of dehydroepiandrosterone are much 
lower and 53.8^) after acid hydrolysis than
without acid hydrolysis (91.4^^ and 92.8^). This 
has been my constant finding. Acid hydrolysis 
therefore alters the steroid molecule in such a way as 
to destroy Zimmermann positivity. It must be remembered 
that the DHEA added to the urine before hydrolysis is 
free and therefore does not have the protection of the
glucuronide moitié. While some freed steroid is
probably degraded by hydrolysis further consideration of 
the /
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Table 1. Recovery experiment of dehydroepiandrosterone (DHKA) 
from adult urine \vith reproduoibility data.
1. Aliquot of urine
2. Chloroform to extract 10 ml.
3* Aliquot Chloroform taken 3 ml.
Zf* DHIA 10 ug« as standard and added to urine aliquots#
Wave length mu 4if-0 520 600 A • C • AC-RB Mean % Recovery
Reagent Blank (RB) 066 060 014 020
Standard DHEA (lOug) 190 273 109 126 106)
II II 192 273 112 123 103J 104
Urine 1 " 5 404 658 318 297 276)
273Urine 1* - 5 ml. 420 634 309 290 27oj
Urine 2 - DHEA = 5 ug# 424 702 341 320 300) 307 63.38
Urine 2*- DHM = 5 ug# 452 738 335 335 315]
Urine 3 - DHEA = 5 ug# 
Urine 3*- DHEA s 5 ug.
415
400
710
700
328
320
339
340
319)
321)
320 %90.38
K
DHISA (lO ug*) added to urine before aoid hydrolysis 
(lO ug.) added to urine after acid hydrolysis.
per cent
IWiil— iiHnin>B|#|i|ii ■! w
recovery
90.38 90.20 97.0
91.24 90.65 93.20
90.86 89.21 90.61
94.21 88 .46 92.80
93.01 91.34 89.00
Mean 91.40^
Recovery rates from a series (15) of reooveiy experiments, the DHKA 
having been added to the urine after acid hydrolysis#
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Table 2» Recovery experiment of dehydroepiandrosterone (DHEA.) from 
infant urine.
1. Aliquot of urine; 10 ml#
2# Chloroform to extract; 10 ml.
3# Aliquot Chloroform taken: 3 ml.
4# DHEA: 10 ug# as standard and added to urine aliquots#
Wave lengtîi mu 44.0 320 600 A#C# 'AC-RB Mean ^ Recovery
Reagent Blank (RB) 066 060 014 020
Standard DHEA (10 ug# )190 275 109 126 106) 104
’* DHEA 192 275 112 123 103]
Urine 1 - 3 ml. 271 282 118 088 068) 067
Urine 1* - 3 ml* 286 290 122 086 066(
Urine 2 - DHEA s 3ug 
Urine 2* * DHEA s 3ug
,440
408
424
413
176
178
116
115
96)
95}
095 53.8
Urine 3 - DHEA 3 ug »456 459 186 136 lié)
115 
...
92.8Urine 3*" DHEA 3 ug 483 474 193 135 iisj
00
DHEA (lO ug.) added to urine before acid hydrolysis 
DHEA (10 ug.) added to urine after acid hydrolysis#
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the possible by-produots of strong aoid hydrolysis Is 
outside the scope of this work,
A fui'ther point of note from Tables 1 and 2 is 
the difference in the optical density readings at 
440, 520 and 600 mp. obtained for adult urine and infant 
urine. This is represented in Pig.3 graphically.
It is clear that an undoubted peak at 520 m p . is obtained 
with adult urine but notLso in ' infant ' urine when no 
peaks are recorded. This failure to obtain a satisfactory 
peak in the latter might have been due to the small amount 
of steroidal material in the urine or to the presence 
of considerable amounts of non-steroidal chromogenic 
material native to infant urine. While in health, the 
urinary excretion of 17-oxosteroids is normally low 
an attempt to improve the specificity of the general 
method was made by introducing the Girard process for 
separating ketonic material from crude extracts. This 
was carried out as earlier indicated. While satisfactory 
recovery rates were obtained by the Girard process 
comparable to those obtained when omitting it, there 
was no improvement in the optical density peak at 
520 mp, from infants' urine alone. This is illustrated
in Table 3«
The introduction in 1963 of repartitioning the 
Zimmermann chromogens between aqueous ethanol and diethyl 
ether has given a more impressive peak at 520 rap. from 
extracts /
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Table 3» Girard T separation of native IT-oxosteroids 
from * infant * urine. Aliquots (IQ ml.) of 
urine used according to method (page ).
Wave-length mu. 440 520 600 A.C.
Infant A 493 496 278 116
480 485 242 124
Infant B 641 658 492 092
623 620 430 096
Infant C 326 350 110 132
325 325 100 113
Note the ahsenoe of distinct peaks at 520 mp.
Zimmermann chromogens were read in ethanol.
153 -
150
100
25 ug. DHEA205 10
Fig. 4# The Zimmermann chromogens developed from dehydroepiandrosterone 
obey Beer's Law in diethyl ether.
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extracts obtained from the urine of children of all 
age groups (Fig. 1 ). Fig. 4 shows that the Zimmermann 
chromogens in the ether layer obey Beer's Law.
- 155 -
Determination of 17-oxogenic steroids and 
total IT-liydroxycorticosteroids in urine.
The term 17-ketosteroid was first used hy Brooks 
and Norymherski (1952; 1953) to indicate those 
corticosteroids which form 17-ketosteroids when suhjected 
to oxidation (the terms 17-oxogenic steroid and 
17-oxosteroid are now preferred). They showed that 
17-hydroxycorticosteroids with an a-ketol (5,1) or a 
glycol (5,2) sidechain would yield 17-oxosteroids 
(5,3) on oxidation with sodium hismuthate.
cjî^ oïï; çh o^h
C=0 HC-OH 0=0
-JDH
(5,2)(5,1)  (5,3)
In health, 17-oxogenic steroids are the normal metabolites 
of hydrocortisone, cortisone and ll-deoxycortisol, the 
latter being an immediate precursor of hydrocortisone.
Urine which has been subjected to this oxidation 
procedure will, of course, contain native 17-oxosteroids 
as well as 17-oxosteroids derived from 17-oxogenic 
steroids. It is therefore necessary to estimate 
17-oxosteroids in the urine before and after oxidation 
and by subtraction, the true value of 17-oxogenic 
steroids may be calculated.
There are also however in health, small amounts and 
in /
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in some disease processes large amounts of a precursor 
of hydrocortisone which is not 17-oxogenic on oxidation* 
This substance is l?a-hydroxy progesterone (5,3) and it 
is present in large amounts when 21-hydroxylation is 
completely or partially absent (this is seen in some 
cases of congenital adrenal hyperplasia)• A metabolite 
of ITa-hydroxyprogesterone, pregnanetriol (5,t) appears 
in the urine in increased amounts when 21-hydroxylation 
is defective.
HC OH HC OH
OH
HO
(5,5)
If 17u~hydroxyprogesterone is reduced in vitro
with sodium or potassium borohydride, a glycol (5,50
is formed which when oxidised will result in the
formation of a 17-oxosteroid. It follows that if a
sample of urine is reduced then oxidised the 17-oxosteroids
will have come from 17-oxogenic steroids and 21-deoxy-
17-hydroxycorticosteroids (5,1; 5,2; 5,4; 5,5), the
native 17-oxosteroids having been reduced to alcohols
which do not then give the Zimmermann reaction. These
former two estimated together rep resent the total
17-hydroxycorticosteroids. It will be seen that by
a combination of 3 steps as outlined, it is possible 
to /
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to estimate 21-deoxy-17-hydroxycorticosteroids and 
this I have used for screening purposes as a rapid test 
for 21-hydroxylation.
A
Urine
17“0X0steroids 
(Native)
B
Urine
U/
oxidation
17“0X0steroids
(Native and 17- 
oxogenic steroids)
G
Urine
reduction
oxidation
i
17-oxosteroids
(17-oxogenic and 
21-deoxyketols.)
21-deoxyketols ^ 0 - (B - A).
Normally in infancy and childhood the urinary total 
17-hydroxycorticosteroids should not be greater than the 
17-oxogenic steroids by more than 200 micrograms/day 
and if it was found to be so then the more time- 
consuming estimation of pregnanetriol - the metabolite 
of 17a-hydroxyprogesterone - was undertaken.
Appleby, Gibson, Norymherski and Stubbs (1955) and 
Appleby and Norymherski, (1955) first published their 
method for the oxidative removal of the a-ketol and glycol 
sidechains of 17-hydroxycorticosteroids and the removal, 
after reduction of 21-deoxy-17,20-ketol sidechains.
They used sodium borohydride for reduction and the 
surface oxidisent sodium hismuthate. I have followed
their method without modification from I960 to 1963 
The /
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The procedure is as follows.
Four alipuots (10 ml.) of urine alle placed in 
B 24 test tubes, sodium borohydride (NaBH^) ; (20 mg.)
is added to 2 tubes and allowed to stand overnight a.t 
room temperature. Glacial acetic acid (lo ml.) and 
sodium bismuthate (2.5 gm.) are added to all four tubes 
and all are shaken for -J- hour in the dark. After the 
addition of 6^ sodium thi0sulphate (Na^S^O^; 25 ml.)
shaking is continued until all the sodium bismuthate is 
reduced - indicated by a change from orange to creamy 
white. 10 K* hydrochloric acid (15 ml.) is added to 
each tube and all placed in a boiling water trough for 
10 minutes and thereafter cooled in ice water. The 
extraction is effected with ethylene dichloride (2 x 
20 ml.) and the ethylene dichloride washed with water 
(10 ml.) and 3 N. - sodium hydroxide (10 ml.). A 
maximum aliquot of ethylene dichloride (30 ml.) is 
blown to dryness and the Zimmermann reaction performed.
In conjunction with a straight estimation of 17-oxosteroids, 
performed on the same urine, the appropriate calculations 
are made. Experiments using 17-hydroxyprogesterone to 
test reduction and oxidation, gave satisfactory recovery 
rates (Table 4)•
The method however has drawbacks, the most 
significant /
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Table 4* Recovery of 17-hydroxyprogesterone from urine
using sodium borohydride for reduction and sodium
bismuthate for oxidation. 17a-hydroxyprogesterone
added to the urine in varying concentrations.
Wave length mp 440 440 520 600 A.O.. AC-RB Mean ^oRecovery
Reagent Blank (HB) 078 070 026 018 018
Standard DHEA (10 ug.) 190 275 109 126 109 107I I M
192 275 112 123 106
Urine 1 - 5ml. 259 383 156 176 159 158
Urine 1' 5 ml . 234 364 144 175 158
Urine 2- 17-P 
Urine 2'-17ifP
12.5ug. 
12.5ug.
451
469
600
670
292
256
293
298
276
281
278 69.6
Urine 3 -17-P 10.Dug. 469 630 254 279 262 263 98.0
Urine 3*-17-P 10.Oug. 555 101 286 281 264
Urine 4 -17-P 7.5ug. 424 585 242 238 235 232 92.0
Urine 4*-17-P 7.5ug. 452 600 264 247 230
Uncorrected for varying chromogenicities. 
17ci-"P 17a“hydroxyprogesterone.
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significant of which are the length of time required 
for oxidation in the dark, the variable oxidising 
capacity of different batches of sodium bismuthate and 
the unpleasantness of working with strong acetic acid.
In 1961 Few published his experience in the use of 
sodium metaperiodate as an oxidising agent to 
replace sodium bismuthate. While the method was no 
saving in time, it had the advantage of being cleaner 
and the oxidative capacity of sodium metaperiodate is 
more reliably constant from batch to batch. Few's 
method (1961) has been followed from 1963 until the 
present, in the following way.
To 2 aliquots of urine (10 ml.) sodium borohydride 
(200 mg.) is added and reduction allowed to take place 
for 2 hours or overnight according to convenience, 
déduction is stopped by the addition of 25 per cent 
acetic acid (0.5 ml.) added drop by drop. After 
15 minutes, 10 per cent sodium periodate (4 ml.) and 
N. sodium hydroxide (1 ml.) are added to each tube.
The pH is adjusted to 7 and the mixtures incubated for 
1 hour at 37^0 to effect oxidation. The glucuronide 
residues of the steroid conjugates are also converted to 
formates by this oxidation step.
The formates are hydrolysed by the addition of 2.5 N
sodium hydroxide (1 ml.) and incubation continued for a 
further /
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further 15 minutes. After cooling, dichioromethane 
(10 ml.) is added to each tube and extraction effected 
by inverting the stoppered tubes 20 to 30 times.
The layers are allowed to separate and the supernatant 
urine is removed by suction. 2.5 per cent sodium 
dithionite in 5 per cent sodium hydroxide (5 ml.) is 
added to the dichloromethane and the tubes shaken 
vigourously. After separa^tion, the upper aqueous layer 
is removed by suction and the organic phase filtered 
through. What man No. 1 paper to remove droplets of any 
remaining aqueous phase. Aliquots (5 ml.) from each 
tube are collected and evaporated in a water bath at 
40^0 under a stream of nitrogen.
The residues are subjected to the Zimmermann reaction 
and estimation of 17-oxosteroids made against standard 
dehydroepiandrosterone. After an adjustment for the 
daily urine volume, the results are expressed as mg. 
total 17“hydrocorticosteroids per 24 hours.
A typical recovery experiment using 17a-hydroxy- 
progesterone as the model is shown in Table 5*
Table 5. /
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Table 5• Recovery of ^ITa-hydroxyprogesterone after 
reduction and oxidation by Fews* (1961) 
method. Dehydroepiandrosterone used as 
standard and no correction made for differing 
chromogenicity.
Wavelength 
mp.
440 520 600 Ac AC-RB ^Recovery
R.B. 082 078 038 18 )
) 17
R.B. 087 077 038 15 )
DHEA 10 pg. 186 242 113 93 76 )
) 77
DHEA 10 pg. 184 240 104 96 79 )
*17aOHP 20 ug. 314 367 164 128 111 72/0
17aOHP 20 ug. 290 364 156 129 112 12,'ôio
17aOHP 20 i^g. 305 366 168 130 113 73^
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Preparation of p-Glucuronidase.
This enzyme is abundant in the dorsal hump of the 
limpet (Patulla Vulgata). A method for preparing an 
acetone precipitate powder from homogenised dorsal 
humps, high in p-glucuronidase activity, has been 
recommended by the M.R.G. (1963)* Fortunately the 
rocky foreshore of the river Clyde south of Gourock 
provides a breeding ground for these molluscs. It 
is my practice to harvest limpets from the rocks 
immediately beyond the village of Seamill. I choose 
those, 4 - 5  cms. in diameter across the base, and 
pick them immediately the high tide ebbs. It is most 
convenient to pick about 11 a.m. carrying them back to 
Glasgow immersed in sea water. Dissection of the 
dorsal humps is carried out immediately on return and 
the first acetone precipitation reached the same 
evening. The calculated Fishman units prepared in this 
way has been valued, according to current prices, at 
£325.
The method is as follows:
The limpet is removed from its shell and the swollen 
dorsal hump dissected from the muscular pad. Batches 
of humps (290 g.) are collected and homogenised with 
ice water (300 ml.) for 5 minutes. The homogenate 
is then centrifuged for 10 minutes at 1500 r.p.m.
The /
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The residue is homogenised a second time with the 
same volume of ice water, and again centrifuged. The 
combined supernatant is treated with acetone to bring 
the concentration to 60 per cent acetone in water.
The mixture is placed in the refrigerator (2 - 4^0) 
overnight and the supernatant removed by centrifugation.
The acetone precipitate is washed 4 times by thorough 
stirring with acetone, followed by centrifugation.
The resulting powder is dried in air. This crude 
preparation is re-processed as above using 30 ml. ice 
water per g. of powder and a fine flaking residue is 
obtained. This final powder is assayed for p-glucuronidase 
activity by the following method (Talalay, Fishman and 
Higgins, 1946).
Solutions; Une litre of Ü.1 M acetate buffer, at 
pH 4.5 is prepared from sodium acetate (5.785 g. ) and 
glacial acetic acid (3-25 ml.) This is stored 
in the 'deep freeze'. One litre 0.4 M glycine buffer 
(pHlO.45) is prepared from aminoacetic acid (16.3 G), 
sodium chloride (12.65 G) and sodium hydroxide (10.9 ml. 
of 100 g. HaOH in 100 ml. water).
Method; Phenolphthalein solution (0.1 per cent is
prepared in 80 per cent ethyl alcohol.) Two hundred
milligrams of the enzyme is suspended in 40 ml. distilled
v/ater. One millilitre of the suspension is made up
to 12.5 ml, with distilled water of which 0.5 ml. 
is /
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is used for the test (“200 p-g. enzyme powder) .
The determinations are carried out in duplicate.
Acetate buffer 0.1 M (4 ml.) is placed in each
tube. Phenolphthalein glucuronide (50 Sng.) is added to
the two experimental tubes but not to the control tubes.
The tubes are then placed in water bath at and
allowed to come to temperature. The enzyme solution
(0.5 ml.) is added to each tube at timed intervals and
mixed, stoppered and incubated for exactly 60 minutes.
Glycine buffer 0.4 M (5 ml.) is then added to each
tube, including the control tubes and then enzyme solution
(0.5 ml.) is added to the control tubes. The optical
densities are read at 540 mp. against standards of
phenolphthalein ( 5 - 4 0  pg.) using an Unicam S.P. 600
and cuvettes with 10 mm. light path. Typical results
are as under;
Blank 000
O D q S t a n d a r d  30 pg.
 ^*■ phenolphthalein 299
OD^^q Test 217
Calculation 30 pg. phenolphthalein = OD 299
21.7 pg. ” = OD 217
200 pg. enzyme powder liberates 21.7 pg. phenolphthalein
1 g. enzyme powder liberates 21.7 x 1000 x 1000
20"0
“ 108500 pg. phenolphthalein.
1 g. enzyme powder contains 108,500 Fishman Units.
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Estimation of Urinary Pregnanetriol.
Pregnanetriol is the metabolite of 17a-hydroxy- 
progesterone and it appears in the urine in excess 
amounts when 21-hydroxylation is defective. (One form 
of congenital adrenal hyperplasia is due to 21-hydroxylase 
deficiency, partial or complete). In the urine, 
pregnanetriol is conjugated with the highly water-soluble 
sugar acid, glucuronic acid. Hydrolysis of the conjugate 
is effected by incubating urine with glucuronidase and 
after extraction of the free pregnanetriol with organic 
phase, it is separated by column chromatography and 
quantitated. Goldzieler and Nakamura's (1962) method 
with slight modification has been used. Two aliquots 
of urine (20 ml.) are pipetted into B 24 test tubes and 
the pH adjusted to 4*5 with 5 N. sulphuric acid or 10 
per cent sodium hydroxide; acetate buffer pH 4.5 (2 ml.) 
and 6000 units of g-blucuronidase are added and incubation 
is carried out at 37*^ 0 for 24 hours. Extraction is 
effected with chloroform (2 x 20 ml.) and separation 
by centrifugation if necessary. The chlorofom 
extracts are bulked quantitatively using additional small 
volumes of chloroform for rinsing. The combined extracts 
are washed with 0.1 N sodium hydroxide (15 ml.) and 
then with water (15 ml.). Anhydrous sodium sulphate 
(10 g.) is added to each tube and allowed to stand for 
10 /
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10 - 15 minutes with occasional swirling. The dried 
chloroform and 2 chloroform washings of the sodium 
sulphate are filtered through Whatman No. 1 filter 
paper into appropriate tubes and blown to dryness in a 
water bath at 40*^ 0 using a stream of nitrogen.
The residues are transferred quantitatively to 
10 ml. volumetric flasks and again blown to dryness.
They are then made up to volume with benzenes for 
chromatographic separation.
Chromatographic columns are prepared from acid- 
washed borosilicate glass (O.D. 8 mm.) tubing. Lengths 
of this (20 cm.) are heated about 3 cm. from one end 
and drawn out to a long fine capillary tip. The tip 
is sealed leaving about 10 cm. of capillary. Benzene 
(2 ml.) is added to each column and a small plug of 
cotton is stamped into the bottom of the column with 
a glass rod so that its U;per surface is flat and its 
depth 4 mm. All air bubbles are expelled and exactly 
1 g. silica gel (100 - 200 mesh, without preconditioning) 
added as a slurry in benzene (3 ml.) The column 
is filled to the top with benzene and the gel settled 
by tsapping the column gently with a glass rod. The tip 
of the capillary is then broken off to allow a flow of 
1 drop per second. The supernatant benzene at the top 
of the column is drawn off and discarded (See Fig.^J .
An /
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Fig. 5. Chromatographic columns used in 
estimation of pregnanetriol.
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An aliquot (5 ml. ) of the benzene solution containing 
the test sample is transferred quantitatively to the 
column without disturbing the surface of the silica 
gel. A small amount of benzene (4 ml.) is used to 
rinse the sample on to the column. The eluate 
from this fraction is discarded. The second phase 
(10 ml.; 25 per cent ethyl acetate in benzene) 
is run through the column allowing the first 1 ml. 
portion through the column separately. This eluate 
is also discarded. The third phase (7 ml.; 50 per cent
ethyl acetate in benzene) is run through as above and 
the eluate discarded. Finally ethyl acetate (10 ml.) 
is run through and collected - this eluate contains 
the pregnanetriol fraction. It is blown to dryness 
with a strea;^ ! of nitrogen in a water bath of 40*^ 0.
The residue is dissolved in alcohol (0.5 ml.) and water 
(10 ml.) added. Oxidation of the pregnanetriol to a 
17-oxosteroid (etiocholanolone) by Few's (1961) method 
follows and the Zimmermann colour reaction is performed. 
This oxidation step is my own modification to the original 
method which utilizes charring of the pregnanetriol 
fraction with sulphuric acid. This latter 
reaction I have found wholly unsatisfactory when applied 
to extracts from childrens' urine because of a high 
content of nonsteroidal chromogenic material. High 
background and no absorption maximum ho,ve been obts.ined 
so /
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so frequently that I have preferred the well proven
estimation of Zimmermann chromogens in ether.
Table 6 gives the scientific data of the method.
Table 6, . Data concerning the recovery of pregnanetriol
estimated as etiocholanolone. Low recovery
rates around 60%,especially when dealing with
small quantities of pregnanetriol (5 pg.)
which are encountered in this field are inevitable ■      — — "—     — — — -
Wave length 
mp.
R.B.
R.B.
Etio. 10 pg
Columned )
)
Rregnanetriol )
5 pg* )
Oxidised 5 pg*)
434
023
021
055
050
036
016
515 595
024
025 
097
092
048
036
010
015
047
042
024
020
AC
8
8
46 ) 
)
46)
18
18
AC-RB
38
12
12
Recovery - 100 x 12 x 2 - 63*1% -- 35
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Estimation of free aldosterone in urine
The method of Brooks' (I960) has been followed 
almosb entirely, the only modification being that, in the 
final chromatogram, aldosterone rather than 
corticosterone diacetate was used as the standard and 
the solvent system iE^ B (isooctane^ tert. butanol, water: 
10:5:9) replaced the Bush A system.
Method:
Urine (500 ml. or the total daily output if less 
than 500 ml.) is adjusted to pH 1 wmth 0 1 N. hydrochloric 
acid. The urine is transferred to a separating flask 
(1 litre capacity) and tritiated aldosterone (10 muc.) 
added for recovery estimations. Chloroform (& vol.) 
is run into the flask and after gentle shaking, a stream 
of nitrogen is bubbled through the urine for 5 minutes 
and the air above the urine displaced by nitrogen. The 
flask is then stoppered and allov/ed to stand for l8 
hours. After gentle agitation, the chloroform extract 
is separated and the urine extra.cted a second time with 
chloroform (i vol.) for 6 hours. Any emulsion that 
forms is broken by centrifugation. The urine is 
discarded and the combined chloroform extracts are 
washed with water (l/20th vol.), O.L.N. sodium hydroxide 
(1/20th vol.) and water (2 x 1/20th vol.). The 
washings are backwashed with chloroform and the total 
extract /
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extract is evaporated to dryness in vacuo at 40^0.
■f’he dry extract is then weighed and a sheet of Whatman 
No. 2 pajier cut so that the los.ding does not exceed 
1 mg. per cm. Side lanes (1.5 cm.) are allowed for 
Standards.
First Chromatogram.
The extract is quantitively applied to the start 
line of the paper which has been impregnated with fomaiaide 
in acetone (30:70) and allowed to dry, suspended in a 
dust-free atmosphere for exactly 10 minutes.
Cortisone (20 pg.) and hydrocortisone (20 pg.) are 
applied to each side lane and in addition, cortisone 
(20 pg.) is applied to the middle of the centre lane.
The paper is allowed to equilibrate for 30 minutes in 
the tank before ,he mobile phase (chloroform saturated 
with formamidc) is added. After development for 3 hours 
o.t 22^0 the paper is removed from the tank and allowed 
to dry for a few minutes in air. Aldosterone in this 
system has a mobility slightly less than that of 
cortisone. From the leading front of cortisone, a 
zone 5 cm. back to the origin is outlined and cut out 
of the chromatogram. This is cut into strips (1 cm. 
wide) and these are eluted together overnight in 80 
per cent methanol in water. The eluate is evaporated
in vacuo to about ^ volume. -^v'ater (10 ml. ) is added
and the mixture extracted with chloroform (3 x 30 ml.)
The /
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The chloroform is then vv^ ashed once with water (10 ml.) 
to remove traces of formamide, and is evaporated to 
dryness in vacuo at 40*^ 0.
Second Chroma, to gram.
The extract is applied to a strip (5 cm. ide with 
1.5 cm. side lanes) of Whatman ho. 2 paper- r sing cortisone 
and hydrocortisone as before for markers. The chromatogram 
is equilibrated overnight in the Bush 0 tank and developed 
in that system for 3 hours. (Bush 0 solvents; toluene, 
ethyl acetate, methanol, water: gO; 10; 50; 50).
Aldosterone has a mobility equal to hydrocortisone in 
this system. A zone corresponding to 2.5 cm. on either 
side of the centre of the hydrocortisone 7,one is cut 
out and eluted in 90 per cent ethanol overnight.
The eluate is evaporated to dryness in vacuo at 40^0.
Third Chromatogram.
Whatman ho. 1 paper is cut into lanes l.d cm. wide 
and 3 cms. long. Bour lanes are cut for each test 
sample. On 3 lanes aldosterone (1 mg.) is spotted 
and on the fourth lane the test extract is a;; plied. The 
spots are washed in with ethylacetate delivered from a 
fine posteur j,ipette so that finally the sa-ijples occupy a 
disc 1 - 2 mm. in diameter. unly by so doing is the area 
occupied by the steroid after development of the 
chromatogram kept within 1 sq.cm. The chromât0grams 
are then equilibrated for 3 hours and developed for 3 hours 
in /
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in the E^B system (isooctane, tert.butanol, water; 10 
5: 9).
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bodium fluorescence; development and
measurement.
After development in the system, the
chromatograms are dried in a.ir and clamped to a sheet 
of glass. They are then sprayed uniformly with a 
solution of 0.004 per cent (w/v) blue tétrazolium 
chloride in 2.4 N-dosium hydroxide. The sprayed 
chromatogram is then covered with a second sheet 
of glass, the edges being sealed to prevent drying, 
and heated for 10 minutes by a 750 watt tadisil heater 
at a distance of 66 cm. The top glass sheet is elevated 
and com,lete drying is effected in a gentle current 
of air blown across the chromâtogram. By preventing
drying while initially heating the chromatogram, it is 
thought that more reproducible results are obtained.
The individual lanes of the chromatogram are then 
detached from one another and examined under UV light 
(235 mm.) to locate the sodium fluorescent spots.
Sections of each lame with the fluorescent spot are 
removed and placed in the fluorimeter carrier. A 
galvanometer reading is taken for the fluorescent spot 
and then a blank reading is taken from the area immediately 
in front of the spot. Buch readings are taken for the 
3 standards of aldosterone (1 pg.) and for the test 
sample(s). /
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sample(s). By deducting the blank readings and 
comparing 'test with standard' readings the microgram 
equivalents in the test sample may be calculated.
Biscussion on method.
This method for the estimation of free aldosterone 
in urine embodies several important physico-chemical 
principles, each of which I have used separately in 
various parts of the original work for this thesis.
I shall discuss these points emphasising their significance 
and application to the estimation of aldosterone in the 
urine of the paediatric patient as well as to their 
separate application elsewhere.
After the second chromatogram, Brooks acetylated 
the residue at room temperature using two drops of 
pyridine and one drop of acetic anhydride. Following 
precisely this procedure I found frequently using 
aliquots of the same urine that two sodium fluorescent 
spots could be obtained on one lan^ of the third 
chromatogram while a second lane had only one fluorescent 
spot. This finding suggested that despite the ostensible 
similarity of conditions for acétylation of the two 
samples, a mixture of the mono- and diacetate of 
aldosterone was being obtained from one of the samples.
I have not diverted to analyse this finding further for 
at the time when I met these difficulties, pure 
aldosterone /
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^'Idosterone became commercially available and it seemed 
reasonable to use aldosterone itself as the standard, 
rather than corticosterone monoacetate which had almost
the same mobility ( g^qaos terone)^" aldosterone
diacetate on the Bush A system used by Brooks (I960).
However, acétylation has the other advantage that 
aldosterone diacetate gives a more intense fluorescence 
compared with free aldosterone (fait, I960). This fact 
seemed less important to me since the fluorimeter in 
use here has been constructed by kr. D. lowan of the 
regional Ihysics Department, Western Regional Hospital 
Boa^-d, modelled on the Brooks (I960) principle, but with 
a more critical selection of primary and secondary 
filters. A primary filter of 3050A^ and a secondary 
filter of 5 9 7 are used. The secondary filter was 
chosen because it gave the best signal to noise ratio 
(i.e. ratio of the fluorescence to be measured to the 
fluorescence from background). The machine had a further 
advantage that with a system of gains (increase in KV) 
maximum galvanometer deflection could be set for the 
standards of free aldosterone so that quantities in the
test samples less than the standards could be 
more precisely estimated.
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Compounds with values similar to 
aldosterone in the 3 solvent systems.
Solvent system Chloroform/ f orm<amide Bush C EgB
Hydrocortisone 1.0 1.0 1.0
Cortisone 2.39 1.38 1.10
Aldosterone 2.25 0.97 0.77
17-iso­
aldosterone 2.22 0.92 0.73
l8“hydroxy-ll“ 
dehydrocorti™ 
costerone. 2.2 1.08 0.74
— 17 9 —
EqB solvent system 
Having omitted the acétylation step it was necessary 
to ensure that there were no other steroids which had 
the same mobility in the three solvent systems used 
(chloroform/formamide; Bush 0 and ' There were
2 possibilities and these are shown in Table 7 with 
their respective mobilities in the 3 systems. In overrun 
extracts only one fluorescent spot on the 3rd chromatogram 
has been encountered. Experience from running many 
samples of aldosterone (1 pg.) has shown that the final 
area is seldom more than 1.0 sq.cm. with a length of 
1 cm. (The carrier aperture on the fluorimeter is 
2.25 sq.cm. - i.e. the area of the paper exposed to the 
photomultiplier). If the test sample gives an area 
greater than 1.0 sq. cm. tmd its length exceeds 1.5 
cm. a second specimen from the same urine is overrun 
to give a running distance for hydrocortisone on the 
side-lanes of 15 cm. Contaminated substances have 
not been accounted.
Only recently have other authors published values
for daily urinary free aldosterone in infancy and
childhood. In my early researches this information vms
not available so that much trial and error was used to
determine (a) the optimum aliquot of the daily urine
volume to be extracted and (b) the proportion of the
extract to be spotted on the final chromatogram 
so /
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so that the quantity of aldosterone estimated would be 
approximately equal to the aldosterone standard (1 pg.).
It was found that where the daily volume of urine was less 
than 500 ml. the whole volume must be tak^n and the 
whole extract had to be spotted on the final 
chromatogram to obtain the maximum fluorescence. This 
prevented an aliquot of the extract being kept for 
estimation of recovery rates. (It will be recalled 
that tritiated aldosterone (7-H'^-aldosterone) 10 mpc. 
is added to the urine before extraction). Since this 
was so in uhe majority of the samples estimated with 
every estimation a recovery experiment was made from 
water. Recovery rates ranged from 43-75 per cent 
when no emulsion was present.
I roof of Method.
Fig.7 shows the proof of the method. The charts 
are the 1st and 2nd chromatograms with their corresponding 
sc^ -n of radi o-activity as obtained from a strip scanner. 
Small peaks of radio-activity are seen in the 1st 
chromatogram corresponding to cortisone and in 
the 2nd, to hydrocortisone.
Emulsions.
In the outline of the method, I stated that 
emulsions which form in the urine during extraction are 
broken /
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Fig. 7. Aldosterone-7-H on Zaffaroni (top) 
and Bush C (bottom) chromatograms.
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broken by centrifugation. Emulsions 
have been a problem and in particular when dealing 
with high protein-containing urines from cases of 
nephrosis. While many authors report high levels of 
urinary aldosterone in this condition, for a time I was 
unable to detect free aldosterone in nephrotic urine 
during the peilod of albuminuria. As soon as the 
diuretic phase commenced and the albuminuria cleared- 
usually between the 10th - 14th day of steroid treatment - 
aldosterone was extract able in high norjiial amounts.
The fluorimeter.
In this instrument (Fig. 6 ) a mercury lamp is used 
as a source for excitation of fluorescence. The 
3650A^ line of the mercury spectrum is selected by 
means of the primary filter. The fluorescence light 
from the sample being tested is made into a parallel 
beam by a quartz lens and a secondary 5975A^ interference 
filter with a band width of 100 A*^  is interposed between 
the lens and a photomultiplier which measures the 
intensity of the fluorescent band. The resultant 
photoelectric current is directly proportional to 
the intensity of fluorescence. For maximum stability 
the photomultiplier is supplied from a highly stabilised 
EHT power supply. The mercury vapour lemp is supplied 
from /
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Fig. 6. Fluorimeter for measuring sodium 
fluorescence on paper.
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from a constant voltage transformer.
Linearity of Galvanometer readings.
The average paper blank reading routinely obtained 
was equivalent to 0.3 Pg* aldosterone. Signal to 
noise ratio of 4 to 1 were consistently obtained with 
a minimum of 0.5 pg. amounts, although galvanometer 
readings could be obtained for 0.1 pg. of aldosterone 
or its diacetate. Linearity was obtained from 0.5 Pg. 
to 3*5 pg. aldosterone but above this quenching caused 
flattening of the curves.
Radio-activity counting.
The specific activity of aliquots from the final 
extracts was counted for me by Dr. J.K. Grant in the 
Department of Steroid Biochemistry at the Royal 
Infirmary, Glasgow. The counting was done on a 
Tri-Garb Liquid Scintillation Spectrometer. With a 
gain setting of 50 per cent and full window, the efficiency 
for is 28 per cent on this instrument. A background 
rate of 24 o.p.m. is registered.
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Estimation of tetrehydroaldosterone 
in urine.
The method of Pasqualini, Eegrand and Jayle 
(1963) has been used without modification.
A suitable aliquot of urine is adjusted to pH 4.8 
using acetic acid/sodium acetate buffer (0.2 M ) . 
Sulphetase and p-glucuronidase are added to make 
the concentration of each 1500 units per ml. of urine. 
Hydrolysis is allowed to proceed for 48 hours and the 
liberated steroids extracted 3 times with 1 volume of 
dichloromethane• The extract is washed once with 
sodium carbonate (w/v - 1/20 vol.) and once with 
water (1/20 vol.) and then evaporated to dryness in a 
water bath at 40^0. The residue is then dissolved in 
dichloromethane (10 ml.) and adsorbed on to a Florisil 
column (20 g. activated by heating at 650^0 for 1-& 
hours). Elution from the column is in three phases;
80 ml. dichloromethane containing 2.5 per cent meth.anol; 
150 ml. dichloromethane containing 12 per cent methanol; 
and finally 80 ml. methanol.
Tetrahydroaldosterone is eluted in the 12 per 
cent methanol fraction which is evaporated to dryness 
and the residue spotted on a Whatman No. 1 chromatogram 
impregnated with formamide/acetone (30/70) as for 
aldosterone. As before standards of cortisone and 
hydro cortisone /
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hydrocortisone are spotted on the side lanes. After 
equilibration for 30 minutes the chromatogram is developed 
for 3 hours at 22^0 using chloroform saturated with 
formamide as the mobile phase. Tetrahydroaldosterone 
in this system has a mobility slightly less than that 
of hydrocortisone. From the leading front of hydrocortisone, 
a zone 2 cm. back to the origin is outlined and cut from 
uhe chromatogram. This is further cut into strips (1 cm. 
wide), and these are eluted t^ge :,her overnight 
in chloroform containing 30 per cent methanol.
The eluate is evaporated and the residue is applied 
to a strip (8 cm. wide with 1.5 cm. side lanes) of 
Whatman No. 1 paj.)er impregnated with formamide/acetone 
(40/60).
Hydrocortisone 2 pg. is applied to the side lanes.
After equilibration for 30 minutes it is developed 
5 hours in the system n-butyl acetate; formamide: 
water (50:10:10). Tetrahydroaldosterone in this system 
has a mobility of 0.45 times that of hydroc:)rtisone. A
zone is outlined between P. (hydroeortisone)
and cut from the chromatogram. This is eluted in
chloroform containing 30 per cent methanol overnight and 
evaporated to dryness.
Third Ghromatogram.
The residue is dissolved in water (10 ml.) and 
extracted /
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extracted 3 times with dichloromethane (10 ml.).
This removes the formamide eluted from the previous 
chromatogram. The dichloromethane is evaporated to 
dryness and a,pplied to a strip (2 cm. wide with 1.5 cm. 
side lanes) of Whatman No. 1 paper. The chromatogram 
is equilibrated for 3 hours and developed for 3 hours 
in the system isopropyl; methanol; water (2;1:1).
In this system tetrahydroaldosterone has a mobility 
of 0.8 times that of hydrocortisone. A zone is outlined
between Eg ( h y d r o c o r t i s o n e ) ® r e m o v e d
and eluted and evaporated to dryness.
Quantitation.
The dried residue, in a B 10 test tube, is 
dissolved in ethanol, (0.3 ml.) 0.5 per cent aqueous 
blue tétrazolium (0.1 ml.) and 1 per cent tétraméthyl­
ammonium hydroxide in ethanol (0.1 ml.) are added and 
the tubes incubated at room temperature for 0.5 hours. 
Glacia.l acetic acid (0.2 ml.) is added to each tube and 
the optical density of the samples read at 460, 510 
and 560 mp. The Allen formula is applied. Cortisone 
(0.5 pg. and 5 pg.) standards are treated similarly.
Standard tetrahydroaldosterone was not available 
for testing recovery rates but it was found that 
aldosterone from the Florisil column appeared in the 
3rd eluate.
5, /
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5, 10 and 15 pg* of aldosterone were put through the 
columns and after chromâtography the following 
recoveries were obtained.
Table .8. Recovery of aldosterone from Florisil 
columns and the 3 chromatograms of the
method.
Aldosterone
p g .
Recovery 
mean of 
(3 )  Pg.
i-
Recovery
5 (3) 3 .2 64
10 (3 ) 7 . 6 75
15 (3) 12 .1 80 .6
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Estimation of Urinary hydrocortisone, cortisone 
and their metabolites, tetrahydrocortisol (THF), 
allotetrahydrocortisol (allo-THF) and tetra- 
hydrocortisone (THE).
Urine (50 - 100 ml.) aliquots are hydrolysed and 
extracted as in the method for pregnanetriol (p. ).
The urine is then brought to pHl and the extract is 
quantitatively applied to a Zaffaroni chromatogram 
as prepared in the method for the estimation of free 
aldosterone (p./7^)» and developed for 3 hours in the 
solvent system chloroform/formamide.
Three zones are removed from the chromatogram
and eluated. Zone 1 corresponding to / .. .\0.2^ F (cortisol; .
to 0.45 containing tetrahydrocortisol (THF) and alio- 
tetrahydrocortisol (allo-THF); Zone 2 corresponding 
to standard hydrocortisone including 0,5 cm. on either 
side - this contains hydrocortisone and tetrahydrocortisone 
(THE); Zone 3 corresponding to cortisone.
The extract from each zone is quantitatively applied 
to separate lanes (1.6 cm.) of a chroinatogram (Whatman 
No. 1) using hydrocortisone and cortisone as standards 
and developed in the E^B system (isooctane, tert. 
butanal, water: 10: 5: 9) for 3 hours. Scanning 
of the Zaffaroni chromatogram under UV light (Hanovia 
lamp = 245 mv) gives an indication of the quantities 
of /
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of UV absorbing compounds present (particularly 
hydrocortisone and cortisone) thus allowing an 
appropriate aliquot ( 1 - 5  pi. containing 1 to 2 pg.
UV-absorbing material) to be applied to the lanes of 
the E^B chromatogram so that the fluorescence when 
developed will be within the sensitivity range of the 
fluorimeter. The appropriate strips containing 
hydrocortisone and cortisone are sprayed as indicated 
for aldosterone ( p. 176".) and the fluorescence measured 
against standard hydrocortisone and cortisone.
The areas containing tetrahydrocortisone (THE; 1.92), 
tetrahydrocortisol (THF; Rp 1.51), and allo-tetrahydro- 
cortisol (allo-THF; Rp 1.37) are cut out, eluted and 
quantitated by the micro-blue tétrazolium method (p.<&7*).
The actual areas for these latter 3 compounds are defined 
by comparison with a duplicate lane stained with blue 
tétrazolium. Recovery experiments using hydrocortisone 
and cortisone ga.ve recovery rates from 50 - 70 per cent 
(hydrocortisone mean 61.5 per cent; cortisone mean 
60 per cent).
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Table 9 . Recovery rates of hydrocortisone and
cortisone obtained by the method. 10 pg. 
of each added to urine before hydrolysis.
recovery pg.
Added ( p g . ) Hydrocortisone Cortisone
10 mg. 6.5 7.0
10 p g. 5.9 6.5
10 Pig. 6.2 5.5
10 Pg. 6.0 5.0
These recovery rates are better than 40 - 50 
per cent obtained by Harris and Crane (1964) but I am 
of the opinion that the improved recovery is related to 
the practice of effecting hydrolysis in an atmosphere 
of nitrogen. By so doing oxidative degradation of 
hydrocortisone, cortisone and their metabolites at 
pHl is reduced to a minimum.
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Hydrolysis of IT-oxosteroid conjugates and 
estimation of the extracted 17-oxosteroids 
after chromatographic separation.
Urine (100 ml.) is brought to pH4 with sulphuric 
acid. Ammonium sulphate (50 g.) is added and extraction 
of the steroid conjugates effected with ethyl acetate 
(300 ml.). The ethyl acetate is then evapo^'ated under 
a. stream of nitrogen. To the residue, ethyl acetate 
(100 ml.) containing 0.01 M perchloric acid is added, 
and hydrolysis allowed to proceed at room temper-'tu re 
for 3 hours. The ethyl acetate is then washed twice 
with 10/ potassium hydroxide (10 ml.), once with water 
(10 ml.) and thereafter evaporated under a stream of 
nitrogen. The residue is again tali en up in ethyl 
alcohol (3 ml.) containing 1 per cent potassium 
hydroxide to hydrolyse acetates formed during extraction. 
Hydrolysis is allowed to proceed at room temp6 2:'ature 
for 1 hour. After hydrolysis the alcohol is diluted 
with water (10 ml.) and the free compounds are then 
extracted with petroleum ether and benzene (2 x 20 ml.
1:1 v/v), and evaporated. This method is recommended 
by De Daoli, Nishizawa and Eik-Nes (1963) for the 
hydrolysis of both sulphates and glucuronides of 17- 
oxosteroids. The final extract obtained is sufficiently 
clean to allow application directly to the chromatogram 
without further purification.
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Separation of ll-deoxy-lT-oxosteroids.
This was done by the method of Morris (1959) 
as modified hy Hill (i960).
The extract is dissolved in a mixture of 
25 per cent (v/v) ethyl acetate in petroleum ether 
and applied to a column (1 cm. diameter) of silica 
gel (100 - 200 mesh, 2 g.). A volume of this solvent 
(20 ml.) is passed through the column and collected.
35 per cent ethyl acetate in petroleum ether (20 ml.) 
is then passed through and collected. Finally 
65 per cent ethyl acetate in petroleum ether (20 ml.) 
is used to elute ll-oxygenated-lT-oxosteroids. 'I'he 
eluates are evaporated to dryness in a stream of 
nitrogen and applied sej.a2?ately as required to the 
chromatograms. Androsterone appears in fraction 1 
and etiocholanolone in fraction 2.
Chromatographic separation.
The extracts are dissolved in ethyl alcohol (250 pi.) 
and 3 aliquots (5-50 pi.) are applied to 1.6 cm. lanes.
The remainder of the extract is oxidised with chromic 
acid (Kiliani reagent) and aliquots (5-50 pi.) are 
applied to 2, 1.6 cm. lanes. Similar quantities of 
uncolumned extract are spotted on 3, 1.6 cm. lanes. 
Desoxycorticosterone on the side lanes is used as a 
reference /
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reference standard. The chromatogram is then 
developed for 3 hours in the Bush 3 system (petroleum, 
ether, benzene, methanol, water; 33:17:40:10) at 
22°G.
Estimation of 17-oxosteroids 
on paper.
Test strips for each fraction are stained with 
Zimmermann reagent 2.5 N and sodium hydroxide. The 
a,ppropriate areas for etiocholanolone and androsterone 
are cut out and eluted. Testosterone and A.4-androstenedione 
fluoresce on paper and separate well on Bush 5 
(testosterone 0.95: A4"-androstenedione 1.45)
from uncolumned extracts. Their fluorescence is 
measured against corresponding standards.
Dehydroepiandrosterone occupies an intermediate position
(^DOG ) between testosterone and androstenedione
and an area corresponding to standard dehydroepiandrosterone
is cut out and eluted. Androsterone, etiocholanolone
and dehydroepiandrosterone are estimated by the
Zimmermann reaction.
Recovery. /
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Recovery.
From mixtures of the six 17-oxo steroids separated, 
and estimated in the above way the following recoveries 
were obtained. (Table 10),
Table 10 > Recovery of 6 , 17-oxosteroids from the Bush 1 
chromatogram. A4-3-ketones estimated by 
sodium fluorescence and 17-ketones by the 
Zimmermann reaction against dehydroepiandrosterone 
No correction made for the different chromo-
genicities.
Substance Spotted. pg* estimated.
A4-andr0 stenedione 2 1.8; 2.0 ;
1.7; 4.1; 3.5
Testosterone (3) 2 1*3; 2.0; 1.9
Andrenosterone (3) 2 1.7; 1.6; 1.9
Dehydroepiandrosterone (3) 10 8; 11; 8.3
Androsterone (3) 10 9; 9*2; 9
Etiocholanolone (3) 10 12; 10; 8.4
*( ) number of estimations.
In the chromatograms of the oxidised extracts for Case 4 
of Chapter 2 a Zimmermann positive spot appeared at 
R(-jPOq ) 3*07 which was not seen before oxidation. In 
Chapter 2 evidence is given that this compound may be 
androstane“17p“Ol-3-one.
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Other methods referred to in the text.
Determination of pregnenetriol,
The estimation of this compound was made during 
the investigation of Case 4 in Chaptei" 2.
Bongiovanni suggested (in personal communication) 
that the use of differential hydrolysis, first with 
P -glucuronidase followed hy solvolysis with extraction 
after each procedure would give an indication of the 
quantities of sulphate conjugates. In this particular 
case 3P j “hydroxy“A.5, and 3p, 21-dihydroxy-A-5 compounds 
appear in the urine in increased quantities.
Urine is therefore hydrolysed as for pregnenetriol, 
extracted (A) and then subjected to pHl hydrolysis, followed 
by further extraction (B). The residues from each 
extraction are reduced, then oxidised by Few's method a.nd 
estimated as 17-oxosteroids. The excess of 17-oxosteroids 
in extract B over extract A is taken to represent 
pregnenetriol.
Oxidation /
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Oxidation by Kiliani reagent (Kiliani
and Mark, 1901).
Kiliani reagent (5 pi.) is added to the steroid
sample dissolved in acetone (0.5 ml.). The mixture
is allowed to stand at room temperature for 20 minutes.
Water (2.5 ml.) is then added and the steroids
recovered by extraction with benzene/chloroform
(6:1 v/v 2 X 2 ml.).
Solvents.
Absolute ethanol (Burroughs) and h-heptane (B D H ) 
were used without purification. Acetone and formamide 
were likewise used as supplied by British Drug Houses Ltd., 
Poole. Ethyl ether was rendered peroxide free. All other 
solvents were A.H. specification and were redistilled.
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